Uncategorized
TCS to Provide Industry-Leading Navigation, Integrated Maps and Software Components
ANNAPOLIS, Md., July 27, 2012 /PRNewswire/ — TeleCommunication Systems, Inc. (TCS) (NASDAQ: TSYS), a world leader in highly reliable and secure mobile communication technology, today announced that it has been selected by a global phone manufacturer to deliver an integrated maps, local search and navigation application featuring real-time traffic and other premium content, along with software components for use by third-party developers to enable location-based services. The agreement marks the first time that TCS’ navigation platform will be a standard feature of a device manufacturer’s offering.
The collaboration with the manufacturer underlines the importance of location and maps as a core feature for mobile devices, and will further enhance the customer experience.
News Facts:
- TCS’ navigation application will be available on the manufacturer’s handsets for customers in markets around the world.
- TCS will develop the customer-branded navigation application and provide associated services.
- With the touch of a button, end users will be empowered to easily search for businesses, points of interest, movie and event information and to navigate to a selected place taking into account real-time traffic conditions.
- The TCS-provided software components will be available to all software developers through API’s, providing developers with easy-to-use and powerful functions to incorporate maps and a range of location-aware content into their applications.
Supporting Quote:
- Jay Whitehurst, senior vice president, Commercial Software Group, TCS, said, “Mobile device manufacturers recognize the value of adding navigation and LBS-based components as an integral part of their offerings, and TCS has been selected for its end-to-end solution, which greatly enhances the performance and ease of use for application developers and end users.”
Supporting Resources:
- TCS Navigation Solutions: http://www.telecomsys.com/products/navigation-telematics/Commercial-solutions.aspx
TCS is a global leader in high-reliability location-based services. It provides complete, end-to-end wireless LBS solutions that include branded and private-label applications, infrastructure, mapping, and content for leading consumer brands, content providers, voice service providers and more than 60 commercial customers worldwide. TCS provided the world’s first wireless location platform, and it is the industry’s leading provider of LBS infrastructure. Using innovative mobile cloud computing services, TCS offers top revenue-producing applications for navigation, hyper-local search, workforce tracking and family locators. For more information on TCS LBS services, visit www.telecomsys.com/LBS.
About TeleCommunication Systems, Inc.
TeleCommunication Systems, Inc. (TCS) (NASDAQ: TSYS) is a world leader in highly reliable and secure mobile communication technology. TCS infrastructure forms the foundation for market leading solutions in E9-1-1, text messaging, commercial location and deployable wireless communications. TCS is at the forefront of new secure multi-media communications, and mobile cloud computing services providing wireless applications for navigation, hyper-local search, asset tracking, social applications and telematics. Millions of consumers around the world use TCS wireless apps as a fundamental part of their daily lives. Government agencies utilize TCS’ cyber security expertise, professional services and highly secure deployable satellite solutions for mission-critical communications. Headquartered in Annapolis, MD, TCS maintains technical, service and sales offices around the world. To learn more about emerging and innovative wireless technologies, visit http://www.telecomsys.com.
Except for the historical information contained herein, this news release contains forward-looking statements as defined within Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. These statements are subject to risks and uncertainties and are based upon TCS’ current expectations and assumptions that if incorrect would cause actual results to differ materially from those anticipated. Risks include without limitation those detailed from time to time in the Company’s SEC reports, including the annual report on Form 10-K for the year ended December 31, 2011 and on Form 10-Q for the quarter ended March 31, 2012.
Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to update or revise the information in this press release, whether as a result of new information, future events or circumstances, or otherwise.
(Logo: http://photos.prnewswire.com/prnh/20120503/PH99996LOGO )
|
Company Contact:
|
Media Contact:
|
Investor Relations:
|
|
TeleCommunication Systems, Inc.
|
Nadel Phelan, Inc.
|
Liolios Group, Inc.
|
|
Meredith Allen
|
Graham Sorkin
|
Scott Liolios
|
|
410-295-1865
|
831-440-2406
|
949-574-3860
|
|
MAllen@telecomsys.com
|
graham@nadelphelan.com
|
info@liolios.com
|
SOURCE TeleCommunication Systems, Inc.
FREMONT, CA — (Marketwire) — 07/26/12 — Mattson Technology, Inc. (NASDAQ: MTSN), a leading supplier of advanced process equipment used to manufacture semiconductors, today announced results for the second quarter of 2012 ended July 1, 2012.
2012 Second Quarter Highlights:
- Net loss for the second quarter of 2012 was $3.3 million, or a $0.06 net loss per share. This compares with a net loss of $1.1 million or a $0.02 net loss per share in the first quarter. Excluding restructuring charges of $0.8 million, non-GAAP net loss per share was $0.04 in the second quarter, compared to the non-GAAP net loss per share of $0.01in the first quarter, excluding restructuring charges of $0.7 million.
- Gross margins were 38 percent for the second quarter of 2012, compared to 34 percent in the prior quarter. The increase in gross margin was primarily due to a favorable change in net sales deferrals as well as an increase of higher margin net sales of thermal systems and spares.
- As a result of our cost reduction efforts, total operating expenses decreased $1.9 million to $16.3 million for the second quarter of 2012, compared to $18.2 million in the prior quarter. Excluding restructuring charges, non-GAAP operating expenses decreased by $2.0 million to $15.5 million for the second quarter of 2012 from $17.5 million in the prior quarter.
- At July 1, 2012, working capital was $55.2 million, with cash, cash equivalents, and restricted cash of $30.7 million and no debt. The decrease in cash during the quarter of $6.7 million was primarily due to increased inventory of $5.8 million, which was principally the result of a customer requested delay in the shipment of systems during the quarter.
David L. Dutton, Mattson Technology’s president and chief executive officer, commented, “As previously announced on July 10, primarily due to a request from a foundry customer to delay the shipment of systems, net sales for the second quarter were lower than expected at $34.9 million, a decrease of 31 percent from $50.5 million in the first quarter. As we previously reported, we also experienced the NAND business softening during the second quarter. We are addressing the near term weakness in our sector by focusing on additional cost reductions and incremental revenue opportunities. We have invested in leading technology and low cost of ownership product offerings that are currently positioned in major customers that we believe will over time lead to share gains, particularly in the etch and rapid thermal processing markets.”
Dutton continued, “We expect to continue to be challenged with significantly lower net sales in the second half of 2012. We are continuing to focus on cost reduction activities and are seeking to reduce our cash flow break-even point to the mid-$30 million quarterly net sales run rate by the end of 2012. We are also continuing our efforts to secure asset based financing. We believe these measures will provide us with adequate liquidity to address our working capital needs.”
Second Quarter 2012 Financial Results
Second quarter 2012 net sales of $34.9 million decreased $15.6 million, or 31 percent, compared with $50.5 million in the first quarter of 2012, and decreased $16.4 million, or 32 percent, compared with $51.3 million in the second quarter of 2011. Gross margin for the second quarter of 2012 was 38 percent as compared to 34 percent in the first quarter of 2012, and represents an eleven-point increase over the 27 percent gross margin in the second quarter of 2011.
Total operating expenses were $16.3 million for the second quarter of 2012, a decrease of $1.9 million compared to the first quarter of 2012. Excluding restructuring charges, non-GAAP operating expenses were $15.5 million in the second quarter of 2012, a $2.0 million decrease compared with $17.5 million in the first quarter of 2012, and a $2.5 million decrease compared with $18.0 million in the second quarter of 2011.
Net loss for the second quarter of 2012 was $3.3 million, or a $0.06 net loss per share. This compares with a net loss of $1.1 million, or a $0.02 net loss per share, in the first quarter of 2012, and a net loss of $5.2 million, or a $0.10 net loss per share, reported in the second quarter of 2011. Excluding restructuring charges, the non-GAAP net loss per share in the second quarter of 2012 was $0.04 as compared to a non-GAAP net loss per share of $0.01 in the first quarter of 2012.
Conference Call
On Thursday, July 26, 2012, at 3:00 p.m. Pacific Time (6:00 p.m. Eastern Time), Mattson Technology will hold a conference call to review the following topics: 2012 second quarter financial results, current business conditions, the near-term business outlook and guidance for the third quarter of 2012. The conference call will be simultaneously webcast at www.mattson.com under the Investors section. In addition to the live webcast, a replay will be available to the public on the Mattson Technology website for one week following the live broadcast. To access the live conference call, please dial (970) 315-0417.
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995:
This news release contains forward-looking statements regarding the Company’s future prospects and plans, including, but not limited to: increases in our market share in certain markets, reduction of costs to a cash flow break-even point, our ability to secure asset based financing and our ability to address our working capital needs. Forward-looking statements address matters that are subject to a number of risks and uncertainties that can cause actual results to differ materially. Such risks and uncertainties include, but are not limited to: the slowdown in NAND sales and delay in shipment to certain foundry customers; the Company’s expectations with respect to continued growth of its business; growth of the industry and the size of the Company’s served available market; the timing of significant customer orders for the Company’s products; customer acceptance of delivered products and the Company’s ability to collect amounts due upon shipment and upon acceptance; the Company’s cash position overall, especially as a result of payments made for inventory and the related collections upon shipment of such inventory; end-user demand for semiconductors, including the growing mobility electronics industry; customer demand for semiconductor manufacturing equipment; the Company’s ability to timely manufacture, deliver and support ordered products; the Company’s ability to bring new products to market, to gain market share with such products and the overall mix of the Company’s products; customer rate of adoption of new technologies; risks inherent in the development of complex technology; the timing and competitiveness of new product releases by the Company’s competitors; the Company’s ability to align its cost structure with market conditions; and other risks and uncertainties described in the Company’s Forms 10-K, 10-Q and other filings with the Securities and Exchange Commission. The Company assumes no obligation to update the information provided in this news release.
About Mattson Technology, Inc.
Mattson Technology, Inc. designs, manufactures and markets semiconductor wafer processing equipment used in the fabrication of integrated circuits. We are a leading supplier of plasma and rapid thermal processing equipment to the global semiconductor industry, and operate in three primary product sectors: dry strip, rapid thermal processing and etch. Through manufacturing and design innovation, we have produced technologically advanced systems that provide productive and cost-effective solutions for customers fabricating current and next-generation semiconductor devices. For more information, please contact Mattson Technology, Inc., 47131 Bayside Parkway, Fremont, CA, 94538. Telephone: (800) MATTSON/(510) 657-5900. Internet: www.mattson.com.
MATTSON TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except per share amounts)
Three Months Ended Six Months Ended
-------------------- --------------------
July 1, July 3, July 1, July 3,
2012 2011 2012 2011
--------- --------- --------- ---------
Net sales $ 34,884 $ 51,259 $ 85,388 $ 98,308
Cost of sales 21,629 37,275 55,199 71,443
--------- --------- --------- ---------
Gross profit 13,255 13,984 30,189 26,865
--------- --------- --------- ---------
Operating expenses:
Research, development and
engineering 5,791 6,645 12,421 13,160
Selling, general and
administrative 9,705 11,380 20,572 22,892
Restructuring charges 831 (13) 1,551 (78)
--------- --------- --------- ---------
Total operating expenses 16,327 18,012 34,544 35,974
--------- --------- --------- ---------
Loss from operations (3,072) (4,028) (4,355) (9,109)
Interest income (expense), net 39 58 70 37
Other income (expense), net (277) (969) 105 (2,475)
--------- --------- --------- ---------
Loss before income taxes (3,310) (4,939) (4,180) (11,547)
Provision for (benefit from)
income taxes 36 274 285 (60)
--------- --------- --------- ---------
Net loss $ (3,346) $ (5,213) $ (4,465) $ (11,487)
========= ========= ========= =========
Net loss per share:
Basic and diluted $ (0.06) $ (0.10) $ (0.08) $ (0.22)
Shares used in computing net
loss per share:
Basic and diluted 58,507 54,550 58,463 52,395
MATTSON TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)
July 1, December 31,
2012 2011
------------ ------------
ASSETS
Current assets:
Cash and cash equivalents $ 28,870 $ 31,073
Restricted cash 1,877 1,877
Accounts receivable, net of allowance for
doubtful accounts of $619 as of July 1, 2012
and $684 as of December 31, 2011 19,028 25,278
Advance billings 2,418 5,071
Inventories 36,581 29,203
Prepaid expenses and other current assets 6,783 9,024
----------- -----------
Total current assets 95,557 101,526
Property and equipment, net 7,687 10,552
Intangibles, net 625 750
Other assets 740 1,015
----------- -----------
Total assets $ 104,609 $ 113,843
=========== ===========
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 15,494 $ 16,785
Deferred revenue-current 9,982 12,117
Other current liabilities 14,842 16,447
----------- -----------
Total current liabilities 40,318 45,349
Deferred revenues, non-current 3,499 3,158
Other long-term liabilities 4,182 5,191
----------- -----------
Total liabilities 47,999 53,698
----------- -----------
Commitments and contingencies
Stockholders' equity:
Preferred stock, 2,000 shares authorized; none
issued and outstanding - -
Common stock, par value $0.001, 120,000 shares
authorized; 62,744 shares issued and 58,654
shares outstanding as of July 1, 2012; and
62,547 shares issued and 58,366 shares
outstanding as of December 31, 2011 63 63
Additional paid-in capital 651,110 650,110
Accumulated other comprehensive income 20,402 20,472
Treasury stock, 4,181 shares as of July 1, 2012
and December 31, 2011 (37,986) (37,986)
Accumulated deficit (576,979) (572,514)
----------- -----------
Total stockholders' equity 56,610 60,145
----------- -----------
Total liabilities and stockholders' equity $ 104,609 $ 113,843
=========== ===========
Mattson Technology Contact
J. Michael Dodson
Mattson Technology, Inc.
tel 1-510-657-5900
fax 1-510-492-5963
26% sequential increase in quarterly revenues Total customer count increases to over 6,600 Strengthened financial position with $12 million growth debt financing
SUNNYVALE, Calif., July 26, 2012 /PRNewswire/ — Meru Networks Inc., (NASDAQ:MERU), a leader in virtualized 802.11 enterprise wireless networking, today announced its financial results for the quarter ended June 30, 2012.
(Logo: http://photos.prnewswire.com/prnh/20100621/SF23611LOGO)
Second Quarter 2012 Financial Results
Total revenues for the second quarter of 2012 were $24.5 million, up 5% from $23.2 million in the second quarter of 2011. Total product and service revenues (excluding ratable revenues) for the second quarter of 2012 were also $24.5 million, up 10% from $22.1 million in the second quarter of 2011. Products revenues for the second quarter of 2012 were $20.3 million, up 7% from the $19.0 million reported in the second quarter of 2011.
Net loss as reported in accordance with U.S. generally accepted accounting principles (GAAP) was $6.5 million for the second quarter of 2012, or a net loss of $0.36 per basic and diluted share, compared to net loss of $9.8 million, or $0.56 loss per basic and diluted share, for the same period of 2011.
Meru reported second quarter fiscal year 2012 non-GAAP net loss of $4.6 million, or a net loss of $0.26 per basic and diluted share, compared to non-GAAP net loss of $0.9 million, or $0.05 loss per basic and diluted share, for the same period of fiscal year 2011. Non-GAAP results for the second quarter of 2012 exclude the impact of stock-based compensation expense of $1.8 million and amortization of acquisition-related intangibles of $0.1 million. Non-GAAP results for the second quarter of 2011 exclude the impact of stock-based compensation expense of $1.6 million, and a litigation reserve expense of $7.3 million. Please refer to the reconciliation of Meru’s GAAP to non-GAAP results provided at the end of this release.
“We are very pleased with our execution in the second quarter, achieving the highest revenue in the company’s history and exceeding the financial goals that we set three months ago. We continue to remain extremely focused on executing in our key markets and improving the efficiency of our business as we optimize our cost structure and drive towards our goals of growth and profitability over the next several quarters,” said Dr. Bami Bastani, president and chief executive officer, Meru Networks.
Second Quarter Business Highlights
- Strengthened financial position with $12 million growth capital debt financing
- Grew customer count to over 6,600, adding more than 400 customers worldwide
- Notable key customer wins and deployments during the quarter include:
- One of the largest further education colleges in the UK and Ireland
- A large hospitality reseller for one of the world’s largest hotel chains
- A major US university expanded its existing Meru deployment
- A large public school district in Florida selected Meru to replace its legacy micro cell WLAN
- A large US hospital expanded its existing Meru deployment for its new tower
- A top 10 University in China with approximately 35,000 students
- A large Japanese electronics company chose Meru for 26 of its warehouses
- A Saudi Arabian Hospital selected Meru technology to displace its legacy micro cell WLAN
- New product announcements include:
- Availability of Identity Manager, the industry’s first integrated Bring-Your-Own-Device (BYOD) provisioning and guest access solution with Property Management System (PMS) capabilities
Conference Call Information
Meru will host a conference call for analysts and investors to discuss its second quarter results, today, July 26 at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). To join the live call, please dial (877) 852-2926 (domestic) and (253) 237-1123 (international) and reference conference ID 99997712.
A telephone replay will be available two hours following the conclusion of the call for a period of 7 days and can be accessed by dialing (855) 859-2056 for domestic callers and (404) 537-3406 for international callers. The call ID for the replay is 99997712. The live and archived webcast of the second quarter 2012 financial results conference call will also be available at the investor relations section of Meru’s website at http://investors.merunetworks.com.
About Meru Networks, Inc.
Meru Networks (NASDAQ: MERU) designs, develops, and distributes virtualized wireless LAN solutions that provide enterprises with the performance, reliability, predictability and operational simplicity of a wired network with the advantages of mobility. Meru Networks eliminates the deficiencies of multichannel, client-controlled architectures with its innovative, single-channel, virtualized network architecture that easily handles device density and diversity. Meru wireless LAN solutions are deployed in major vertical industries including Fortune 500 businesses, education, hospitality, healthcare and retail supply chain. Founded in 2002, Meru is headquartered in Sunnyvale, Calif., with operations in North America, Europe, the Middle East and Asia Pacific. Visit www.merunetworks.com or call (408) 215-5300 for more information.
Cautionary Statement Regarding Forward Looking Statements
This press release contains forward-looking statements and information. All statements other than statements of historical facts that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements. Such statements include, but are not limited to, those statements regarding the company’s belief regarding its ability to execute in its key markets, improve the efficiency of its business, optimize its cost structure and drive towards its goals of growth and profitability. We have identified some of these forward-looking statements with words like “believe,” “may,” “will,” “should,” “expect,” “intend,” “plan,” “predict,” “anticipate,” “estimate” or “continue” and other words and terms of similar meaning. These forward-looking statements involve risks and uncertainties, including risks related to product and executive transitions, that may further affect future operating periods. These forward-looking statements also involve assumptions that, if they do not fully materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The risks and uncertainties that could cause our results to differ materially from those expressed or implied by such forward-looking statements include our ability to react to trends and challenges in our business and the markets in which we operate; our ability to anticipate market needs and performance requirements or develop new or enhanced products to meet those needs and requirements; the adoption rate of our products; our ability to establish and maintain successful relationships with our distribution partners; our ability to compete in our industry; fluctuations in demand, sales cycles and prices for our products and services; shortages or price fluctuations in our supply chain; our ability to protect our intellectual property rights; general political, economic and market conditions and events, including lengthening sales cycles, primarily for domestic education customers; and other risks and uncertainties described more fully in our documents filed with or furnished to the Securities and Exchange Commission (“SEC”). More information about these and other risks that may impact Meru Networks’ business are set forth in our Quarterly Report on Form 10-Q filed with the SEC on May 4, 2012, as well as subsequent reports filed with the SEC. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we assume no obligation to update these forward-looking statements.
Non-GAAP Financial Measurements
In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Meru reports non-GAAP net income (loss),and non-GAAP income (loss) from operations which both exclude stock-based compensation expense, amortization of intangible assets related to the company’s acquisition of Identity Networks in the third fiscal quarter of 2011, chief executive officer transition costs, amortization of common stock warrants issued in connection with debt financing and other items outside the ordinary course of business such as litigation reserves expense. Meru believes that its non-GAAP net income (loss) and non-GAAP income (loss) from operations provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. Meru also believes the non-GAAP measures provide useful supplemental information for investors to evaluate its operating results in the same manner as the research analysts that follow Meru, all of whom will present non-GAAP projections in their published reports. As such, the non-GAAP measures provided by Meru facilitate a more direct comparison of its performance with the financial projections published by the analysts as well as its competitors, many of whom report financial results on a non-GAAP basis. The economic substance behind Meru’s decision to use such non-GAAP measures is that such measures approximate its controllable operating performance more closely than the most directly comparable GAAP financial measures. For example, Meru’s management has no control over certain variables that have a major influence in the determination of stock-based compensation such as the volatility of its stock price and changing interest rates. In addition, Meru’s management does not consider the amortization of intangible assets related to the company’s acquisition of Identity Networks relevant when comparing its performance to prior periods. Meru believes that all of these excluded expenses do not accurately reflect the underlying performance of its continuing operations for the period in which they are incurred, even though these excluded items may be incurred and reflected in Meru’s GAAP financial results.
The material limitation associated with the use of non-GAAP financial measures is that the non-GAAP measures may not reflect the full economic impact of Meru’s activities. Meru’s non-GAAP measures may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, investors are cautioned not to place undue reliance on non-GAAP information.
|
MERU NETWORKS, INC.
|
|
Condensed Consolidated Balance Sheets
|
|
(Unaudited)
|
|
(In thousands)
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
December 31,
|
|
|
|
2012
|
|
2011
|
|
ASSETS
|
|
|
|
|
CURRENT ASSETS:
|
|
|
|
|
Cash and cash equivalents
|
$ 30,430
|
|
$ 35,259
|
|
Short-term investments
|
–
|
|
5,000
|
|
Accounts receivable, net
|
12,271
|
|
13,038
|
|
Inventory
|
7,629
|
|
6,548
|
|
Deferred inventory costs, current portion
|
52
|
|
86
|
|
Prepaid expenses and other current assets
|
1,321
|
|
912
|
|
Total current assets
|
51,703
|
|
60,843
|
|
|
|
|
|
|
|
Property and equipment, net
|
2,107
|
|
1,476
|
|
Goodwill
|
1,658
|
|
1,658
|
|
Intangible assets, net
|
548
|
|
693
|
|
Deferred inventory costs, net of current portion
|
4
|
|
26
|
|
Other assets
|
2,169
|
|
2,147
|
|
TOTAL ASSETS
|
$ 58,189
|
|
$ 66,843
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
CURRENT LIABILITIES:
|
|
|
|
|
Accounts payable
|
$ 4,268
|
|
$ 5,733
|
|
Accrued liabilities
|
11,086
|
|
12,394
|
|
Long-term debt, current portion
|
2,979
|
|
–
|
|
Deferred revenue, current portion
|
10,347
|
|
11,764
|
|
|
Total current liabilities
|
28,680
|
|
29,891
|
|
|
|
|
|
|
|
Long-term debt, net of current portion
|
8,148
|
|
–
|
|
Deferred revenue, net of current portion
|
5,279
|
|
4,481
|
|
Other long-term liabilities
|
69
|
|
–
|
|
|
Total liabilities
|
42,176
|
|
34,372
|
|
|
|
|
|
|
|
STOCKHOLDERS’ EQUITY:
|
|
|
|
|
Preferred stock
|
–
|
|
–
|
|
Common stock
|
9
|
|
9
|
|
Additional paid-in capital
|
259,197
|
|
254,576
|
|
Accumulated other comprehensive loss
|
(317)
|
|
(197)
|
|
Accumulated deficit
|
(242,876)
|
|
(221,917)
|
|
|
Total stockholders’ equity
|
16,013
|
|
32,471
|
|
|
|
|
|
|
|
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
|
$ 58,189
|
|
$ 66,843
|
|
|
|
|
|
|
|
MERU NETWORKS, INC.
|
|
Condensed Consolidated Statements of Operations
|
|
(Unaudited)
|
|
(In thousands, except for share and per share amounts)
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Six months ended
|
|
June 30,
|
|
June 30,
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
REVENUES:
|
|
|
|
|
|
|
|
|
Products
|
$ 20,296
|
|
$ 19,015
|
|
$ 36,099
|
|
$ 34,455
|
|
Support and services
|
4,161
|
|
3,120
|
|
7,719
|
|
6,260
|
|
Ratable products and services
|
42
|
|
1,094
|
|
92
|
|
2,665
|
|
Total revenues
|
24,499
|
|
23,229
|
|
43,910
|
|
43,380
|
|
|
|
|
|
|
|
|
|
COSTS OF REVENUES:
|
|
|
|
|
|
|
|
|
Products
|
7,146
|
|
6,664
|
|
12,600
|
|
12,375
|
|
Support and services
|
1,518
|
|
1,043
|
|
2,973
|
|
1,940
|
|
Ratable products and services
|
24
|
|
639
|
|
55
|
|
1,491
|
|
Total costs of revenues *
|
8,688
|
|
8,346
|
|
15,628
|
|
15,806
|
|
|
|
|
|
|
|
|
|
Gross margin
|
15,811
|
|
14,883
|
|
28,282
|
|
27,574
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES:
|
|
|
|
|
|
|
|
|
Research and development *
|
3,668
|
|
3,393
|
|
7,539
|
|
6,815
|
|
Sales and marketing *
|
14,979
|
|
10,445
|
|
30,553
|
|
20,057
|
|
General and administrative *
|
3,200
|
|
3,426
|
|
8,233
|
|
6,344
|
|
Litigation reserve
|
–
|
|
7,250
|
|
2,350
|
|
7,250
|
|
Total operating expenses
|
21,847
|
|
24,514
|
|
48,675
|
|
40,466
|
|
|
|
|
|
|
|
|
|
Loss from operations
|
(6,036)
|
|
(9,631)
|
|
(20,393)
|
|
(12,892)
|
|
|
|
|
|
|
|
|
|
Interest expense, net *
|
(260)
|
|
(62)
|
|
(289)
|
|
(154)
|
|
Other income (expense), net
|
(14)
|
|
13
|
|
14
|
|
68
|
|
Loss before provision for income taxes
|
(6,310)
|
|
(9,680)
|
|
(20,668)
|
|
(12,978)
|
|
|
|
|
|
|
|
|
|
Provision for income taxes
|
162
|
|
86
|
|
291
|
|
163
|
|
Net loss
|
$ (6,472)
|
|
$ (9,766)
|
|
$ (20,959)
|
|
$ (13,141)
|
|
|
|
|
|
|
|
|
|
Net loss per share of common stock, basic and diluted
|
$ (0.36)
|
|
$ (0.56)
|
|
$ (1.18)
|
|
$ (0.76)
|
|
|
|
|
|
|
|
|
|
Shares used in computing net loss per share of common stock, basic and diluted
|
17,845,376
|
|
17,393,322
|
|
17,773,251
|
|
17,183,907
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
*Includes stock-based compensation expense as follows:
|
|
|
|
|
|
|
|
|
Costs of revenues
|
$ 82
|
|
$ 97
|
|
$ 178
|
|
$ 163
|
|
Research and development
|
254
|
|
264
|
|
609
|
|
542
|
|
Sales and marketing
|
683
|
|
532
|
|
1,538
|
|
951
|
|
General and administrative
|
770
|
|
678
|
|
1,696
|
|
1,279
|
|
$ 1,789
|
|
$ 1,571
|
|
$ 4,021
|
|
$ 2,935
|
|
|
|
|
|
|
|
|
|
*Includes amortization of acquisition-related intangible assets as follows:
|
|
|
|
|
|
|
|
|
Costs of revenues
|
$ 53
|
|
$ –
|
|
$ 105
|
|
$ –
|
|
Sales and marketing
|
20
|
|
–
|
|
40
|
|
–
|
|
$ 73
|
|
$ –
|
|
$ 145
|
|
$ –
|
|
|
|
|
|
|
|
|
|
*Includes chief executive officer transition costs as follows:
|
|
|
|
|
|
|
|
|
General and administrative
|
$ –
|
|
$ –
|
|
$ 911
|
|
$ –
|
|
|
|
|
|
|
|
|
|
*Includes amortization of common stock warrant issued in connection with debt financing as follows:
|
|
|
|
|
|
|
|
|
Interest expense, net
|
$ 16
|
|
$ –
|
|
$ 16
|
|
$ –
|
|
|
|
|
|
|
|
|
|
MERU NETWORKS, INC.
|
|
GAAP to Non-GAAP Reconciliation
|
|
(Unaudited)
|
|
(In thousands, except share and per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Six months ended
|
|
|
June 30,
|
|
June 30,
|
|
|
2012
|
|
2011
|
|
2011
|
|
2010
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss
|
$ (6,472)
|
|
$ (9,766)
|
|
$ (20,959)
|
|
$ (13,141)
|
|
|
|
.
|
|
|
|
.
|
|
|
Plus:
|
|
|
|
|
|
|
|
|
a) Stock-based compensation
|
1,789
|
|
1,571
|
|
4,021
|
|
2,935
|
|
b) Litigation reserve
|
–
|
|
7,250
|
|
2,350
|
|
7,250
|
|
c) Amortization of acquisition-related intangible assets
|
73
|
|
–
|
|
145
|
|
–
|
|
d) Chief executive officer transition costs
|
–
|
|
–
|
|
911
|
|
–
|
|
e) Amortization of common stock warrant issued in connection with debt financing
|
16
|
|
–
|
|
16
|
|
–
|
|
Non-GAAP net loss
|
$ (4,594)
|
|
$ (945)
|
|
$ (13,516)
|
|
$ (2,956)
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss per share of common stock, basic
|
(0.36)
|
|
$ (0.56)
|
|
$ (1.18)
|
|
$ (0.76)
|
|
|
|
|
|
|
|
|
|
|
Plus:
|
|
|
|
|
|
|
|
|
a) Stock-based compensation
|
0.10
|
|
0.09
|
|
0.23
|
|
0.17
|
|
b) Litigation reserve
|
|
|
0.42
|
|
0.13
|
|
0.42
|
|
c) Amortization of acquisition-related intangible assets
|
–
|
|
–
|
|
0.01
|
|
–
|
|
d) Chief executive officer transition costs
|
–
|
|
|
|
0.05
|
|
–
|
|
e) Amortization of common stock warrant issued in connection with debt financing
|
–
|
|
–
|
|
–
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net loss per share of common stock, basic and diluted
|
$ (0.26)
|
|
$ (0.05)
|
|
$ (0.76)
|
|
$ (0.17)
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing basic and diluted non-GAAP net loss
|
|
|
|
|
|
|
|
|
per share of common stock
|
17,845,376
|
|
17,393,322
|
|
17,773,251
|
|
17,183,907
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP loss from operations
|
$ (6,036)
|
|
$ (9,631)
|
|
$ (20,393)
|
|
$ (12,892)
|
|
|
|
|
|
|
|
|
|
|
Plus stock-based compensation:
|
|
|
|
|
|
|
|
|
Costs of revenues
|
$ 82
|
|
$ 97
|
|
$ 178
|
|
$ 163
|
|
Research and development
|
254
|
|
264
|
|
609
|
|
542
|
|
Sales and marketing
|
683
|
|
532
|
|
1,538
|
|
951
|
|
General and administrative
|
770
|
|
678
|
|
1,696
|
|
1,279
|
|
|
1,789
|
|
1,571
|
|
4,021
|
|
2,935
|
|
|
|
|
|
|
|
|
|
|
Litigation reserve
|
–
|
|
7,250
|
|
2,350
|
|
7,250
|
|
Amortization of acquisition-related intangible assets
|
73
|
|
–
|
|
145
|
|
–
|
|
Chief executive officer transition costs
|
–
|
|
–
|
|
911
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP loss from operations
|
$ (4,174)
|
|
$ (810)
|
|
$ (12,966)
|
|
$ (2,707)
|
|
MERU NETWORKS, INC.
|
|
Condensed Consolidated Statements of Cash Flows
|
|
(Unaudited)
|
|
(In thousands)
|
|
|
Six months ended
|
|
June 30,
|
|
2012
|
|
2011
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
Net loss
|
$(20,959)
|
|
$(13,141)
|
|
|
|
|
|
Adjustments to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
Depreciation and amortization
|
585
|
|
291
|
|
|
Stock-based compensation
|
4,021
|
|
2,935
|
|
|
Accrued interest on long-term debt
|
165
|
|
–
|
|
|
Amortization of issuance costs
|
22
|
|
44
|
|
|
Bad debt expense
|
49
|
|
9
|
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
Accounts receivable, net
|
717
|
|
(906)
|
|
|
|
Inventory
|
(1,081)
|
|
(577)
|
|
|
|
Deferred inventory costs
|
56
|
|
961
|
|
|
|
Prepaid expenses and other assets
|
(517)
|
|
78
|
|
|
|
Accounts payable
|
(1,465)
|
|
(149)
|
|
|
|
Accrued liabilities
|
(1,370)
|
|
(1,648)
|
|
|
|
Litigation reserve
|
–
|
|
7,250
|
|
|
|
Deferred revenue
|
(619)
|
|
(3,369)
|
|
|
|
|
|
Net cash used in operating activities
|
(20,396)
|
|
(8,222)
|
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
Purchases of property and equipment
|
(1,110)
|
|
(506)
|
|
Purchases of short-term investments
|
–
|
|
(4,997)
|
|
Proceeds from maturities of short-term investments
|
5,000
|
|
5,000
|
|
|
|
|
|
Net cash provided by (used in) investing activities
|
3,890
|
|
(503)
|
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
Proceeds from long-term debt, net of issuance costs
|
11,489
|
|
–
|
|
Proceeds from issuance of common stock
|
5
|
|
1,991
|
|
Proceeds from employee stock purchase plan
|
279
|
|
844
|
|
Taxes paid related to net share settlement of equity awards
|
(71)
|
|
–
|
|
Repayment of long-term debt
|
–
|
|
(2,852)
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
11,702
|
|
(17)
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
(25)
|
|
24
|
|
|
NET DECREASE IN CASH AND CASH EQUIVALENTS
|
(4,829)
|
|
(8,718)
|
|
|
CASH AND CASH EQUIVALENTS — Beginning of period
|
35,259
|
|
62,270
|
|
|
CASH AND CASH EQUIVALENTS — End of period
|
$ 30,430
|
|
$ 53,552
|
Use of Non-GAAP Financial Information
In addition to the reasons stated above, which are generally applicable to each of the items Meru excludes from its non-GAAP financial measures, the company believes it is appropriate to exclude certain items for the following reasons:
Stock-Based Compensation. When evaluating the performance of its consolidated results, Meru does not consider stock-based compensation charges. Likewise, the Meru management team excludes stock-based compensation expense from its operating plans. In contrast, the Meru management team is held accountable for cash-based compensation and such amounts are included in its operating plans. Further, when considering the impact of equity award grants, Meru places a greater emphasis on overall stockholder dilution rather than the accounting charges associated with such grants. Meru believes it is useful to provide a non-GAAP financial measure that excludes stock-based compensation in order to better understand the long-term performance of its business.
Amortization of intangible assets. The company excludes amortization of acquired intangible assets because it is non-cash in nature and because the company believes that the non-GAAP financial measures excluding this item provide meaningful supplemental information regarding operational performance and liquidity. In addition, excluding this item from various non-GAAP measures facilitates internal comparisons to historical operating results and comparisons to competitors’ operating results.
Chief Executive Officer transition costs. The company excludes the chief executive officer transition costs when evaluating the performance of its consolidated results. The company believes these costs are unusual in nature and the company does not expect them to recur in the ordinary course of its business. The company further believes these costs are unrelated to the ongoing operation of the business in the ordinary course.
Other Items. The company excludes items such as litigation reserves expense and the amortization of common stock warrants issued in connection with debt financing when evaluating the performance of its consolidated results. The company believes these costs are unusual in nature and the company does not expect them to recur in the ordinary course of its business. The company further believes these costs are unrelated to the ongoing operation of the business in the ordinary course.
Investors contact:
Steve Pasko
Market Street Partners
(415) 445-3238 ir@merunetworks.com
SOURCE Meru Networks, Inc.
- Exceeds revenue guidance with quarterly revenue of $322 million; up 24% year-over-year
- A record 1,263 megawatts of inverters shipped in the quarter
- Reports second quarter EPS of $0.30
- Operating cash flow of $56 million in the quarter
CAMARILLO, Calif., July 26, 2012 (GLOBE NEWSWIRE) — Power-One, Inc. (Nasdaq:PWER), a leading provider of renewable energy and energy-efficient power conversion and power management solutions, today announced financial results for the second quarter of 2012. For the quarter ended July 1, 2012, Power-One recorded net sales of $322 million with Renewable Energy Solutions contributing $255 million and Power Solutions posting $67 million. Net income attributable to common stockholders for the second quarter was $47 million, or $0.30 per diluted share. This includes a gain, net of tax, of $0.06 per share on foreign currency remeasurement due to the recent weakening of the Euro versus the dollar.
“In the second quarter of 2012, Power-One shipped over 1.2 gigawatts of inverters, a company record, primarily driven by strength in Europe, particularly in the commercial rooftop segment of the market,” said Richard Thompson, Chief Executive Officer of Power-One, “Demand is very robust for our recently introduced TRIO 20/27.5KW inverters which have become our largest selling product line.”
“The higher revenue along with reductions in material costs enabled us to increase our operating income in the second quarter to $60 million, or 19% of revenue,” continued Mr. Thompson. “Improved profitability and working capital management added to our liquidity as cash and equivalents increased to $259 million. This further strengthens Power-One’s bankability in the renewable market.”
Renewable Energy Solutions
In the second quarter of 2012, Renewable Energy (RE) Solutions benefited from strength in the European region, particularly in Italy and Germany. Inverter and related products generated sales of $255 million and an operating margin of 26% for the second quarter of 2012. Operating margin doubled sequentially from the first quarter due to stable pricing, cost reductions in materials, and improved absorption on higher volumes. In the quarter, Power-One shipped 1,263 megawatts of inverters, up 88% sequentially and up 76% year-over-year.
Power Solutions
Power Solutions recorded sales of $67 million and an operating margin of 4% for the second quarter of 2012. In the quarter, the Servers, Storage and Networking segment faced weaker demand as some customers delayed their orders as a result of macroeconomic uncertainties. Power Solutions operating margin declined sequentially as a result of the reduced volumes and corresponding lower overhead absorption.
Balance Sheet
At July 1, 2012, Power-One had cash and cash equivalents of $259 million, as compared with $205 million at January 1, 2012. During the quarter, Power-One repurchased 1.1 million shares of common stock for approximately $5 million.
Business Outlook
As demand in Germany and Italy is expected to moderate, Power-One forecasts revenue of $260 million to $280 million in the third quarter of 2012. At the midpoint, this would represent a 10% increase over the revenue generated in the third quarter of 2011.
Earnings Conference Call
Power-One will discuss its 2012 second quarter results today at 2:00 p.m. Pacific Time. The call will be available both via the telephone at (877) 390-5535 or (631) 291-4579, conference ID # 99604981, or over the Internet through the Power-One investor relations web site at http://investor.power-one.com. To listen to the call, please log-in at least 10 minutes early to register, download, and install any necessary audio software. An accompanying slide presentation for the conference call is also available in the investor relations section of the web site. For those who cannot listen to the live broadcast, the webcast will be available on the investor relations section of the Power-One web site at http://investor.power-one.com/events.cfm throughout the current quarter.
About Power-One
Power-One is a leading provider of renewable energy and energy-efficient power conversion and power management solutions and is the world’s second largest designer and manufacturer of photovoltaic inverters. Its renewable energy products enable the industry’s highest yielding conversion of power from solar arrays for use by utilities, commercial enterprises and homes. Power-One has a 40 year history as the leader in high efficiency and high density power supply products for a variety of industries including Renewable Energy, Servers, Storage & Networking, Industrial and Network Power Systems. The company is headquartered in Camarillo, CA and has global sales offices, manufacturing, and R&D operations in Asia, Europe, and the Americas. Power-One is traded on NASDAQ under the ticker symbol PWER. For more information, please visit www.Power-One.com.
The Power-One, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=7338
Safe Harbor Statement
Statements made in this press release which state the Company’s or management’s intentions, beliefs, expectations or predictions for the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, and may include statements regarding anticipated future productivity. It is important to note that future performance and actual results could differ materially from those discussed in or underlying such forward-looking statements as a result of risks and uncertainties that cannot be predicted or quantified and that are beyond the Company’s control. Important factors that could cause actual results to differ materially include, but are not limited to: economic conditions in general and business conditions in the power supplies and renewable energy markets; foreign exchange rates; the Company’s ability to improve its operational and supply chain efficiencies; competitive factors such as pricing and technology; the timing and results achieved in completing product manufacturing transitions to Company facilities in China or other low-cost locations; the threat of a prolonged economic slowdown or a lengthy or severe recession; continued volatility of the financial markets, including fluctuations in interest rates and trading prices of the Company’s equity securities; the results of pending legal proceedings; the Company’s ability to secure market share in higher margin, high-growth markets; the market growth of product sectors targeted by the Company as sectors of focus; and the Company’s ability to increase working capital. Additional information concerning factors that could cause actual results to differ materially from expectations expressed in this press release are described in the Company’s reports filed with the Securities and Exchange Commission pursuant to the Securities Exchange Act of 1934 from time to time, which are also available through the Company’s Website at www.power-one.com or through the SEC’s Electronic Data Gathering and Analysis Retrieval System (EDGAR) at www.sec.gov. Power-One undertakes no obligation to publicly update or revise any forward-looking statement.
| |
|
|
|
|
| POWER-ONE, INC. |
| CONSOLIDATED STATEMENT OF OPERATIONS |
| (In thousands, except per share data) |
| (UNAUDITED) |
|
|
|
|
|
|
Three Months Ended |
Six Months Ended |
|
July 1, |
July 3, |
July 1, |
July 3, |
|
2012 |
2011 |
2012 |
2011 |
|
|
|
|
|
| RENEWABLE ENERGY SALES |
$ 254,622 |
$ 180,026 |
$ 403,358 |
$ 331,655 |
| POWER SOLUTIONS SALES |
66,900 |
80,278 |
143,913 |
173,192 |
| TOTAL SALES |
321,522 |
260,304 |
547,271 |
504,847 |
| COST OF GOODS SOLD |
224,021 |
172,926 |
394,786 |
333,211 |
| GROSS PROFIT |
97,501 |
87,378 |
152,485 |
171,636 |
|
|
|
|
|
| GENERAL AND ADMINISTRATIVE |
|
|
|
|
| Selling, general and administrative |
25,392 |
20,895 |
49,639 |
41,980 |
| Research and development |
11,947 |
12,086 |
23,688 |
23,382 |
| Litigation charges |
— |
638 |
82 |
873 |
| Amortization of intangibles |
409 |
468 |
822 |
910 |
| Total expenses |
37,748 |
34,087 |
74,231 |
67,145 |
|
|
|
|
|
| INCOME FROM OPERATIONS |
59,753 |
53,291 |
78,254 |
104,491 |
|
|
|
|
|
| INTEREST AND OTHER INCOME (EXPENSE): |
|
|
|
|
| Interest income |
643 |
709 |
845 |
1,192 |
| Interest expense |
(567) |
(1,631) |
(806) |
(3,018) |
| Other income (expense), net |
12,214 |
(4,496) |
3,263 |
(6,709) |
| Total interest and other income (expense) |
12,290 |
(5,418) |
3,302 |
(8,535) |
|
|
|
|
|
| INCOME BEFORE INCOME TAXES |
72,043 |
47,873 |
81,556 |
95,956 |
|
|
|
|
|
| PROVISION FOR INCOME TAXES |
25,249 |
16,601 |
29,480 |
34,052 |
| EQUITY IN EARNINGS (LOSSES) FROM JOINT VENTURE |
(82) |
413 |
(385) |
595 |
| NET INCOME |
$ 46,712 |
$ 31,685 |
$ 51,691 |
$ 62,499 |
|
|
|
|
|
| PREFERRED STOCK DIVIDEND AND ACCRETION |
— |
870 |
— |
1,736 |
|
|
|
|
|
| NET INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS |
$ 46,712 |
$ 30,815 |
$ 51,691 |
$ 60,763 |
|
|
|
|
|
| BASIC INCOME PER SHARE |
$ 0.31 |
$ 0.26 |
$ 0.35 |
$ 0.51 |
| DILUTED INCOME PER SHARE |
$ 0.30 |
$ 0.21 |
$ 0.33 |
$ 0.41 |
|
|
|
|
|
| BASIC WEIGHTED AVERAGE SHARES OUTSTANDING |
121,901 |
103,636 |
121,898 |
103,713 |
| DILUTED WEIGHTED AVERAGE SHARES OUTSTANDING |
155,828 |
140,283 |
156,030 |
140,602 |
|
| POWER-ONE, INC. |
| CONSOLIDATED BALANCE SHEETS |
| (In thousands) |
| (UNAUDITED) |
|
|
|
|
July 1, |
January 1, |
|
2012 |
2012 |
|
|
|
| ASSETS |
|
|
|
|
|
| CURRENT ASSETS: |
|
|
| Cash and cash equivalents |
$ 259,169 |
$ 204,881 |
| Accounts receivable: |
|
|
| Trade (net of allowance) |
260,562 |
233,252 |
| Other |
5,163 |
9,639 |
| Inventories |
171,025 |
160,515 |
| Prepaid expenses and other current assets |
12,924 |
15,351 |
|
|
|
| Total current assets |
708,843 |
623,638 |
|
|
|
| PROPERTY AND EQUIPMENT, net |
90,571 |
87,223 |
| INTANGIBLE ASSETS, net |
16,417 |
17,414 |
| OTHER ASSETS |
12,714 |
15,241 |
|
|
|
| TOTAL ASSETS |
$ 828,545 |
$ 743,516 |
|
|
|
| LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
| CURRENT LIABILITIES: |
|
|
| Accounts payable |
$ 200,718 |
$ 177,333 |
| Income tax payable |
12,017 |
4,020 |
| Other accrued expenses and current liabilities |
69,234 |
64,754 |
|
|
|
| Total current liabilities |
281,969 |
246,107 |
|
|
|
| OTHER LONG-TERM LIABILITIES |
63,810 |
56,824 |
|
|
|
| STOCKHOLDERS’ EQUITY: |
|
|
| Preferred stock |
36,326 |
36,326 |
| Common stock |
121 |
122 |
| Additional paid-in capital |
654,279 |
652,971 |
| Accumulated other comprehensive income (loss) |
(6,769) |
4,048 |
| Accumulated deficit |
(201,191) |
(252,882) |
|
|
|
| Total stockholders’ equity |
482,766 |
440,585 |
|
|
|
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ 828,545 |
$ 743,516 |
CONTACT: Investor Contact:
Larry Clark
Investor Relations for Power-One
Investor.Relations@Power-One.com
(310) 478-2700 ext. 29
SAN DIEGO, July 26, 2012 /PRNewswire/ — Cardium Therapeutics (NYSE MKT: CXM) today announced the publication of preclinical findings demonstrating that cardiac ischemia plays an important role in adenovector gene delivery (transfection) in mammalian hearts. The new findings were published in the peer-reviewed journal Human Gene Therapy Methods in an article entitled “Ischemia-Reperfusion Increases Transfection Efficiency of Intracoronary Adenovirus type 5 in Pig Heart in Situ,” which is available online at http://online.liebertpub.com/doi/full/10.1089/hgtb.2012.048.
(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)
The published findings demonstrate that Cardium’s innovative technique employing transient cardiac ischemia can be used to dramatically enhance gene delivery and transfection efficiency after one-time intracoronary administration of adenovector in mammalian hearts. Two consecutive but brief periods of coronary artery occlusion combined with co-administration of nitroglycerin increased both adenovector presence (measured by PCR) and transgene expression (assessed by luciferase activity) by over two orders of magnitude (>100 fold) in the heart, as compared to prior intracoronary artery delivery methods.
“The clinical success of DNA-based therapies can be enhanced by employing optimized gene delivery methods,” stated Dr. Gabor M. Rubanyi, Cardium’s Chief Scientific Officer and co-author of the published paper. “In addition, data analysis from the AGENT 1 through 4 clinical studies, involving more than 650 patients in Phase 1/2 through Phase 2/3, showed that patients with more severe forms of coronary artery disease – which is associated with increased ischemia – tended to be more responsive to the one-time administration of Generx than patients with less severe disease. The research results published in Human Gene Therapy Methods extend those findings and demonstrate that Cardium’s new technique for adenovector gene delivery in the heart can be used to dramatically boost adenovector delivery. By enhancing uptake even in patients with less severe forms of disease and ischemia, it would be expected to reduce response variability and allow for the potential treatment of patients with a broader range of associated coronary artery disease. The new treatment protocols for Cardium’s recently-initiated ASPIRE clinical study have been developed to use our knowledge about induced transient ischemia techniques to leverage these research findings and enhance the non-surgical, catheter-based delivery of Generx to the heart,” stated Dr. Rubanyi.
Cardium’s new method of adenovector delivery to the heart takes advantage of the fact that transient ischemia may reduce the permeability barrier of the vascular endothelium and may increase the number of available coxsackie-adenovirus receptors mediating adenovector uptake. Balloon angioplasty catheters have been used for many years to dilate blocked coronary arteries, sometimes with use of a stent, and these catheters have also been used safely by cardiologists in patients with coronary artery disease to study the effects of brief ischemia. Cardium’s new technique inflates the balloon in non-narrowed coronary artery areas, just enough to briefly interrupt flow using inflation pressure that is significantly less than that used for performing routine angioplasty procedures.
Cardium’s recently initiated Russian-based ASPIRE Phase 3 registration study of patients with chronic myocardial ischemia and advanced angina pectoris uses transient ischemia techniques during non-surgical percutaneous catheterization with a standard angioplasty catheter together with the intracoronary infusion of nitroglycerin with the Generx® [Ad5FGF-4] product candidate. The Company’s Generx product candidate is intended to stimulate the growth of collateral blood vessels to effectively bypass coronary artery atherosclerotic blockages without surgical procedures or angioplasty and stents.
The studies published in Human Gene Therapy Methods were conducted at Emory University School of Medicine by Jakob Vinten-Johansen, Ph.D. and colleagues, and were co-sponsored by a Small Business Innovation Research grant from the National Institutes of Health (Cardium Therapeutics) and the Carlyle Fraser Heart Center (Emory). A presentation titled: “New Perspectives for Angiogenic Gene Therapy to Treat Myocardial Ischemia in Patients with Coronary Disease” was presented at the 2012 American Society of Gene & Cell Therapy Meeting in May 2012 and is available for viewing at http://www.cardiumthx.com/pdf/Generx-ASGCT-May-2012-Rubanyi.pdf. At the conference, Cardium also presented a late-breaking poster titled “Transient Ischemia is Necessary for Efficient Adenovector Gene Transfer in the Heart”. The poster presentation can be viewed at http://www.cardiumthx.com/pdf/Generx-ASGCT-Poster-Presentation-May-2012.pdf.
About Generx and the ASPIRE Study
Generx (Ad5FGF-4) is a disease-modifying regenerative medicine biologic that is being developed to offer a one-time, non-surgical option for the treatment of myocardial ischemia in patients with stable angina due to coronary artery disease, who might otherwise require surgical and mechanical interventions, such as coronary artery by-pass surgery or balloon angioplasty and stents. Similar to surgical/mechanical revascularization approaches, the goal of Cardium’s Generx product candidate is to improve blood flow to the heart muscle – but to do so non-surgically, following a single administration from a standard balloon angioplasty catheter. The video “Cardium Generx Cardio-Chant” provides an overview Generx and can be viewed at http://www.youtube.com/watch?v=pjUndFhJkjM.
In March 2012, Cardium reported on the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of its lead product candidate Generx in patients with myocardial ischemia due to coronary artery disease. The ASPIRE study, a 100-patient, randomized and controlled multi-center study to be conducted at up to eight leading cardiology centers in the Russian Federation, is designed to further evaluate the safety and effectiveness of Cardium’s Generx DNA-based angiogenic product candidate, which has already been tested in clinical studies involving 650 patients at more than one hundred medical centers in the U.S., Europe and elsewhere. The efficacy of Generx will be quantitatively assessed using rest and stress SPECT (Single-Photon Emission Computed Tomography) myocardial imaging to sensitively measure improvements in microvascular cardiac perfusion following a one-time, non-surgical, catheter-based administration of Generx. A recent article, “Cardium’s Heart Disease Gene Therapy Advancing with New Discoveries,” outlining the history of the Generx clinical development program is available at http://sandiegobiotechnology.com/topics/4705/cardiums-heart-disease-gene-therapy-moving-toward-commercialization/.
About Cardium
Cardium is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering and other economic monetizations. Cardium’s current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company’s in-house MedPodium® Health Sciences healthy lifestyle product platform. The Company’s lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. Cardium’s lead clinical development product candidate Generx® is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company’s biomedical investment portfolio. News from Cardium is located at www.cardiumthx.com.
Forward-Looking Statements
Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from stated expectations. For example, there can be no assurance that enhancements in the uptake of adenovectors can be successfully applied to improve the uptake, applicability or therapeutic effects of Generx in human patients; that Generx can be successfully advanced in clinical studies outside of the U.S.; that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or procedures, or that clinical studies even if successful will lead to product advancement or partnering; that improvements in the formulation or use of Generx will be commercially practicable, or that Generx could be successfully advanced as a therapeutic in developing markets or that the results of studies in such markets could be used to advance or broaden the regulatory or commercialization activities of Generx in the U.S. or other markets; that the ASPIRE clinical study will be successful or will lead to approval of Generx by the Russian Health Authority for marketing and sales in Russia or lead to approvals in other countries of the Commonwealth of Independent States; that additional clinical evidence regarding the safety and effectiveness of Generx that might be obtained in Russia would be useful for optimizing and broadening commercial development pathways in other industrialized countries; that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive; that FDA or other regulatory clearances or other certifications, or other commercialization efforts will be successful or will effectively enhance our businesses or their market value; that our products or product candidates will prove to be sufficiently safe and effective after introduction into a broader patient population; or that third parties on whom we depend will perform as anticipated.
Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and in the conduct of human clinical trials, including the timing, costs and outcomes of such trials, our ability to obtain necessary funding, regulatory approvals and expected qualifications, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.
Copyright 2012 Cardium Therapeutics, Inc. All rights reserved.
For Terms of Use Privacy Policy, please visit www.cardiumthx.com.
Cardium Therapeutics®, Generx®,Cardionovo™, Tissue Repair™, Gene Activated Matrix™, GAM™, Excellagen®, Excellarate™, Osteorate™, MedPodium®, Appexium®, Linée®, Alena®, Cerex®, D-Sorb™, Neo-Energy®, Neo-Carb Bloc®, Neo-Chill™, and Nutra-Apps® are trademarks of Cardium Therapeutics, Inc. or Tissue Repair Company.
SOURCE Cardium Therapeutics
COLUMBUS, OH — (Marketwire) — 07/26/12 — GlobalWise Investments, Inc. (OTCBB: GWIV) (OTCQB: GWIV) (www.GlobalWiseInvestments.com) and its wholly owned subsidiary Intellinetics, Inc., a leading-edge technology company focused on the design, implementation and management of cloud-based Enterprise Content Management (“ECM”) systems in both the public and private sectors, today announce the acceptance of the Company as a member of the highly esteemed office technology organization, Technology United.
Technology United was established by GlobalWise Channel Partner MWAi’s CEO Mike Stramaglio to form a strategic hub alliance that provides the best-in-class and most aggressive solutions and services that can collectively cover the technology needs within the office space, including IT automation, security and document management services, such as those provided by GlobalWise.
“Technology United’s mission is to pull the best partners together with the best technology to deliver a superior user experience. The solutions created will allow businesses to enjoy efficiencies and cost savings that can significantly impact their bottom line,” stated Mike Stramaglio, CEO of MWAi and founder of Technology United.
The membership in Technology United continues the GlobalWise approach to utilizing Channel Partners for lead generation and partnering approaches to solving complex office technology issues and provides a new avenue to sell cloud-based ECM solutions. Technology United members include Intel, Green Hills Software, Newfield IT and RIM, in addition to MWAi.
“I am excited our Company has been accepted into this prestigious, members-only organization,” stated William J. “BJ” Santiago, CEO of GlobalWise. “Mike has done a fantastic job putting together the best of the best in the office technology space. Each member represents a specific niche within this space, such as copier hardware, security, embedded technologies, tracking, and for our Company, the most cost effective cloud-based ECM solution for the SMB market. I see this membership as a great validator of our 18-year history as a software company providing the most robust ECM solutions in the industry.”
About GlobalWise Investments, Inc.
GlobalWise Investments, Inc., via its wholly owned subsidiary Intellinetics, Inc., is a Columbus, Ohio based Enterprise Content Management (ECM) pioneer with industry-leading software that delivers cloud ECM based solutions on-demand. The Company’s flagship platform, Intellivue™, represents a new industry benchmark and game-changing solution by enabling clients to access and manage the content of every scanned document, file, spreadsheet, email, photo, audio file or video tape — virtually anything that can be digitized — in their enterprise from any PC, laptop, tablet or smartphone from anywhere in the world.
For additional information, please visit the Company’s corporate website: www.GlobalWiseInvestments.com
This press release may contain “forward-looking statements.” Expressions of future goals and similar expressions reflecting something other than historical fact are intended to identify forward-looking statements, but are not the exclusive means of identifying such statements. These forward-looking statements may include, without limitation, statements about our market opportunity, strategies, competition, expected activities and expenditures as we pursue our business plan. Although we believe that the expectations reflected in any forward-looking statements are reasonable, we cannot predict the effect that market conditions, customer acceptance of products, regulatory issues, competitive factors, or other business circumstances and factors described in our filings with the Securities and Exchange Commission may have on our results. The company undertakes no obligation to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this press release.
GlobalWise Investments, Inc.
Columbus, Ohio
www.GlobalWiseInvestments.com
614-388-8909
Contact@GlobalWiseInvestments.com
Mission Investor Relations
Atlanta, Georgia
http://www.MissionIR.com
404-941-8975
Investors@MissionIR.com
DENVER, CO–(Marketwire – July 25, 2012) – Golden Star Resources Ltd. (NYSE MKT: GSS) (TSX: GSC) (GHANA: GSR)
– Intersects 59.4 meters grading 2.5 grams per tonne (g/t) gold beneath the current 242 reserve pit designs
– Intersects 25.2 meters grading 4.1 g/t gold and 20.6 meters grading 2.7 g/t gold beneath the currently operating Starter Pit
– Intersects 33.9 meters grading 2.2 g/t gold and 31.9 meters grading 1.8 g/t gold beneath the currently operating South East Pit
Golden Star Resources Ltd. (NYSE MKT: GSS) (TSX: GSC) (GHANA: GSR) (“Golden Star” or the “Company”) today provided an update on exploration activities at its Wassa mine in Ghana. Complete drill results, plans and sections are posted on the Company’s website at www.gsr.com or click the following link: http://www.gsr.com/Operations/Wassa.asp. (Note: All references to “widths” in this news release are to true widths unless otherwise indicated and all references to “m” are to meters.)
The exploration drilling at Wassa Main continued to intersect wider zones of over 2 g/t gold mineralization along strike and down dip. The current drilling program consists predominantly of step-out drilling testing the extents of the deeper mineralization below the current reserve pit designs. Preliminary in-house resource models and pit shells show that this mineralization could be economic should the grades and widths intersected thus far show good continuity. In order to accelerate the 50,000-meter drilling program now underway below the Wassa Main pit designs, the Company is augmenting its current drilling fleet of two owner-operated drill rigs with three additional contractor-operated multipurpose drilling rigs. The drilling contract has been awarded and the contractor has begun mobilizing equipment to site to commence drilling during August 1, 2012.
During the second quarter of 2012 a further 33 drill holes were completed totaling 8,040 meters. Drilling continued testing the B Shoot, Starter, South East and 242 areas at Wassa. Drilling results from the Starter area, which is the surface projection of the interpreted large scale fold hinge zone, have thus far been encouraging. These results include hole STDD018, which intersected 4.1 g/t gold over 25.2 meters at 15 meters below the current mining surface and within the current reserve pit. This hole also intersected another deeper zone (approximately 65 meters below the reserve pit design) of 2.7 g/t gold over 20.6 meters. Further drilling has been planned to follow up on this deeper zone both along strike and down dip. Significant results from the Starter (hinge zone) drilling during the second quarter of 2012 are summarized in the table below.
Starter Q2 2012 significant drill intersections
----------------------------------------------------------------------------
-
Easting Northing Elev Az Dip From To Drilled True Gold
Hole ID (m) (m) (m) (deg.) (deg.) (m) (m) Width Width Grade
(m) (m) g/t
============================================================================
STDD015 39977 20251 961 90 -49 19.0 25.0 6.0 5.0 5.5
STDD016 39979 20225 961 90 -48 87.4 104.8 17.4 14.8 2.0
STDD016 39979 20225 961 90 -48 147.8 158.2 10.4 8.8 3.3
STDD018 40012 20375 958 90 -52 163.2 188.7 25.5 20.6 2.7
STDD018 40012 20375 958 90 -52 16.0 48.0 32.0 25.2 4.1
STDD019 40000 20332 957 90 -51 199.0 214.0 15.0 12.3 2.1
STDD019 40000 20332 957 90 -51 246.0 253.5 7.5 6.1 5.8
----------------------------------------------------------------------------
Additional drilling was also conducted along the limbs of the Wassa Main fold targeting both B Shoot and South East deeper mineralization on the eastern limb. The South East drilling continued to intersect wider zones of gold mineralization, including BSDD124, which intersected South East mineralization at depth but was collared in the B Shoot pit, which drilled 33.9 meters true width grading 2.2 g/t gold. This intersection is approximately 50 meters below the deepest part of the current reserve pit designs and has confirmed previously announced (see the Company’s February 6, 2012, news release) mineralization intersected in SEDD039 (36.3 meters grading 5.4 g/t gold) and SEDD035 (20.9 meters grading 1.9 g/t gold), which are located approximately 60 meters up dip and 50 meters along strike from hole BSDD124, respectively. Significant results intersected at B shoot and South East during the second quarter are tabulated below.
B Shoot Q2 2012 significant drill intersections
----------------------------------------------------------------------------
-
Easting Northing Elev Az Dip From To Drilled True Gold
Hole ID (m) (m) (m) (deg.) (deg.) (m) (m) Width Width Grade
(m) (m) g/t
============================================================================
BSDD124 40026 19825 983 90 -50 86.2 98.0 11.8 9.7 3.0
BSDD124 40026 19825 983 90 -50 239.5 280.9 41.4 33.9 2.2
BSDD124 40026 19825 983 90 -50 329.0 341.6 12.6 10.3 3.1
BSDD125 39757 20050 1015 90 -55 136.1 152.3 16.2 12.4 2.2
BSDD127 39854 20175 985 90 -59 80.4 88.8 8.4 6.0 12.3
BSDD127 39854 20175 985 90 -59 231.0 236.5 5.5 4.0 7.8
----------------------------------------------------------------------------
South East Q2 2012 significant drill intersections
----------------------------------------------------------------------------
-
Easting Northing Elev Az Dip From To Drilled True Gold
Hole ID (m) (m) (m) (deg.) (deg.) (m) (m) Width Width Grade
(m) (m) g/t
============================================================================
SEDD050A 40071 19875 1009 90 -53 218.9 223.0 4.1 3.3 11.5
SEDD050A 40071 19875 1009 90 -53 237.2 252.9 15.7 12.5 2.7
SEDD051 40052 19775 1008 90 -60 272.5 286.0 13.5 9.7 4.1
SEDD052 40072 19850 1007 90 -55 48.0 53.0 5.0 3.9 10.6
SEDD057A 40331 19950 1001 90 -46 98.0 134.8 36.8 31.9 1.8
SEDD058 40239 19951 1000 90 -55 161.7 166.7 5.0 3.9 21.3
----------------------------------------------------------------------------
Limited drilling was conducted on the western limb of the fold along the 242 trend. The drilling tested the down dip extent of mineralization and defined the boundaries of a diorite body, which occupies the core of the fold. The diorite is a syn-volcanic intrusion, which provides rheological contrasts with the surrounding mafic volcanic flows, generating dilation zones where wide accumulations of gold mineralization occur. For example, hole 242DD054 intersected 59.4 meters grading 2.5 g/t gold. Where the mineralized structure intersects the diorite body, mineralization is often present but exhibits narrower zones and lower grade. Further drilling has been planned to test the extents of the diorite on both margins within the hinge zone to assist in delineating geometry of the mineralization. Significant drilling results in the 242 limb are outlined in the underlying table.
242 Pit Q2 2012 significant drill intersections
----------------------------------------------------------------------------
-
Easting Northing Elev Az Dip From To Drilled True Gold
Hole ID (m) (m) (m) (deg.) (deg.) (m) (m) Width Width Grade
(m) (m) g/t
============================================================================
242DD051 39912 20236 970 325 -70 73.2 78.0 4.8 4.4 5.9
242DD052 40019 20347 958 325 -75 54.0 67.0 13.0 11.4 2.3
242DD054 39756 20067 1000 325 -58 156.3 217.0 60.7 59.4 2.5
----------------------------------------------------------------------------
With the addition of the three contractor-operated drilling rigs to complete Phases 1 and 2 of the program, Golden Star expects to spend approximately $10.4 million over the next nine months, and drilling results will be used to update resource models and pit optimizations. Pending positive results of this program, further infill drilling campaigns in 2013 will be required to increase confidence in the classification of the resources and to enable possible conversion to reserves. Drilling results for the first half of 2012 are being incorporated into an updated resource estimate for the year-end resources and reserves statements.
Mitchel Wasel, Vice President of Exploration, commented, “The commitment from the Board to expand the drilling program at the Wassa Main deposits will enable Golden Star to make informed decisions on possible expansion scenarios over the next 18 months. Recent drilling results, which indicate that Wassa mineralization at depth is wider and higher grade than what has been mined to date, clearly support the Company’s plans to move forward aggressively with this drilling program.”
COMPANY PROFILE
Golden Star Resources holds the largest land package in one of the world’s largest and most prolific gold producing regions. The Company holds a 90% equity interest in Golden Star (Bogoso/Prestea) Limited and Golden Star (Wassa) Limited, which respectively own the Bogoso/Prestea and Wassa/HBB open-pit gold mines in Ghana, West Africa. In addition, Golden Star has an 81% interest in the currently inactive Prestea Underground mine in Ghana, as well as gold exploration interests elsewhere in Ghana, in other parts of West Africa and in Brazil in South America. Golden Star has approximately 259 million shares outstanding. Additional information is available at www.gsr.com.
Statements Regarding Forward-Looking Information: Some statements contained in this news release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable securities laws. Such statements include: our expectations regarding our planned drilling and exploration activities for the remainder of 2012 and the timing thereof; the impact of our results of exploration on our reserves and resources and on the Wassa pit and Wassa operations; the potential for infill drilling campaigns in 2013; the timing of commencement of contract drilling; plans to spend approximately $10.4 million over the next nine months; and the timing of decisions with respect to expansion plans. Investors are cautioned that forward-looking statements are inherently uncertain and involve risks and uncertainties. Factors that could cause actual results to differ materially include timing of and unexpected events during exploration; variations in ore grade; variations in relative amounts of refractory, non-refractory and transition ores; technical or permitting issues, and fluctuations in gold price and costs. There can be no assurance that future developments affecting the Company will be those anticipated by management. Please refer to the discussion of these and other factors in our Form 10-K for 2011 and subsequent Forms 10-Q for 2012 and other filings of the Company with the United States Securities and Exchange Commission and the applicable Canadian securities regulatory authorities. The forecasts contained in this press release constitute management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. While we may elect to update these estimates at any time, we do not undertake to update any estimate at any particular time or in response to any particular event.
QA/QC:
The technical contents of this press release have been reviewed by S. Mitchel Wasel, BSc Geology, a Qualified Person pursuant to National Instrument 43-101. Mr. Wasel is Vice President of Exploration for Golden Star and an active member and Registered Chartered Professional of the Australasian Institute of Mining and Metallurgy.
The results for Wassa quoted herein are based on the analysis of saw-split HQ/NQ diamond half core or a three kilogram single stage riffle split of a nominal 25 to 30 kg Reverse Circulation chip sample which has been sampled over nominal one meter intervals (adjusted where necessary for mineralized structures). Sample preparation and analyses have been carried out at SGS Laboratories in Tarkwa using a 1,000 gram slurry of sample and tap water which is prepared and subjected to an accelerated cyanide leach (LEACHWELL). The sample is then rolled for twelve hours before being allowed to settle. An aliquot of solution is then taken, gold extracted into Di-iso Butyl Keytone (DiBK), and determined by flame Atomic Absorption Spectrophotometry (AAS). Detection Limit is 0.01ppm.
All analytical work is subject to a systematic and rigorous Quality Assurance-Quality Control (QA-QC). At least 5% of samples are certified standards and the accuracy of the analysis is confirmed to be acceptable from comparison of the recommended and actual “standards” results. The remaining half core is stored on site for future inspection and detailed logging, to provide valuable information on mineralogy, structure, alteration patterns and the controls on gold mineralization.
Additional information on earlier drilling results at Wassa are available in our February 6, 2012, press release.
TriQuint Semiconductor, Inc. (NASDAQ:TQNT), a leading RF solutions supplier and technology innovator, announces its financial results for the quarter ended June 30, 2012, including the following highlights:
- Revenue for the quarter was $178.0 million
- GAAP net loss for the quarter was $16.5 million, or $(0.10) per share
- Non-GAAP net loss for the quarter was $15.0 million, or $(0.09) per share
- Booked $13 million in orders for F-35 Lightning II Joint Strike Fighter and TPQ-53 Army radar
- Announced $12.3 million GaN DARPA contract to develop Ultra-Fast Power Switch technology
- Shipping MMPA & BAW content on new Galaxy* phone for Verizon
- Introduced industry’s first 802.11ac Wi-Fi RF module for next-generation smartphones and tablets
- Closed major design wins in Fiber-to-the-Home and optical networks
Commenting on the results for the quarter ended June 30, 2012, Ralph Quinsey, President and Chief Executive Officer, stated, “TriQuint’s second quarter performance was in line with expectations. Mobile devices demand was soft in the second quarter as the smartphone industry prepares for a seasonally strong second half, and our Defense and Networks revenue was slightly up year-to-date with a healthy outlook for the remainder of the year. We believe TriQuint is well positioned for revenue growth and improved financial performance in the second half of 2012.”
Summary Financial Results for the Three and Six Months Ended June 30, 2012:
Revenues for the second quarter of 2012 were $178.0 million, down 22% from the second quarter of 2011 and down 18% sequentially. Mobile Devices market revenue declined 24%, Networks declined 5% and Defense was consistent sequentially. Revenue for the six months ended June 30, 2012 was $394.7 million, down 13% from the six months ended July 2, 2011.
GAAP
Gross margin for the second quarter of 2012 was 25.2%, down sequentially from 28.9%. Gross margin for the six months ended June 30, 2012 was 27.2%, down from 39.6% for the same period in 2011 due to low factory utilization.
Operating expenses for the second quarter of 2012 were $69.4 million, or 39% of revenue, up from $66.2 million in the previous quarter due primarily to higher medical and engineering expenses. Operating expenses for the six months ended June 30, 2012 were $135.5 million compared to $138.0 million for the same period in 2011.
Net loss for the second quarter of 2012 was $16.5 million or $(0.10) per share, down from net income of $1.9 million, or $0.01 per diluted share, in the previous quarter. Net loss for the six months ended June 30, 2012 was $14.6 million or $(0.09) per share compared to a net income of $29.0 million or $0.17 per share for the six months ended July 2, 2011.
Cash and investments decreased by $32.5 million to $162.4 million in the quarter due primarily to the stock repurchase of nearly 4.9 million shares for approximately $25 million.
Non-GAAP
Gross margin for the second quarter was 27.9%, down sequentially from 30.4%. Gross margin for the six months ended June 30, 2012 was 29.2% down from 40.7% for the same period in 2011.
Operating expenses for the quarter were $64.3 million, or 36% of revenue, up from $61.4 million in the prior quarter. Operating expenses for the six months ended June 30, 2012 was $125.7 million or 32% of revenue.
Net loss for the second quarter of 2012 was $15.0 million, or $(0.09) per share, down sequentially from net income of $4.1 million or $0.02 per diluted share. Net loss for the six months ended June 30, 2012 was $10.9 million or $(0.07) per share compared to a net income of $55.0 million or $0.32 per diluted share for the six months ended July 2, 2011.
Please see the discussion of non-GAAP financial measures below and the attached supplemental schedule for a reconciliation of GAAP to non-GAAP financial measures.
Outlook:
The Company believes third quarter 2012 revenues will be between $195 million and $205 million and non-GAAP gross margin is expected to be between 30% and 32%. Third quarter non-GAAP net income per share is expected to be about breakeven. The Company is 90% booked to the midpoint of revenue guidance.
Additional Information Regarding June 30, 2012 Results:
GAAP and non-GAAP financial measures are presented in the tables below (in millions, except for percentage and per share information). Non-GAAP financial measures are reconciled to the corresponding GAAP financial measures in the financial statement portion of this press release.
|
| GAAP RESULTS |
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
Q2 2012 |
|
Q1 2012 |
|
Change
vs. Q1
2012 |
|
Q2 2011 |
|
Change
vs. Q2
2011 |
|
Q2 2012 |
|
Q2 2011 |
|
Change
vs. Q2
2011 |
| Revenue |
|
$ |
178.0 |
|
|
$ |
216.7 |
|
|
(18 |
)% |
|
$ |
228.8 |
|
|
(22 |
)% |
|
$ |
394.7 |
|
|
$ |
453.1 |
|
|
(13 |
)% |
| Gross Profit |
|
$ |
44.9 |
|
|
$ |
62.6 |
|
|
(28 |
)% |
|
$ |
92.1 |
|
|
(51 |
)% |
|
$ |
107.5 |
|
|
$ |
179.5 |
|
|
(40 |
)% |
| Gross Margin % |
|
25.2 |
% |
|
28.9 |
% |
|
(3.7 |
)% |
|
40.3 |
% |
|
(15.1 |
)% |
|
27.2 |
% |
|
39.6 |
% |
|
(12.4 |
)% |
| Op (Loss) Income |
|
$ |
(24.4 |
) |
|
$ |
(3.6 |
) |
|
578 |
% |
|
$ |
21.3 |
|
|
(215 |
)% |
|
$ |
(28.0 |
) |
|
$ |
41.6 |
|
|
(167 |
)% |
| Net (Loss) Income |
|
$ |
(16.5 |
) |
|
$ |
1.9 |
|
|
(968 |
)% |
|
$ |
16.6 |
|
|
(199 |
)% |
|
$ |
(14.6 |
) |
|
$ |
29.0 |
|
|
(150 |
)% |
| Diluted per share |
|
$ |
(0.10 |
) |
|
$ |
0.01 |
|
|
$ |
(0.11 |
) |
|
$ |
0.10 |
|
|
$ |
(0.20 |
) |
|
$ |
(0.09 |
) |
|
$ |
0.17 |
|
|
$ |
(0.26 |
) |
|
| NON-GAAP RESULTS A |
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
Q2 2012 |
|
Q1 2012 |
|
Change
vs. Q1
2012 |
|
Q2 2011 |
|
Change
vs. Q2
2011 |
|
Q2 2012 |
|
Q2 2011 |
|
Change
vs. Q2
2011 |
| Revenue |
|
$ |
178.0 |
|
|
$ |
216.7 |
|
|
(18 |
)% |
|
$ |
228.8 |
|
|
(22 |
)% |
|
$ |
394.7 |
|
|
$ |
453.1 |
|
|
(13 |
)% |
| Gross Profit |
|
$ |
49.7 |
|
|
$ |
65.8 |
|
|
(24 |
)% |
|
$ |
94.8 |
|
|
(48 |
)% |
|
$ |
115.4 |
|
|
$ |
184.5 |
|
|
(37 |
)% |
| Gross Margin % |
|
27.9 |
% |
|
30.4 |
% |
|
(2.5 |
)% |
|
41.4 |
% |
|
(13.5 |
)% |
|
29.2 |
% |
|
40.7 |
% |
|
(11.5 |
)% |
| Op (Loss) Income |
|
$ |
(14.7 |
) |
|
$ |
4.4 |
|
|
(434 |
)% |
|
$ |
29.2 |
|
|
(150 |
)% |
|
$ |
(10.3 |
) |
|
$ |
55.7 |
|
|
(118 |
)% |
| Net (Loss) Income |
|
$ |
(15.0 |
) |
|
$ |
4.1 |
|
|
(466 |
)% |
|
$ |
28.9 |
|
|
(152 |
)% |
|
$ |
(10.9 |
) |
|
$ |
55.0 |
|
|
(120 |
)% |
| Diluted per share |
|
$ |
(0.09 |
) |
|
$ |
0.02 |
|
|
$ |
(0.11 |
) |
|
$ |
0.17 |
|
|
$ |
(0.26 |
) |
|
$ |
(0.07 |
) |
|
$ |
0.32 |
|
|
$ |
(0.39 |
) |
| A |
|
Excludes stock based compensation charges, non-cash tax expense, certain entries associated with acquisitions, restructuring and other specifically identified non-routine transactions. |
|
Conference Call:
TriQuint will host a conference call this afternoon at 2:00 p.m. PDT to discuss the results for the quarter and our future expectations for the company. To access the conference call, please dial (888) 813-6582 domestically, or (706) 643-7082 internationally, approximately ten minutes prior to the beginning of the call, using passcode 91818717. The call can also be heard via webcast accessed through the “Investors” section of TriQuint’s web site at: http://invest.triquint.com. A replay of the conference call will be available until August 1, 2012.
Non-GAAP Financial Measures:
This press release provides financial measures for non-GAAP net income (loss), diluted earnings (loss) per share, gross profit, gross margin, operating expenses and operating income (loss) that exclude equity compensation expense, non-cash tax expense, certain entries associated with acquisitions, restructuring charges and other specifically identified non-routine items, and are therefore not calculated in accordance with accounting principles generally accepted in the United States (“GAAP”). The charges associated with acquisitions reflect the amortization of intangible and tangible assets recorded in connection with acquisition accounting and charged to the income statement. The non-cash tax expense excludes certain deferred tax charges and benefits that do not result in a tax payment or tax refund. Management believes that these non-GAAP financial measures provide meaningful supplemental information that enhances management’s and investors’ ability to evaluate TriQuint’s operating results.
These non-GAAP financial measures are not intended to be used in isolation and should not be considered a substitute for any other performance measure determined in accordance with GAAP. Investors and potential investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool, including that other companies may calculate similar non-GAAP financial measures differently than we do, limiting their usefulness as a comparative tool. The company compensates for these limitations by providing specific information regarding the GAAP amount excluded from the non-GAAP financial measures. The company further compensates for the limitations of our use of non-GAAP financial measures by presenting comparable GAAP measures more prominently. Investors and potential investors are encouraged to review the reconciliation of non-GAAP financial measures contained within this press release with our GAAP net income and net income per share.
Forward-Looking Statements:
This press release contains forward-looking statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding TriQuint’s anticipated third quarter revenues, non-GAAP gross margin, net income and our bookings to revenue; expected seasonality in the smartphone market; and revenue growth and improved financial performance. These forward-looking statements are statements of management’s opinion and are subject to various assumptions, risks, uncertainties and changes in circumstances. Actual results may vary materially from those expressed or implied in the statements herein or from historical results, due to changes in economic, business, competitive, technological and/or regulatory factors. More detailed information about risk factors that may affect actual results are set forth in TriQuint’s reports on Form 10-K and 10-Q and other filings with the Securities and Exchange Commission. These reports can be accessed at the SEC web site, www.sec.gov. Except as required by law, TriQuint undertakes no obligation to revise or publicly release the results of any revision to these forward-looking statements.
A reader of this release should understand that it is not possible to predict or identify all risk factors and should not consider the risk factors described in TriQuint’s filings with the Securities and Exchange Commission to be a complete statement of all potential risks and uncertainties.
Facts About TriQuint
Founded in 1985, TriQuint Semiconductor (NASDAQ: TQNT) is a leading RF solutions supplier and technology innovator for the world’s top communications, defense and aerospace companies. People and organizations around the world need real-time, all-the-time connections; TriQuint products help reduce the cost and increase the performance of connected mobile devices and the networks that deliver critical voice, data and video communications. With the industry’s broadest technology portfolio, recognized R&D leadership, and expertise in high-volume manufacturing, TriQuint creates standard and custom products using gallium arsenide (GaAs), gallium nitride (GaN), surface acoustic wave (SAW) and bulk acoustic wave (BAW) technologies. The company has ISO9001-certified manufacturing facilities in the U.S., production in Costa Rica, and design centers in North America and Germany. For more information, visit www.triquint.com.
TriQuint: Connecting the Digital World to the Global Network®
*Other names and brands may be claimed as the property of others
TQNT – F
|
TriQuint Semiconductor, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands) |
|
|
|
June 30, 2012 |
|
December 31,
2011 |
| Assets |
|
|
|
|
| Current assets: |
|
|
|
|
| Cash and cash equivalents |
|
$ |
127,296 |
|
|
$ |
116,305 |
| Investments in marketable securities |
|
35,102 |
|
|
46,006 |
| Accounts receivable, net |
|
98,367 |
|
|
129,103 |
| Inventories |
|
154,760 |
|
|
151,577 |
| Prepaid expenses |
|
9,599 |
|
|
7,051 |
| Deferred tax assets, net |
|
11,526 |
|
|
11,857 |
| Other current assets |
|
47,527 |
|
|
35,756 |
| Total current assets |
|
484,177 |
|
|
497,655 |
| Property, plant and equipment, net |
|
456,303 |
|
|
469,943 |
| Goodwill |
|
3,376 |
|
|
3,376 |
| Intangible assets, net |
|
19,576 |
|
|
22,732 |
| Deferred tax assets – noncurrent, net |
|
58,451 |
|
|
48,957 |
| Other noncurrent assets, net |
|
32,264 |
|
|
12,605 |
| Total assets |
|
$ |
1,054,147 |
|
|
$ |
1,055,268 |
|
|
|
|
|
| Liabilities and Stockholders’ Equity |
|
|
|
|
| Current liabilities: |
|
|
|
|
| Accounts payable |
|
$ |
62,537 |
|
|
$ |
67,812 |
| Accrued payroll |
|
31,255 |
|
|
28,519 |
| Other accrued liabilities |
|
11,620 |
|
|
9,901 |
| Total current liabilities |
|
105,412 |
|
|
106,232 |
| Long-term liabilities: |
|
|
|
|
| Long-term income tax liability |
|
2,619 |
|
|
735 |
| Cross-licensing liability |
|
13,316 |
|
|
— |
| Other long-term liabilities |
|
10,976 |
|
|
11,013 |
| Total liabilities |
|
132,323 |
|
|
117,980 |
| Stockholders’ equity: |
|
|
|
|
| Common stock |
|
164 |
|
|
166 |
| Additional paid-in capital |
|
677,584 |
|
|
678,412 |
| Accumulated other comprehensive income |
|
138 |
|
|
140 |
| Retained earnings |
|
243,938 |
|
|
258,570 |
| Total stockholders’ equity |
|
921,824 |
|
|
937,288 |
| Total liabilities and stockholders’ equity |
|
$ |
1,054,147 |
|
|
$ |
1,055,268 |
|
|
TriQuint Semiconductor, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts) |
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30,
2012 |
|
March 31,
2012 |
|
July 2,
2011 |
|
June 30,
2012 |
|
July 2,
2011 |
|
|
|
|
|
|
|
|
|
|
|
| Revenues |
|
$ |
178,002 |
|
|
$ |
216,730 |
|
|
$ |
228,785 |
|
|
$ |
394,732 |
|
|
$ |
453,108 |
|
| Cost of goods sold |
|
133,064 |
|
|
154,141 |
|
|
136,643 |
|
|
287,205 |
|
|
273,572 |
|
| Gross profit |
|
44,938 |
|
|
62,589 |
|
|
92,142 |
|
|
107,527 |
|
|
179,536 |
|
|
|
|
|
|
|
|
|
|
|
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
| Research, development and engineering |
|
38,084 |
|
|
37,074 |
|
|
37,955 |
|
|
75,158 |
|
|
74,431 |
|
| Selling, general and administrative |
|
27,588 |
|
|
25,222 |
|
|
25,386 |
|
|
52,810 |
|
|
50,615 |
|
| Litigation expense |
|
3,682 |
|
|
3,864 |
|
|
7,512 |
|
|
7,546 |
|
|
12,911 |
|
| Total operating expenses |
|
69,354 |
|
|
66,160 |
|
|
70,853 |
|
|
135,514 |
|
|
137,957 |
|
|
|
|
|
|
|
|
|
|
|
|
| Operating (loss) income |
|
(24,416 |
) |
|
(3,571 |
) |
|
21,289 |
|
|
(27,987 |
) |
|
41,579 |
|
|
|
|
|
|
|
|
|
|
|
|
| Other (expense) income: |
|
|
|
|
|
|
|
|
|
|
| Interest income |
|
89 |
|
|
49 |
|
|
106 |
|
|
138 |
|
|
210 |
|
| Interest expense |
|
(313 |
) |
|
(350 |
) |
|
(354 |
) |
|
(663 |
) |
|
(741 |
) |
| Foreign currency (loss) gain |
|
(154 |
) |
|
36 |
|
|
87 |
|
|
(118 |
) |
|
31 |
|
| Gain/recovery of investment |
|
4 |
|
|
6,953 |
|
|
356 |
|
|
6,957 |
|
|
507 |
|
| Other, net |
|
189 |
|
|
74 |
|
|
71 |
|
|
263 |
|
|
94 |
|
| Other (expense) income, net |
|
(185 |
) |
|
6,762 |
|
|
266 |
|
|
6,577 |
|
|
101 |
|
|
|
|
|
|
|
|
|
|
|
|
| (Loss) income before income tax |
|
(24,601 |
) |
|
3,191 |
|
|
21,555 |
|
|
(21,410 |
) |
|
41,680 |
|
|
|
|
|
|
|
|
|
|
|
|
| Income tax (benefit) expense |
|
(8,086 |
) |
|
1,308 |
|
|
4,990 |
|
|
(6,778 |
) |
|
12,676 |
|
| Net (loss) income |
|
$ |
(16,515 |
) |
|
$ |
1,883 |
|
|
$ |
16,565 |
|
|
$ |
(14,632 |
) |
|
$ |
29,004 |
|
|
|
|
|
|
|
|
|
|
|
|
| Per Share Data: |
|
|
|
|
|
|
|
|
|
|
| Basic per share net (loss) income |
|
$ |
(0.10 |
) |
|
$ |
0.01 |
|
|
$ |
0.10 |
|
|
$ |
(0.09 |
) |
|
$ |
0.18 |
|
| Diluted per share net (loss) income |
|
$ |
(0.10 |
) |
|
$ |
0.01 |
|
|
$ |
0.10 |
|
|
$ |
(0.09 |
) |
|
$ |
0.17 |
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted-average shares outstanding: |
|
|
|
|
|
|
|
|
|
|
| Basic |
|
165,355 |
|
|
166,237 |
|
|
164,110 |
|
|
165,796 |
|
|
163,257 |
|
| Diluted |
|
165,355 |
|
|
170,566 |
|
|
173,518 |
|
|
165,796 |
|
|
173,222 |
|
|
|
TriQuint Semiconductor, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(% of revenue) |
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30,
2012 |
|
March 31,
2012 |
|
July 2,
2011 |
|
June 30,
2012 |
|
July 2,
2011 |
|
|
|
|
|
|
|
|
|
|
|
| Revenues |
|
100.0 |
% |
|
100.0 |
% |
|
100.0 |
% |
|
100.0 |
% |
|
100.0 |
% |
| Cost of goods sold |
|
74.8 |
% |
|
71.1 |
% |
|
59.7 |
% |
|
72.8 |
% |
|
60.4 |
% |
| Gross profit |
|
25.2 |
% |
|
28.9 |
% |
|
40.3 |
% |
|
27.2 |
% |
|
39.6 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
| Research, development and engineering |
|
21.4 |
% |
|
17.1 |
% |
|
16.6 |
% |
|
19.0 |
% |
|
16.4 |
% |
| Selling, general and administrative |
|
15.4 |
% |
|
11.6 |
% |
|
11.1 |
% |
|
13.4 |
% |
|
11.2 |
% |
| Litigation expense |
|
2.1 |
% |
|
1.7 |
% |
|
3.3 |
% |
|
1.9 |
% |
|
2.8 |
% |
| Total operating expenses |
|
38.9 |
% |
|
30.4 |
% |
|
31.0 |
% |
|
34.3 |
% |
|
30.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Operating (loss) income |
|
(13.7 |
)% |
|
(1.5 |
)% |
|
9.3 |
% |
|
(7.1 |
)% |
|
9.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Other (expense) income: |
|
|
|
|
|
|
|
|
|
|
| Interest income |
|
0.0 |
% |
|
0.0 |
% |
|
0.1 |
% |
|
0.0 |
% |
|
0.1 |
% |
| Interest expense |
|
(0.2 |
)% |
|
(0.2 |
)% |
|
(0.2 |
)% |
|
(0.2 |
)% |
|
(0.2 |
)% |
| Foreign currency (loss) gain |
|
(0.1 |
)% |
|
0.0 |
% |
|
0.0 |
% |
|
(0.0 |
)% |
|
0.0 |
% |
| Gain/recovery of investment |
|
0.0 |
% |
|
3.2 |
% |
|
0.2 |
% |
|
1.8 |
% |
|
0.1 |
% |
| Other, net |
|
0.2 |
% |
|
0.0 |
% |
|
0.0 |
% |
|
0.1 |
% |
|
0.0 |
% |
| Other (expense) income, net |
|
(0.1 |
)% |
|
3.0 |
% |
|
0.1 |
% |
|
1.7 |
% |
|
0.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
| (Loss) income before income tax |
|
(13.8 |
)% |
|
1.5 |
% |
|
9.4 |
% |
|
(5.4 |
)% |
|
9.2 |
% |
|
|
|
|
|
|
|
|
|
|
|
| Income tax (benefit) expense |
|
(4.5 |
)% |
|
0.6 |
% |
|
2.2 |
% |
|
(1.7 |
)% |
|
2.8 |
% |
| Net (loss) income |
|
(9.3 |
)% |
|
0.9 |
% |
|
7.2 |
% |
|
(3.7 |
)% |
|
6.4 |
% |
|
|
TriQuint Semiconductor, Inc.
SUPPLEMENTAL RECONCILIATION OF GAAP TO NON-GAAP RESULTS
(Unaudited)
(Dollars in thousands, except per share amounts) |
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
June 30, 2012 |
|
March 31, 2012 |
|
July 2, 2011 |
|
June 30, 2012 |
|
July 2, 2011 |
|
|
(% of revenues) |
|
(% of revenues) |
|
(% of revenues) |
|
(% of revenues) |
|
(% of revenues) |
| GAAP GROSS PROFIT |
|
$ |
44,938 |
|
|
25.2 |
% |
|
$ |
62,589 |
|
|
28.9 |
% |
|
$ |
92,142 |
|
|
40.3 |
% |
|
$ |
107,527 |
|
|
27.2 |
% |
|
$ |
179,536 |
|
|
39.6 |
% |
| Adjustment for stock based compensation charges |
|
1,823 |
|
|
1.0 |
% |
|
2,106 |
|
|
1.0 |
% |
|
1,585 |
|
|
0.7 |
% |
|
3,929 |
|
|
1.0 |
% |
|
2,804 |
|
|
0.6 |
% |
| Adjustment for restructuring charges |
|
1,763 |
|
|
1.0 |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
1,763 |
|
|
0.5 |
% |
|
— |
|
|
— |
% |
| Adjustment for charges associated with acquisitions |
|
1,126 |
|
|
0.7 |
% |
|
1,095 |
|
|
0.5 |
% |
|
1,079 |
|
|
0.4 |
% |
|
2,221 |
|
|
0.5 |
% |
|
2,144 |
|
|
0.5 |
% |
| NON-GAAP GROSS PROFIT |
|
$ |
49,650 |
|
|
27.9 |
% |
|
$ |
65,790 |
|
|
30.4 |
% |
|
$ |
94,806 |
|
|
41.4 |
% |
|
115,440 |
|
|
29.2 |
% |
|
184,484 |
|
|
40.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP OPERATING EXPENSES |
|
$ |
69,354 |
|
|
38.9 |
% |
|
$ |
66,160 |
|
|
30.5 |
% |
|
$ |
70,853 |
|
|
31.0 |
% |
|
$ |
135,514 |
|
|
34.3 |
% |
|
$ |
137,957 |
|
|
30.4 |
% |
| Adjustment for stock based compensation charges |
|
(5,735 |
) |
|
(3.2 |
)% |
|
(4,591 |
) |
|
(2.1 |
)% |
|
(5,716 |
) |
|
(2.5 |
)% |
|
(10,326 |
) |
|
(2.6 |
)% |
|
(9,402 |
) |
|
(2.1 |
)% |
| Adjustment for charges associated with acquisitions |
|
714 |
|
|
0.4 |
% |
|
(202 |
) |
|
(0.1 |
)% |
|
473 |
|
|
0.2 |
% |
|
512 |
|
|
0.1 |
% |
|
257 |
|
|
0.2 |
% |
| NON-GAAP OPERATING EXPENSES |
|
$ |
64,333 |
|
|
36.1 |
% |
|
$ |
61,367 |
|
|
28.3 |
% |
|
$ |
65,610 |
|
|
28.7 |
% |
|
$ |
125,700 |
|
|
31.8 |
% |
|
$ |
128,812 |
|
|
28.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP OPERATING (LOSS) INCOME |
|
$ |
(24,416 |
) |
|
(13.7 |
)% |
|
$ |
(3,571 |
) |
|
(1.6 |
)% |
|
$ |
21,289 |
|
|
9.3 |
% |
|
$ |
(27,987 |
) |
|
(7.1 |
)% |
|
$ |
41,579 |
|
|
9.2 |
% |
| Adjustment for stock based compensation charges |
|
7,558 |
|
|
4.2 |
% |
|
6,697 |
|
|
3.1 |
% |
|
7,301 |
|
|
3.2 |
% |
|
14,255 |
|
|
3.6 |
% |
|
12,206 |
|
|
2.7 |
% |
| Adjustment for restructuring charges |
|
1,763 |
|
|
1.0 |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
1,763 |
|
|
0.5 |
% |
|
— |
|
|
— |
% |
| Adjustment for charges associated with acquisitions |
|
412 |
|
|
0.3 |
% |
|
1,297 |
|
|
0.6 |
% |
|
606 |
|
|
0.3 |
% |
|
1,709 |
|
|
0.4 |
% |
|
1,887 |
|
|
0.4 |
% |
| NON-GAAP OPERATING (LOSS) INCOME |
|
$ |
(14,683 |
) |
|
(8.2 |
)% |
|
$ |
4,423 |
|
|
2.1 |
% |
|
$ |
29,196 |
|
|
12.8 |
% |
|
$ |
(10,260 |
) |
|
(2.6 |
)% |
|
$ |
55,672 |
|
|
12.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP NET (LOSS) INCOME |
|
$ |
(16,515 |
) |
|
(9.3 |
)% |
|
$ |
1,883 |
|
|
0.9 |
% |
|
$ |
16,565 |
|
|
7.2 |
% |
|
$ |
(14,632 |
) |
|
(3.7 |
)% |
|
$ |
29,004 |
|
|
6.4 |
% |
| Adjustment for stock based compensation charges |
|
7,558 |
|
|
4.2 |
% |
|
6,697 |
|
|
3.1 |
% |
|
7,301 |
|
|
3.2 |
% |
|
14,255 |
|
|
3.6 |
% |
|
12,206 |
|
|
2.7 |
% |
| Adjustment for restructuring charges |
|
1,763 |
|
|
1.0 |
% |
|
— |
|
|
— |
% |
|
— |
|
|
— |
% |
|
1,763 |
|
|
0.5 |
% |
|
— |
|
|
— |
% |
| Adjustment for gain/recovery of investment |
|
(4 |
) |
|
0.0 |
% |
|
(6,953 |
) |
|
(3.2 |
)% |
|
(356 |
) |
|
(0.2 |
)% |
|
(6,957 |
) |
|
(1.8 |
)% |
|
(507 |
) |
|
(0.1 |
)% |
| Adjustment for non-cash tax expense |
|
(8,238 |
) |
|
(4.6 |
)% |
|
1,143 |
|
|
0.5 |
% |
|
4,734 |
|
|
2.1 |
% |
|
(7,095 |
) |
|
(1.9 |
)% |
|
12,338 |
|
|
2.7 |
% |
| Adjustment for charges associated with acquisitions |
|
412 |
|
|
0.3 |
% |
|
1,323 |
|
|
0.6 |
% |
|
628 |
|
|
0.3 |
% |
|
1,735 |
|
|
0.5 |
% |
|
1,949 |
|
|
0.4 |
% |
| NON-GAAP NET (LOSS) INCOME |
|
$ |
(15,024 |
) |
|
(8.4 |
)% |
|
$ |
4,093 |
|
|
1.9 |
% |
|
$ |
28,872 |
|
|
12.6 |
% |
|
$ |
(10,931 |
) |
|
(2.8 |
)% |
|
$ |
54,990 |
|
|
12.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GAAP DILUTED (LOSS) EARNINGS PER SHARE |
|
$ |
(0.10 |
) |
|
|
|
$ |
0.01 |
|
|
|
|
$ |
0.10 |
|
|
|
|
$ |
(0.09 |
) |
|
|
|
$ |
0.17 |
|
|
|
| Adjustment for stock based compensation charges |
|
0.05 |
|
|
|
|
0.04 |
|
|
|
|
0.04 |
|
|
|
|
0.09 |
|
|
|
|
0.07 |
|
|
|
| Adjustment for restructuring charges |
|
0.01 |
|
|
|
|
0.00 |
|
|
|
|
0.00 |
|
|
|
|
0.01 |
|
|
|
|
0.00 |
|
|
|
| Adjustment for gain/recovery of investment |
|
(0.00 |
) |
|
|
|
(0.04 |
) |
|
|
|
(0.00 |
) |
|
|
|
(0.04 |
) |
|
|
|
(0.00 |
) |
|
|
| Adjustment for non-cash tax expense |
|
(0.05 |
) |
|
|
|
0.00 |
|
|
|
|
0.03 |
|
|
|
|
(0.05 |
) |
|
|
|
0.07 |
|
|
|
| Adjustment for charges associated with acquisitions |
|
0.00 |
|
|
|
|
0.01 |
|
|
|
|
0.00 |
|
|
|
|
0.01 |
|
|
|
|
0.01 |
|
|
|
| NON-GAAP DILUTED (LOSS) EARNINGS PER SHARE |
|
$ |
(0.09 |
) |
|
|
|
$ |
0.02 |
|
|
|
|
$ |
0.17 |
|
|
|
|
$ |
(0.07 |
) |
|
|
|
$ |
0.32 |
|
|
|
|
Our earnings release contains forward looking estimates of non-GAAP gross margin and earnings per share for the third quarter of 2012. We provide these non-GAAP measures on a prospective basis for the same reasons that we provide them to investors on a historical basis. The following table provides a reconciliation of GAAP gross margin and loss per share to non-GAAP gross margin and earnings per share for the third quarter of 2012 based on the mid-point of guidance.
|
| Forward Looking GAAP Gross Margin |
|
29.5 |
% |
| Adjustment for stock based compensation charges |
|
1.0 |
% |
| Adjustment for charges associated with acquisitions |
|
0.5 |
% |
| Forward Looking non-GAAP Gross Margin |
|
31.0 |
% |
|
|
|
| Forward Looking GAAP Loss per Share |
|
$ |
(0.06 |
) |
| Adjustment for stock based compensation charges |
|
0.05 |
|
| Adjustment for non-cash tax expense |
|
— |
|
| Adjustment for charges associated with acquisitions |
|
0.01 |
|
| Forward Looking non-GAAP Earnings per Share |
|
$ |
— |
Hudson Technologies, Inc. (NASDAQ: HDSN) will host a conference call and webcast on Thursday, August 2, 2012 at 10:00 a.m. Eastern Time to discuss the Company’s second quarter and six month results.
To access the live webcast, log onto the Hudson Technologies website at www.hudsontech.com, and click on “Investor Relations”.
To participate in the call by phone, dial (877) 407-9205 approximately five minutes prior to the scheduled start time. International callers please dial (201) 689-8054.
A replay of the teleconference will be available until September 1, 2012 and may be accessed by dialing (877) 660-6853 and international callers may dial (201) 612-7415. Callers should use account number 286 and pass code 397607. A transcript of the call will be available on the Hudson Technologies website approximately 24 hours after its completion.
About Hudson Technologies
Hudson Technologies, Inc. is a leading provider of innovative solutions to recurring problems within the refrigeration industry. Hudson’s proprietary RefrigerantSide® Services increase operating efficiency and energy savings, and remove moisture, oils and other contaminants frequently found in the refrigeration circuits of large comfort cooling and process refrigeration systems. Performed at a customer’s site as an integral part of an effective scheduled maintenance program or in response to emergencies, RefrigerantSide® Services offer significant savings to customers due to their ability to be completed rapidly and at higher purity levels, and can be utilized while the customer’s system continues to operate. In addition, the Company sells refrigerants and provides traditional reclamation services to the commercial and industrial air conditioning and refrigeration markets. For further information on Hudson, please visit the Company’s web site at www.hudsontech.com.
Safe Harbor Statement under the Private Securities Litigation Act of 1995
Statements contained herein, which are not historical facts constitute forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changes in the markets for refrigerants (including unfavorable market conditions adversely affecting the demand for, and the price of refrigerants), the Company’s ability to source refrigerants, regulatory and economic factors, seasonality, competition, litigation, the nature of supplier or customer arrangements which become available to the Company in the future, adverse weather conditions, possible technological obsolescence of existing products and services, possible reduction in the carrying value of long-lived assets, estimates of the useful life of its assets, potential environmental liability, customer concentration, the ability to obtain financing and other risks detailed in the Company’s periodic reports filed with the Securities and Exchange Commission. The words “believe”, “expect”, “anticipate”, “may”, “plan”, “should” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.
iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will release financial results for the second quarter and six months ended June 30, 2012, following the close of the market on Wednesday, August 1, 2012.
Ken Ferry, President and Chief Executive Officer, and Kevin C. Burns, Executive Vice President and Chief Financial Officer, will host a conference call for investors beginning at 10:00 a.m. ET on Thursday, August 2, 2012 to discuss the second quarter 2012 financial results and to answer questions.
Shareholders and other interested parties may participate in the conference call by dialing 800-510-9834 (domestic) or 617-614-3669 (international) and entering passcode 86742657. The call also will be broadcast live on the Internet at www.streetevents.com, www.fulldisclosure.com and www.icadmed.com.
A replay of the conference call will be accessible two hours after its completion through August 9, 2012 by dialing 888-286-8010 (domestic) or 617-801-6888 (international) and entering passcode 47354887. The call will also be archived for 90 days at www.streetevents.com, www.fulldisclosure.com and www.icadmed.com.
About iCAD, Inc.
iCAD is an industry-leading provider of Computer-Aided Detection (CAD) technologies, advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft system, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft system is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. For more information, call (877) iCADnow, or visit www.icadmed.com.
“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the Company’s ability to defend itself in litigation matters, the risks relating to the Company’s acquisition of Xoft including, the expected benefits of the acquisition may not be achieved in a timely manner, or at all; the Xoft business operations may not be successfully integrated with iCAD’s and iCAD may be unable to achieve the expected synergies, business and strategic objectives following the transaction, the risks of uncertainty of patent protection; the impact of supply and manufacturing constraints or difficulties; product market acceptance; possible technological obsolescence; increased competition; customer concentration; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe”, “demonstrate”, “intend”, “expect”, “estimate”, “anticipate”, “likely”, and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at http://www.icadmed.com and on the SEC’s website at http://www.sec.gov.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 1b clinical trial to determine the maximum tolerated dose and to evaluate preliminary efficacy of aldoxorubicin (formerly INNO-206) administered in combination with the commonly used chemotherapeutic agent doxorubicin in patients with advanced solid tumors who have failed other therapies. Aldoxorubicin is a tumor-targeting conjugate of doxorubicin.
“Recent trials conducted by Dr. Felix Kratz of the Tumor Biology Institute in Freiburg, Germany using animal models of human tumors showed that the combination of aldoxorubicin and free doxorubicin administered at 50% each of their respective maximum tolerated dose provided complete and prolonged remissions in ovarian and pancreatic cancers with minimal weight loss compared with each drug administered individually at its maximum tolerated dose,” said Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center in Santa Monica, Calif. “Given these favorable results, the combination of aldoxorubicin plus doxorubicin warrants further evaluation as a treatment for patients with solid tumors.”
The single-center Phase 1b clinical trial will be conducted under the direction of Dr. Chawla and will enroll up to 24 patients. Doxorubicin will be administered at 50% of its maximum tolerated dose in combination with escalating doses of aldoxorubicin to determine the maximum tolerated dose of the combination of these two drugs in this patient population.
In June, CytRx reported results for a Phase 1b/2 clinical trial indicating that aldoxorubicin administered at its maximum tolerated dose showed clinical benefit (defined as partial response and stable disease of more than four months following up to eight cycles of treatment) in 10 of 13 (77%) evaluable patients with relapsed or refractory soft tissue sarcoma. All patients in the Phase 1b/2 trial had either not responded to or relapsed after treatment with between one and three prior chemotherapy regimens. Based on the results of this trial CytRx plans to meet with the FDA in the second half of 2012 to discuss a potential Phase 3 pivotal trial as a therapy for patients with soft tissue sarcomas whose tumors have progressed following treatment with chemotherapy.
“We are delighted that such a distinguished sarcoma expert as Dr. Chawla has agreed to serve as principal investigator for yet another trial with aldoxorubicin,” said CytRx CEO Steven A. Kriegsman. “Dr. Chawla led our Phase 1b/2 clinical trial with aldoxorubicin in patients with advanced solid tumors and presented clinical results from this trial at the American Society of Clinical Oncology (ASCO) conference last month. He also is leading our global Phase 2b clinical trial designed to compare aldoxorubicin head-to-head with doxorubicin as a first-line treatment for patients with advanced soft tissue sarcoma. Enrollment completion and data analysis are expected for this trial in 2013.”
About CytRx Corporation
CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. The CytRx oncology pipeline includes three programs in clinical development for cancer indications: aldoxorubicin (formerly known as INNO-206), tamibarotene and bafetinib. With its tumor-targeted doxorubicin conjugate aldoxorubicin, CytRx has initiated an international Phase 2b clinical trial as a treatment for soft tissue sarcomas, has completed its Phase 1b/2 clinical trial primarily in the same indication, recently initiated a Phase 2 trial for patients with advanced pancreatic ductual adenocarcinomas, and plans to meet with the FDA in the second half of 2012 to discuss a potential Phase 3 pivotal trial as a therapy for patients with soft tissue sarcomas whose tumors have progressed following treatment with chemotherapy. CytRx’s pipeline also includes tamibarotene, which it is testing in a double-blind, placebo-controlled, international Phase 2b clinical trial in patients with non-small-cell lung cancer, and which is in a Phase 2 clinical trial as a treatment for acute promyelocytic leukemia (APL). The Company completed its evaluation of bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL), and plans to seek a partner for further development of bafetinib. For more information about the Company, visit www.cytrx.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Such statements involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements, including the risk that any human testing of aldoxorubicin in combination with doxorubicin as a therapy for cancer, including the Phase 1b maximum tolerated dose study described in this press release, might not produce positive results or results similar to those seen in preclinical studies, risks and uncertainties related to the outcome, timing and results of CytRx’s other ongoing and planned clinical trials with aldoxorubicin, the risk that aldoxorubicin alone, or in combination with free doxorubicin, might not show greater efficacy than doxorubicin alone notwithstanding the administration of higher doses than the standard of care, the risk that additional longer-term dosing of aldoxorubicin might cause adverse events not seen to date, uncertainties regarding whether aldoxorubicin effectively targets doxorubicin to tumors, uncertainties regarding regulatory approvals for current and future clinical testing of aldoxorubicin and the scope of the clinical testing that may eventually be required by regulatory authorities for aldoxorubicin, the significant time and expense that will be incurred in developing any of the potential commercial applications for aldoxorubicin, including for soft tissue sarcomas, risks related to CytRx’s ability to manufacture its drug candidates, including aldoxorubicin, in a timely fashion, cost-effectively or in commercial quantities in compliance with stringent regulatory requirements, risks related to CytRx’s need for additional capital or strategic partnerships to fund its ongoing working capital needs and development efforts, including any future clinical development of aldoxorubicin, and the risks and uncertainties described in the most recent annual and quarterly reports filed by CytRx with the Securities and Exchange Commission and current reports filed since the date of CytRx’s most recent annual report. All forward-looking statements are based upon information available to CytRx on the date the statements are first published. CytRx undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
NEW YORK, NY — (Marketwire) — 07/24/12 — Chyron (NASDAQ: CHYR) will provide 10 HyperX3.1 on-air graphics playout systems to NBC Olympics during its production of the 2012 London Olympic Games, July 27-August 12, 2012. The announcement was made today by Philip Paully, Director, Graphics Engineering and Operations, NBC Olympics, and Peter Morrone, Senior Vice President, Product Engineering, Chyron.
“In our operation, there’s no room for error, and every second counts. The centralized asset storage capability powered by Chyron’s HyperX3.1 and Apple®’s Xsan 2 is a tremendous time-saver, enabling our operators to instantly access media assets that were once only available to the Mac® systems,” Paully said.
Relying on Chyron’s HyperX3.1 and Apple’s Xsan 2 storage area network, this collaborative workflow environment promises to bring powerful new efficiencies and time savings to the NBC Olympics’ graphics production team as they insert graphics displays for the network’s live coverage of the London Games.
NBC Olympics worked closely with Chyron and Dynamic Performance Technologies to integrate this powerful graphics workflow solution. After building graphics elements in Adobe® Creative Suite®, the NBC Olympics production team is able to move them seamlessly to editing suites and then to devices for playout to air. Since HyperX3.1 supports Adobe’s XMP metadata platform, artists are able to embed critical information about each graphical element, for instance, the correctly spelled name, age, and home country embedded in a specific athlete’s head shot.
The finished graphics can then be instantly accessed by the HyperX3.1 operators by clicking a folder from their workstations, a capability that previously was only possible by searching for the assets on a server and then downloading them into the playout system. Any changes to image metadata need only be made once, and the metadata fields are automatically populated at every point at which the graphic will be used. When the graphic is inserted into the programming, the accompanying metadata is automatically extracted and displayed, so NBC Olympics’ production staff no longer needs to worry if names are spelled correctly and information about the graphic is accurate.
“This summer’s London Olympic Games promise to be a record-breaker, with more than 3,500 hours of broadcast content over a 19-day period from more than a dozen different sports venues. Since much of this programming will be produced live, accuracy and efficiency is critical to success,” Morrone said. “We are honored to provide NBC Olympics with state-of-the-art HyperX3.1 graphics playout systems integrated with Adobe’s XMP and Apple’s Xsan 2 for their production of the London Olympics.”
About NBC Olympics:
A division of the NBC Sports Group, NBC Olympics is responsible for producing, programming and promoting NBCUniversal’s Olympic coverage. It is renowned for its unsurpassed Olympic heritage, award-winning production, and ability to aggregate the largest audiences in U.S. television history.
Having produced every Summer Olympics since Seoul in 1988 and every Winter Olympics since Salt Lake City in 2002, the networks of NBCUniversal are synonymous with the Games in the United States. In 2011, NBCUniversal acquired the U.S. media rights on all platforms to the 2014 Sochi Winter Olympics, the 2016 Rio Summer Olympics, the 2018 Pyeongchang Winter Olympics, and the 2020 Summer Olympics. At the conclusion of the 2020 Games, NBCUniversal will have presented 17 total Olympic Games and 11 consecutive, the most for a U.S. media company in both categories.
NBC has won an unprecedented 91 Emmy Awards for its Olympics coverage, as well as a prestigious Peabody Award for its presentation of the Beijing Opening Ceremony in 2008, which USA Today said was “the best overall Olympic experience ever provided by a U.S. network.”
In addition to its unsurpassed heritage and award-winning production, NBCUniversal is known for aggregating large Olympic audiences, as nine of the top 11 most-watched U.S. television events of all time are Olympic Games presented across the networks of NBCUniversal. The Beijing Summer Olympics rank No. 1 with 215 million viewers.
About Chyron
Chyron (NASDAQ: CHYR) is a leading provider of Graphics as a Service for on-air and digital video applications including newsrooms, studios, sports broadcasting facilities, and corporate video environments. An Emmy® Award-winning company whose products have defined the world of digital and broadcast graphics, Chyron’s graphics solutions include the Axis World Graphics online content creation software and order management system, on-air graphics systems, clip servers, channel branding, and graphics asset management solutions, all of which may be incorporated into the company’s BlueNet™ end-to-end graphics workflow. More information about Chyron products and services is available on the company websites: www.chyron.com and www.axisgraphics.tv. The company’s investor relations information is at www.chyron.com via the “Investors” link.
Blog: http://chyronchat.com
Facebook: http://www.facebook.com/chyronmelville
LinkedIn: http://www.linkedin.com/company/chyron
Twitter: http://twitter.com/chyronmelville
Tumblr: http://chyronmelville.tumblr.com/
User Forum: http://forum.chyron.com/vbb/index.php
YouTube: http://www.youtube.com/user/chyronmelville
Pinterest: http://pinterest.com/chyron/
Chyron Contact:
Allyson Patanella
PR/Marketing Coordinator
Tel: +1 (631) 845-2102
Email: Email Contact
Agency Contact:
Sarah Schraad Wall Street Communications
Tel: +1 (303) 567-4048
NORTHBROOK, Ill., July 24, 2012 (GLOBE NEWSWIRE) — Nanosphere, Inc. (the “Company”) (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the closing of its previously announced underwritten public offering of 12,075,000 shares of its common stock at a public offering price of $2.40 per share, including 1,575,000 shares of common stock issued pursuant to the underwriters’ exercise in full of their over-allotment option, resulting in gross proceeds of approximately $29.0 million. Piper Jaffray & Co. acted as the sole book-running manager and Roth Capital Partners acted as co-manager for the offering.
Net proceeds from the sale of the shares after underwriting discounts and commissions and other offering expenses are expected to be approximately $26.9 million. The Company plans to use the net proceeds from the offering for general corporate purposes and working capital.
The offering was made pursuant to a prospectus supplement to the Company’s prospectus, dated September 15, 2009, filed as part of the Company’s effective $100 million shelf registration statement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Copies of the final prospectus supplement and accompanying prospectus relating to these securities may be obtained by contacting Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402 or by telephone at 800-747-3924 or by email at prospectus@pjc.com.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for detection of life threatening infections and cardiovascular diseases. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.
The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344
Except for historical information, the matters discussed in this press release are “forward-looking statements” and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere’s ability to develop commercially viable products; (ii) Nanosphere’s ability to achieve profitability; (iii) Nanosphere’s ability to produce and market its products; (iv) Nanosphere’s ability to obtain regulatory approval of its products; (v) Nanosphere’s ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere’s ability to obtain additional financing to support its operations. Additional risks are discussed in the Company’s current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
CONTACT: Investors:
Nanosphere, Inc.
Roger Moody, 847-400-9021
Chief Financial Officer
rmoody@nanosphere.us
or
Media
The Torrenzano Group
Ed Orgon, 212-681-1700
ed@torrenzano.com
NEW YORK, NY — (Marketwire) — 07/24/12 — The Biotechnology Industry has been soaring in 2012 as companies — both large and small — have shown impressive growth. The SPDR S&P Biotech ETF (XBI) and the First Trust NYSE Arca Biotech Index ETF (FBT) year-to-date are up 38 percent and 37 percent, respectively, outperforming the broader market by a wide margin. The Paragon Report examines investing opportunities in the Biotechnology Industry and provides equity research on StemCells, Inc. (NASDAQ: STEM) and Keryx Biopharmaceuticals (NASDAQ: KERX).
Access to the full company reports can be found at:
www.ParagonReport.com/STEM
www.ParagonReport.com/KERX
Despite having to negotiate a more challenging regulation process biotech companies have continued to show investors strong gains in 2012. The FDA Amendments Act of 2007 forced regulators to increase standards for approvals of new drugs, introducing mandatory risk evaluation and mitigation strategies. According to a Pharmaceuticals & Biotechnology report from IMAP, several pharmaceutical firms have altered their drug portfolios from primary care driven blockbusters towards specialties such as oncology, immunology and inflammation, where the medical need is “so high that prices are more easily accepted by the regulators.”
Paragon Report releases regular market updates on the Biotechnology Industry so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.ParagonReport.com and get exclusive access to our numerous stock reports and industry newsletters.
StemCells is engaged in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery. The company recently announced preclinical data demonstrating that its proprietary human neural stem cells restored memory and enhanced synaptic function in two animal models relevant to Alzheimer’s disease. Shares of the company have soared nearly 90 percent this year.
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of renal disease. Keryx is developing Zerenex (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. Shares of the company have rebounded nearly 50 percent over the last three months.
The Paragon Report has not been compensated by any of the above-mentioned publicly traded companies. Paragon Report is compensated by other third party organizations for advertising services. We act as an independent research portal and are aware that all investment entails inherent risks. Please view the full disclaimer at: http://www.paragonreport.com/disclaimer
Strategic Initiatives on Track; Restores Profitability
DALLAS, July 24, 2012 (GLOBE NEWSWIRE) — Frozen Food Express Industries, Inc. (Nasdaq:FFEX) today announced its financial and operating results for the quarter ended June 30, 2012. Highlights of second quarter of 2012 financial results include:
- Income from operations of $1.6 million compared to a loss of $3.8 million in the same period of 2011.
- Net income of $1.1 million compared to a loss of $3.3 million in the same period of 2011.
- Total operating revenue decreased 5.6% to $95.7 million, primarily due to the exit from the dedicated dry van services business.
- Total operating revenue, net of fuel surcharges, decreased 2.9% to $76.3 million.
- Revenue per truck per week increased 6.7% to $3,559 compared to $3,335 in the same period of 2011.
- Net income per share of diluted common stock was $0.06, compared to a net loss per diluted common share of $0.19 in the same period of 2011.
| Revenue (in $ millions) from: |
2Q12 |
2Q11 |
% Change |
| Total Truckload |
37.7 |
47.2 |
(20.3%) |
| Less-than-truckload (“LTL”) |
31.1 |
29.0 |
7.5% |
| Brokerage, Logistics and Equipment Rental |
7.5 |
2.4 |
212.7% |
| Operating Revenue (Excluding Fuel Surcharges) |
76.3 |
78.6 |
(2.9%) |
| Fuel Surcharges |
19.4 |
22.7 |
(14.7%) |
| Total Operating Revenue |
95.7 |
101.3 |
(5.6%) |
“Excluding fuel surcharge revenue and the revenue contribution from dedicated dry van services, a business which we exited last year, we experienced a 5.7% revenue growth benefiting from both higher yields and pricing in our refrigerated services and the impact of the new water services revenue on our logistics services,” said Russell Stubbs, the Company’s President and Chief Executive Officer. “Our LTL business continues to benefit from improved demand and pricing, producing 7.5% growth, the best second quarter performance in five years.”
During the second quarter of 2012, total operating expenses decreased $10.9 million, or 10.4%, to $94.1 million compared to $105.1 million during the second quarter of 2011, which yielded an operating ratio of 98.4 compared to a 103.7 for the same period in 2011. Fuel costs decreased $5.6 million and represented approximately half of the year-over-year cost savings. The reduction in fuel costs was related to fewer trucks in service, lower fuel prices, and increased fuel economy from a younger fleet. Excluding fuel costs, operating costs decreased 6.7%, driven by decreases in deprecation, salaries and wages, as well as reduced maintenance costs. Net of the impact of fuel on revenue and expenses, the company generated an operating ratio of 97.4 in the second quarter of 2012, compared to a 101.4 in the second quarter of 2011.
For the six months ended June 30, 2012, total operating revenue decreased 5.1%, or $9.8 million, to $183.6 million compared to $193.4 million in the same period of 2011. Total operating revenue, excluding fuel surcharges, decreased 3.7% to $146.5 million from $152.1 million during the same period a year ago. Net loss for the six months ended June 30, 2012 was $4.6 million, compared to a net loss of $11.2 million in the same period of 2011. In the first six months of 2012, on a per share basis, the net loss equated to $0.26 per diluted share compared to a net loss of $0.64 per diluted share in the same period of 2011.
Strategic Plan Update
Updates on the key elements of its strategic plan to restore profitability during fiscal 2012 include:
• Exit low margin/ low return businesses – During the fourth quarter of 2011, the Company completed the sale of 415 dry van trailers and 228 tractors and no longer provides dry van services via a dedicated fleet of dry van trailers. This action removed a line of lower margin services, and lowered the average age of the fleet to 2.1 years during the first six months of 2012 from 2.8 years during the same period last year. As a result, during the first six months of 2012, tractor maintenance expense was in line with our plan and fuel economy improved by approximately 5 percent.
• Reinvest in growth businesses – The Company began providing bulk tank water transportation services for the crude oil drilling industry during the fourth quarter of 2011. “We are pleased with the results we are obtaining from this operation,” said Mr. Stubbs, “After a slow start in the first quarter we are on track to achieve the earnings contribution goals set in our plan for this year.”
• Improve operating efficiencies – Non-driver employee headcount at the end of the second quarter was 681, a 4.9% reduction from the same period a year ago. The Company is on track to realize annualized cost savings of approximately $5 million as the result of its previously announced reduction in non-driver staffing levels.
• Improve yields in core temperature controlled business – The Company believes market conditions are improving in the Company’s core refrigerated truckload (TL) and less-than-truckload (LTL) shipping markets. As a result, revenue per loaded mile has increased 7.0% during the first six months of 2012 and LTL shipments and revenue per hundredweight increased 8.4% and 4.7%, respectively.
Outlook
The Company expects that quarterly results will continue to improve throughout the year. In addition, capital expenditures are not expected to exceed $1.0 million, net of proceeds from disposition, and cash flows are expected to remain positive throughout the balance of fiscal 2012. “The strategic initiatives that we have implemented are on track and yielding positive results. We have posted our first quarter of profitability since the economic recession began and are well positioned to build on the progress we have made. Given the higher fixed cost nature of the LTL business, incremental contribution from even modest improvements in revenue can have a significant impact on our profitability and returns, which is evident in our improving results. Combined with a growing contribution from our water transportation business, we are on track to restore the Company to profitability this year,” said Russell Stubbs.
Conference Call
The Company plans to host a conference call on Monday, July 30, 2012 at 5:00 PM Eastern Time (4:00 PM Central Time) to discuss its financial results for the first half of 2012 and review its strategic plan for returning to profitability. Parties interested in participating in the conference call may dial-in at (866) 757-6808. The conference call will be webcast and can be accessed at www.ffex.net.
About FFEX
Frozen Food Express Industries, Inc. is one of the leading temperature-controlled truckload and less-than-truckload carriers in the United States with core operations in the transport of temperature-controlled products and perishable goods including food, health care and confectionery products. Service is offered in over-the-road and intermodal modes for temperature-controlled truckload and less-than-truckload, as well as dry truckload on a non-dedicated fleet basis. We also provide bulk tank water transportation, brokerage/logistics and dedicated services to our customers. Additional information about Frozen Food Express Industries, Inc. can be found at http://www.ffeinc.com. To join our email alert list, please click on the following link: http://financials.ffex.net/alerts.cfm. The Company’s common stock is traded on the Nasdaq Global Select market under the symbol FFEX.
The Frozen Food Express Industries, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3209
Forward-Looking Statements
This press release contains certain statements that may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements relating to plans, strategies, objectives, expectations, intentions, and adequacy of resources, and may be identified by words such as “will”, “could”, “should”, “believe”, “expect”, “intend”, “plan”, “schedule”, “estimate”, “project”, and similar expressions. Those statements are based on current expectations and are subject to uncertainty and change. Although our management believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will be realized. Should one or more of the risks or uncertainties underlying such expectations not materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those expected. Among the key factors that are not within our management’s control and that may cause actual results to differ materially from those projected in such forward-looking statements are demand for the Company’s services and products, and its ability to meet that demand, which may be affected by, among other things, competition, weather conditions and the general economy, the availability and cost of labor and owner-operators, the ability to negotiate favorably with lenders and lessors, the continued growth of hydraulic fracturing techniques for oil and gas drilling in West Texas, the effects of terrorism and war, the availability and cost of equipment, fuel and supplies, the market for previously-owned equipment, the impact of changes in the tax and regulatory environment in which the Company operates, operational risks and insurance, risks associated with the technologies and systems used and the other risks and uncertainties described in our filings with the Securities and Exchange Commission. Given the volatility in fuel prices and the impact fuel surcharge revenues have on total operating revenues, we often make reference to total operating revenue excluding fuel surcharges to provide a more consistent basis for comparison of operating revenue without the impact of fluctuating fuel prices. Readers should review and consider these factors along with the various disclosures by the Company in its press releases, stockholder reports and filings with the Securities and Exchange Commission. The Company does not assume, and specifically disclaims, any obligation to update or revise any forward-looking statements to reflect actual results or changes in the factors affecting the forward-looking information.
|
| Frozen Food Express Industries, Inc. and Subsidiaries |
| Consolidated Condensed Balance Sheets |
| (Unaudited and in thousands, except per-share amounts) |
|
|
|
| Assets |
June 30,
2012 |
December 31,
2011 |
| Current assets |
|
|
| Cash and cash equivalents |
$ 1,826 |
$ 1,048 |
| Accounts receivable, net |
41,478 |
43,450 |
| Tires on equipment in use, net |
6,573 |
5,968 |
| Equipment held for sale |
2,282 |
3,437 |
| Other current assets |
9,031 |
7,868 |
| Total current assets |
61,190 |
61,771 |
|
|
|
| Property and equipment, net |
50,601 |
57,757 |
| Deferred income taxes |
1,009 |
1,009 |
| Other assets |
5,814 |
5,867 |
| Total assets |
$118,614 |
$126,404 |
|
|
|
| Liabilities and Shareholders’ Equity |
|
|
| Current liabilities |
|
|
| Accounts payable |
$26,441 |
$30,339 |
| Insurance and claims accruals |
8,719 |
10,667 |
| Accrued payroll and deferred compensation |
3,802 |
4,047 |
| Accrued liabilities |
1,205 |
1,251 |
| Current maturities of notes payable and capital lease obligations |
2,027 |
1,936 |
| Deferred income taxes |
690 |
690 |
| Total current liabilities |
42,884 |
48,930 |
|
|
|
| Borrowings under credit facility |
24,259 |
19,888 |
| Long-term notes payable and capital lease obligations |
7,890 |
8,901 |
| Insurance and claims accruals |
5,083 |
5,783 |
| Total liabilities |
80,116 |
83,502 |
|
|
|
| Shareholders’ equity |
|
|
| Common stock, $1.50 par value per share; 75,000 shares authorized; 18,572 shares issued |
27,858 |
27,858 |
| Additional paid-in capital |
666 |
427 |
| Accumulated other comprehensive loss |
(63) |
(67) |
| Retained earnings |
16,994 |
21,572 |
| Total common shareholders’ equity |
45,455 |
49,790 |
| Treasury stock (988 and 980 shares), at cost |
(6,957) |
(6,888) |
| Total shareholders’ equity |
38,498 |
42,902 |
| Total liabilities and shareholders’ equity |
$118,614 |
$126,404 |
|
|
|
|
|
|
|
|
|
| Frozen Food Express Industries, Inc. and Subsidiaries |
| Consolidated Condensed Statements of Operations |
| (Unaudited and in thousands, except per-share amounts) |
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
|
2012 |
2011 |
2012 |
2011 |
| Total operating revenue |
$ 95,705 |
$ 101,329 |
$ 183,640 |
$ 193,436 |
| Operating expenses |
|
|
|
|
| Salaries, wages and related expenses |
28,078 |
29,642 |
57,303 |
59,102 |
| Purchased transportation |
16,487 |
17,283 |
32,320 |
33,499 |
| Fuel |
19,752 |
25,333 |
38,769 |
47,800 |
| Supplies and maintenance |
12,362 |
14,229 |
24,766 |
26,851 |
| Revenue equipment rent |
10,302 |
8,749 |
20,514 |
17,353 |
| Depreciation |
2,908 |
4,552 |
5,967 |
9,048 |
| Communications and utilities |
1,243 |
1,048 |
2,176 |
2,347 |
| Claims and insurance |
1,864 |
2,419 |
3,769 |
5,728 |
| Operating taxes and licenses |
1,065 |
1,069 |
2,152 |
2,104 |
| Gain on sale of property and equipment |
(777) |
(574) |
(2,537) |
(573) |
| Miscellaneous |
864 |
1,346 |
2,097 |
2,726 |
| Total operating expenses |
94,148 |
105,096 |
187,296 |
205,985 |
| Income (loss) from operations |
1,557 |
(3,767) |
(3,656) |
(12,549) |
|
|
|
|
|
| Interest and other expense (income) |
|
|
|
|
| Interest income |
— |
2 |
— |
— |
| Interest expense |
398 |
136 |
769 |
233 |
| Equity in earnings of limited partnership |
(97 |
(260) |
(332) |
(359) |
| Life insurance and other |
129 |
269 |
371 |
368 |
| Total interest and other expense (income) |
430 |
147 |
808 |
242 |
| Income (loss) before income taxes |
1,127 |
(3,914) |
(4,464) |
(12,791) |
| Income tax expense (benefit) |
56 |
(609) |
114 |
(1,549) |
| Net income (loss) |
$ 1,071 |
$ (3,305) |
$ (4,578) |
$ (11,242) |
|
|
|
|
|
| Net income (loss) per share of common stock |
|
|
|
|
| Basic |
$ 0.06 |
$ (0.19) |
$ (0.26) |
$ (0.64) |
| Diluted |
$ 0.06 |
$ (0.19) |
$ (0.26) |
$ (0.64) |
| Weighted average shares outstanding |
|
|
|
|
| Basic |
17,872 |
17,534 |
17,799 |
17,490 |
| Diluted |
17,872 |
17,534 |
17,799 |
17,490 |
The following table summarizes and compares the significant components of revenue and presents our operating ratio and revenue per truck per week for each of the three and six month periods ended June 30:
|
|
|
|
|
|
Three Months |
Six Months |
| Revenue from (a) |
2012 |
2011 |
2012 |
2011 |
| Temperature-controlled services |
$ 27,320 |
$ 30,940 |
$ 51,822 |
$ 60,356 |
| Dry-freight services |
5,617 |
11,703 |
11,062 |
23,123 |
| Total truckload linehaul services |
32,937 |
42,643 |
62,884 |
83,479 |
| Dedicated services |
4,719 |
4,606 |
9,555 |
8,911 |
| Total truckload |
37,656 |
47,249 |
72,439 |
92,390 |
| Less-than-truckload linehaul services |
31,148 |
28,967 |
59,454 |
55,168 |
| Fuel surcharges |
19,362 |
22,702 |
37,156 |
41,385 |
| Brokerage and logistics services |
6,588 |
1,546 |
12,704 |
2,684 |
| Equipment rental |
951 |
865 |
1,887 |
1,809 |
| Total operating revenue |
95,705 |
101,329 |
183,640 |
193,436 |
|
|
|
|
|
| Operating expenses |
94,148 |
105,096 |
187,296 |
205,985 |
| Income (loss) from operations |
$ 1,557 |
$ (3,767) |
$ (3,656) |
$ (12,549) |
| Operating ratio (b) |
98.4% |
103.7% |
102.0% |
106.5% |
|
|
|
|
|
| Total truckload revenue |
$ 37,656 |
$ 47,249 |
$ 72,439 |
$ 92,390 |
| Less-than-truckload linehaul revenue |
31,148 |
28,967 |
59,454 |
55,168 |
| Total linehaul and dedicated services revenue |
$ 68,804 |
$ 76,216 |
$ 131,893 |
$ 147,558 |
|
|
|
|
|
| Weekly average trucks in service |
1,487 |
1,758 |
1,487 |
1,765 |
| Revenue per truck per week (c) |
$ 3,559 |
$ 3,335 |
$ 3,411 |
$ 3,233 |
|
|
|
|
|
| Computational notes: |
| (a) Revenue and expense amounts are stated in thousands of dollars. |
| (b) Operating expenses divided by total operating revenue. |
| (c) Average daily revenue, times seven, divided by weekly average trucks in service. |
The following table summarizes and compares selected statistical data relating to our freight operations for each of the three and six month periods ended June 30:
|
|
|
|
|
|
Three Months |
Six Months |
| Truckload |
2012 |
2011 |
2012 |
2011 |
| Total linehaul miles (a) |
21,792 |
29,863 |
42,342 |
59,754 |
| Loaded miles (a) |
19,185 |
26,444 |
37,341 |
53,080 |
| Empty mile ratio (b) |
12.0% |
11.4% |
11.8% |
11.2% |
| Linehaul revenue per total mile (c) |
$ 1.51 |
$ 1.43 |
$ 1.49 |
$ 1.40 |
| Linehaul revenue per loaded mile (d) |
$ 1.72 |
$ 1.61 |
$ 1.68 |
$ 1.57 |
| Linehaul shipments (a) |
21.0 |
29.3 |
40.6 |
58.5 |
| Loaded miles per shipment (e) |
913 |
902 |
920 |
907 |
| LTL |
|
|
|
|
| Hundredweight |
2,179,967 |
2,132,554 |
4,183,502 |
4,066,405 |
| Shipments (a) |
71.7 |
67.0 |
138.8 |
128.0 |
| Linehaul revenue per hundredweight (f) |
$ 14.29 |
$ 13.58 |
$ 14.21 |
$ 13.57 |
| Linehaul revenue per shipment (g) |
$ 434 |
$ 432 |
$ 428 |
$ 431 |
| Average weight per shipment (h) |
3,040 |
3,182 |
3,014 |
3,177 |
|
|
|
|
|
| Computational notes: |
| (a) Amounts are stated in thousands. |
| (b) Total truckload linehaul miles less truckload loaded miles, divided by total truckload linehaul miles. |
| (c) Revenue from truckload linehaul services divided by total truckload linehaul miles. |
| (d) Revenue from truckload linehaul services divided by truckload loaded miles. |
| (e) Total truckload loaded miles divided by number of truckload linehaul shipments. |
| (f) LTL revenue divided by LTL hundredweight. |
| (g) LTL revenue divided by number of LTL shipments. |
| (h) LTL hundredweight times one hundred divided by number of shipments. |
The following table summarizes and compares the makeup of our fleets between company-provided tractors and tractors provided by owner-operators as of June 30:
|
2012 |
2011 |
| Total company tractors available for freight operations |
1,348 |
1,576 |
| Total owner-operator tractors available for freight operations |
260 |
264 |
| Total tractors available for freight operations |
1,608 |
1,840 |
| Total trailers available for freight operations |
2,968 |
3,516 |
|
|
|
CONTACT: Frozen Food Express Industries, Inc.
Russell Stubbs, President and CEO
John Hickerson, EVP and COO
John McManama, SVP and CFO
(214) 630-8090
Dave Mossberg, Investor Relations
Three Part Advisors, LLC
817 310-0051
Adjusted EBITDA for 2012 to be Between $60.0 and $66.0 million
NASSAU, Bahamas, July 24, 2012 (GLOBE NEWSWIRE) — Ultrapetrol (Bahamas) Limited (Nasdaq:ULTR) (the “Company”), an industrial transportation company serving marine transportation needs in three markets (River Business, Offshore Supply Business and Ocean Business), today announced the sale of a further 14 wet and dry barges to a third party in Colombia. The barges are scheduled for delivery starting at the end of 2012 and extending through the second quarter of 2013. This sale will provide the Company with proceeds of $20.3 million, of which 50% will be advanced by the buyer. With this sale, the yard is fully employed until the end of the first quarter of 2013.
In addition, the Company provided a brief update on its operations and EBITDA expectations for the remainder of the year. In the River Business, levels in the High Paraguay River have recovered and it is currently expected that iron ore shipments will continue as normal until October 2012.
In the Offshore Supply Business, the first newbuilding from a shipyard in India, the UP Jade, is arriving in Rio de Janeiro, Brazil next Friday, July 27, 2012 and will be delivered to Petrobras on a four year charter at a rate of $33,000 per day. As previously announced, the Company is currently under firm negotiations with Petrobras to renew the contracts for three of its PSV’s that expire in 2012, each for four year periods at increased rates. These new contracts are expected to generate a combined increase in earnings of approximately $8.0 million per year.
The Company expects 2012 adjusted EBITDA to be between $60.0 and $66.0 million (including the EBITDA resulting from the firm sale of 24 barges which will be built for a third party and that will be leased to the Company as previously reported).
About Ultrapetrol
Ultrapetrol is an industrial transportation company serving the marine transportation needs of its clients in the markets on which it focuses. It serves the shipping markets for containers, grain and soya bean products, forest products, minerals, crude oil, petroleum, and refined petroleum products, as well as the offshore oil platform supply market with its extensive and diverse fleet of vessels. These include river barges and pushboats, platform supply vessels, tankers and two container feeder vessels. More information on Ultrapetrol can be found at www.ultrapetrol.net.
The Ultrapetrol (Bahamas) Limited logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3164.
Forward-Looking Statements
Our disclosure and analysis in this release concerning our operations, cash flows and financial position, including, in particular, the likelihood of our success in developing and expanding our business, include forward-looking statements. Statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “projects,” “forecasts,” “will,” “may,” “should,” and similar expressions are forward-looking statements. Although these statements are based upon assumptions we believe to be reasonable based upon available information, including projections of revenues, operating margins, earnings, cash flow, working capital, and capital expenditures, they are subject to risks and uncertainties. These forward-looking statements represent our estimates and assumptions only as of the date of this release and are not intended to give any assurance as to future results. As a result, you should not place undue reliance on any forward-looking statements. We assume no obligation to update any forward-looking statements to reflect actual results, changes in assumptions or changes in other factors, except as required by applicable securities laws.
ULTR-G
CONTACT: The IGB Group
Leon Berman
212-477-8438
lberman@igbir.com
or
David Burke
646-673-9701
dburke@igbir.com
JINHUA, CHINA — (Marketwire) — 07/23/12 — Kandi Technology Corp. (the ‘Company’ or ‘Kandi’) (NASDAQ: KNDI), a leading Chinese manufacturer and developer of pure electric vehicles (EVs) and all-terrain vehicles (ATVs), today announced that the Company’s wholly owned subsidiary, Zhejiang Kandi Vehicles Co., Ltd. (“Kandi Vehicles”), has signed a framework agreement with the government of Weifang Binhai Economic Development Zone (“Weifang Development Zone”) in Wei Fang City of Shandong Province, under which Kandi Vehicles intends to invest and establish a project company in the development zone that will have a capacity annually to produce key components and parts for 100,000 EVs (the “Project”).
Shandong is the first province in China that commercialized EV and has the biggest EV market in China. Weifang Development Zone (http://www.wfbinhai.gov.cn) is a national level economic and technology development zone and a key automotive industry base approved by the National Development and Reform Commission. It is also the National Priority Area in Shandong Peninsula Blue Economic Zone and the Yellow River Delta Efficient Eco-economic Zone.
In order to gain market position for Kandi EVs in Shandong province and receive the support from the local government, upon the invitation of Weifang Development Zone, Kandi Vehicles has discussed and executed the framework agreement with Weifang Development Zone on July 13, 2012 after extensive discussion and negotiation between the parties. The main provisions of the framework agreement are as follows:
1. The Project is invested by Kandi Vehicles. The annual revenue of the Project is expected to be approximately RMB3 billion when it reaches its full capacity.
2. Weifang Development Zone will nominate the Project as one of the key projects to be supported in Shandong Province and will try to receive support for this Project under the provincial government’s preferential policies.
3. Weifang Development Zone agrees to provide Kandi Vehicles 500 mu (approximately 333,300 square meters) construction land for project use at a favorable price.
4. Upon the completion of the Project, Weifang Development Zone will work actively to gain national, provincial and municipal supportive policies for the EV industry, and fully promote the use and acceptance of Kandi EVs in Shandong province. In principle, the government will have a special supportive policy for no less than 20,000 EVs every year.
5. The Project will receive local government tax incentive and preferential treatment.
6. The entire project is expected to be completed within 2 years as soon as Kandi Vehicles obtains the land-use right.
Mr. Xiaoming Hu, Chairman and the Chief Executive Officer of Kandi, commented, “Shandong provincial government’s strong support is essential for Kandi to enter into the EV market in Shandong province. The practice is that local governments have various supporting policies for local companies, therefore the cooperation with Weifang Development Zone to establish a local project company will provide a firm foundation for Kandi to become the leader in the EV market in China. In the meantime, Kandi has full confidence that it will achieve success in the EV market in Shandong.”
About Kandi Technologies, Corp.
Kandi Technologies, Corp. (KNDI) is a manufacturer and exporter of a variety of vehicles in China, making it a world leader in the production of popular off-road vehicles (ORVs). It also ranks among the leading manufacturers in China of all-terrain vehicles (ATVs), specialized utility vehicles (UTVs), and a recently introduced second-generation high mileage, two-seat three-wheeled motorcycle. Another major company focus has been on the manufacture and sale of the COCO electric vehicle (EV), a highly economical, beautifully designed, all-electric super mini-car for neighborhood driving and commuting. The convertible and hardtop models of the COCO EV are available in the United States and other countries, while the Chinese government has approved the sale of Kandi EVs in China since 2010. More information can be viewed at its corporate website is http://www.chinakandi.com.
Safe Harbor Statement
This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on the SEC’s website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2045899
Company Contact:
China
Email: IR@kandigroup.com
Phone: 86-579-82239856
U.S.A.
Email: IR@kandigroup.com
FRESNO, Calif., July 23, 2012 /PRNewswire/ — United Security Bancshares (http://www.unitedsecuritybank.com/) (Nasdaq Global Select: UBFO) reported today unaudited consolidated net income of $2,173,000 or $0.16 per basic and diluted common share for the quarter ended June 30, 2012 and $3,224,000 or $.23 per basic and diluted common share for the six months ended June 30, 2012, as compared to a net loss of $6.3 million or ($0.46) per basic and diluted common shares for the quarter ended June 30, 2011 and a net loss of $6.0 million or ($.43) per basic and diluted shares for the six months ended June 30, 2011.
Annualized return on average equity (ROAE) for the quarter ended June, 2012 was 13.83%, compared to (31.64%) for the same period in 2011, and was 10.23% for the six months ended June 30, 2012 compared to (15.63)% for the six months ended June 30, 2011. Annualized return on average assets (ROAA) was 1.44% for the three months ended June 30, 2012 compared to (3.85%) for the same three-month period in 2011, and was 1.06% for the six months ended June 30, 2012 compared to (1.83%) for the six months ended June 30, 2011.
The Board of Directors of United Security Bancshares declared a secondquarter 2012 stock dividend of one percent (1%) on June 26, 2012. The stock dividend was payable to shareholders of record on July 13, 2012, and the shares will be issued on July 25, 2012.
Dennis R. Woods, President and Chief Executive Officer of the Company, remarks “The direction of our earnings has clearly changed and is a result of the continued reduction of problem assets since 2011 and stabilization in the real estate market.” Shareholders’ equity at June 30, 2012 was $65.8 million, up $3.6 million from shareholders’ equity of $62.2 million at December 31, 2011.
Net interest income before provision for credit losses for the quarter ended June 30, 2012 totaled $6.0 million and $12.0 million for the six months ended June 30, 2012, down just $310,000 from $6.3 million reported for the quarter ended June 30, 2011 and down $450,000 from the 12.5 million reported for the six months ended June 30, 2011, respectively. The net interest margin was 4.71% for the quarter ended June 30, 2012, and 4.69% for the six months ended June 30, 2012, as compared to 4.52% for the quarter ended June 30, 2011 and 4.47% for the six months ended June 30, 2011. The Company continues to benefit from decreasing costs on interest-bearing liabilities.
Noninterest income for the quarter ended June 30, 2012 totaled $3.7 million, reflecting an increase of $2.5 million from $1.2 million in noninterest income reported for the quarter ended June 30, 2011. Noninterest income for the six months ended June 30, 2012 totaled $4.6 million, reflecting an increase of $2.2 million from $2.3 million in noninterest income reported for the six months ended June 30, 2011. Customer service fees continue to provide the majority of the Company’s noninterest income, totaling $897,000 for the quarter ended June 30, 2012, as compared to $894,000 for the quarter ended June 30, 2011, and $1.8 million for the six months ended June 30, 2012 and 2011. Changes in noninterest income on a quarter-to-quarter comparative basis between the second quarters of 2012 and 2011 are largely the result of an increase of $1.8 million on gains realized on the sale of investments and an increase of $598,000 on gains realized on the sale of other real estate owned. On a six month comparative basis, changes in noninterest income again were the result of an increase of $1.8 million on gains realized on the sale of investments and an increase of $381,000 on gains realized on the sale of other real estate owned.
Noninterest expense totaled $5.0 million for the quarter ended June 30, 2012, down $3.3 million from $8.2 million reported for the quarter ended June 30, 2011. For the six months ended June 30, 2012, noninterest expense totaled $10.5 million as down $3.8 million from the $14.3 million for the six months ended June 30, 2011. Between the second quarters of 2012 and 2011, the company experienced significant decreases in impairment losses on goodwill, impairment losses on other real estate owned, other real estate owned expenses, and professional fees. On a six month comparative basis, additional decreases in the above listed areas as well as decreases in regulatory assessments and occupancy expenses contributed to the overall decrease.
The Company had a provision for loan loss reserve of $1.0 million for the quarter ended June 30, 2012 and the six months ended June 30, 2012, compared to $9.2 million for the quarter ended June 30, 2011 and $10.1 million for the six months ended June 30, 2011. Net loan charge-offs totaled $2.4 million for the quarter ended June 30, 2012 and $3.0 million for the six months ended June 30, 2012 as compared to $12.0 million for the quarter ended June 30, 2011, and $12.7 million for the six months ended June 30, 2011. With continued weakness in the economy and real estate markets within our service area, we have maintained an adequate allowance for loan losses which totaled 2.94% of total loans at June 30, 2012 compared to 3.28% of total loans at March 31, 2012 and 3.29% at June 30, 2011. In determining the adequacy of the allowance for loan losses, Management’s judgment is the primary determining factor for establishing the amount of the provision for loan losses and management considers the allowance for loan and lease losses June 30, 2012 to be adequate.
Non-performing assets, comprised of nonaccrual loans, troubled debt restructures (TDR), other real estate owned through foreclosure (OREO), and loans more than 90 days past days and still accruing interest, decreased approximately $4.7 million between December 31, 2011 and June 30, 2012. Additionally, nonperforming assets as a percentage of total assets decreased from 8.84% at December 31, 2011 to 8.76% at June 30, 2012. Nonaccrual loans decreased $1.2 million between December 31, 2011 and June 30, 2012, while OREO, decreased $3.2 million during the same period. Impaired loans totaled $28.4 million at June 30, 2012, down $3.5 million from the balance of $31.9 million at December 31, 2011.
United Security Bancshares is a $600+ million bank holding company. United Security Bank, its principal subsidiary is a state chartered bank and member of the Federal Reserve Bank of San Francisco.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and the Company intends such statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995.
Forward-looking statements are based on management’s knowledge and belief as of today and include information concerning the Company’s possible or assumed future financial condition, and its results of operations, business and earnings outlook. These forward-looking statements are subject to risks and uncertainties. A number of factors, some of which are beyond the Company’s ability to control or predict, could cause future results to differ materially from those contemplated by such forward-looking statements. These factors include (1) changes in interest rates, (2) significant changes in banking laws or regulations, (3) increased competition in the company’s market, (4) other-than-expected credit losses, (5) earthquake or other natural disasters impacting the condition of real estate collateral, (6) the effect of acquisitions and integration of acquired businesses, (7) the impact of proposed and/or recently adopted changes in laws, and regulations on the Company and its business; (8) changing bank regulatory conditions, policies, whether arising as new legislation or regulatory initiatives or changes in our regulatory classifications, that could lead to restrictions on activities of banks generally or as to the Bank, including specifically the formal order between the Federal Reserve Bank of San Francisco and the Company and the Bank, (9) failure to comply with the regulatory agreement under which the Company is subject and (10) unknown economic impacts caused by the State of California’s budget issues. Management cannot predict at this time the severity or duration of the effects of the recent business slowdown on our specific business activities and profitability. Weaker or a further decline in capital and consumer spending, and related recessionary trends could adversely affect our performance in a number of ways including decreased demand for our products and services and increased credit losses. Likewise, changes in interest rates, among other things, could slow the rate of growth or put pressure on current deposit levels and affect the ability of borrowers to repay loans. Forward-looking statements speak only as of the date they are made, and the company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the statements are made, or to update earnings guidance including the factors that influence earnings. For a more complete discussion of these risks and uncertainties, see the Company’s Annual Report on Form 10-K for the year ended December 31, 2011, and particularly the section of Management’s Discussion and Analysis. Readers should carefully review all disclosures we file from time to time with the Securities and Exchange Commission (“SEC”).
|
United Security Bancshares
|
|
|
|
|
Consolidated Balance Sheets
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
June 30,
|
|
December 31,
|
|
2012
|
|
2011
|
|
Assets
|
|
|
|
|
Cash and noninterest-bearing deposits in other banks
|
$22,400
|
|
$28,052
|
|
Cash and due from Federal Reserve Bank
|
76,990
|
|
96,132
|
|
Federal funds sold
|
0
|
|
0
|
|
Cash and cash equivalents
|
99,390
|
|
124,184
|
|
Interest-bearing deposits in other banks
|
2,103
|
|
2,187
|
|
Investment securities (AFS at market value)
|
35,553
|
|
38,458
|
|
Loans and leases, net of unearned fees
|
394,563
|
|
408,146
|
|
Less: Allowance for credit losses
|
(11,610)
|
|
(13,648)
|
|
Net loans
|
382,953
|
|
394,498
|
|
Premises and equipment – net
|
12,566
|
|
12,675
|
|
Bank owned life insurance
|
16,413
|
|
16,150
|
|
Intangible assets
|
4,871
|
|
5,041
|
|
Other real estate owned
|
23,894
|
|
27,091
|
|
Deferred Income Taxes
|
11,154
|
|
11,485
|
|
Other assets
|
16,710
|
|
19,563
|
|
Total assets
|
$605,607
|
|
$651,332
|
|
Deposits:
|
|
|
|
|
Noninterest bearing demand and NOW
|
$197,052
|
|
$224,907
|
|
Money market and savings
|
213,204
|
|
206,036
|
|
Time
|
114,746
|
|
143,484
|
|
Total deposits
|
525,002
|
|
574,427
|
|
Borrowed funds
|
0
|
|
0
|
|
Other liabilities
|
5,512
|
|
5,705
|
|
Junior subordinated debentures (at fair value)
|
9,276
|
|
9,027
|
|
Total liabilities
|
539,790
|
|
589,159
|
|
Shareholders’ equity:
|
|
|
|
|
Common shares outstanding:
|
|
|
|
|
13,133,871 at March 31, 2012
|
|
|
|
|
13,531,832 at December 31, 2011
|
42,087
|
|
41,435
|
|
Retained earnings
|
24,029
|
|
21,447
|
|
Accumulated other comprehensive loss
|
(299)
|
|
(709)
|
|
Total shareholders’ equity
|
65,817
|
|
62,173
|
|
Total liabilities and shareholders’ equity
|
$605,607
|
|
$651,332
|
|
|
|
|
|
|
United Security Bancshares
|
|
|
|
|
|
(dollars in 000s, except per share amounts)
|
|
|
|
|
|
Three Months Ended
|
Three Months Ended
|
Six Months Ended
|
Six Months Ended
|
|
June 30,
|
June 30,
|
June 30,
|
June 30,
|
|
2012
|
2011
|
2012
|
2011
|
|
Interest income:
|
|
|
|
|
|
Interest and fees on loans
|
$5,966
|
$6,437
|
$12,009
|
$12,857
|
|
Interest on investment securities
|
457
|
540
|
978
|
1,137
|
|
Interest on deposits in FRB
|
43
|
43
|
94
|
94
|
|
Interest on deposits in other banks
|
10
|
10
|
20
|
20
|
|
Total interest income
|
6,476
|
7,030
|
13,101
|
14,108
|
|
Interest expense:
|
|
|
|
|
|
Interest on deposits
|
437
|
668
|
915
|
1,436
|
|
Interest on other borrowed funds
|
72
|
83
|
138
|
168
|
|
Total interest expense
|
509
|
751
|
1,053
|
1,6042
|
|
Net interest income before provision for credit losses
|
5,967
|
6,279
|
12,048
|
12,504
|
|
Provision for credit losses
|
1,004
|
9,161
|
1,006
|
10,051
|
|
Net interest income
|
4,963
|
(2,882)
|
11,042
|
2,453
|
|
Noninterest income:
|
|
|
|
|
|
Customer service fees
|
897
|
894
|
1,797
|
1,761
|
|
Increase in cash surrender value of
|
|
|
|
|
|
bank owned life insurance
|
144
|
140
|
280
|
281
|
|
Gain (Loss) on sale of other real estate owned
|
275
|
(324)
|
337
|
(44)
|
|
Gain (loss) on Fair Value Option of Financial Assets
|
364
|
222
|
(112)
|
(145)
|
|
Other noninterest income
|
1,984
|
242
|
2,256
|
449
|
|
Total noninterest income
|
3,664
|
1,174
|
4,558
|
2,302
|
|
Noninterest expense:
|
|
|
|
|
|
Salaries and employee benefits
|
2,176
|
2,220
|
4,598
|
4,541
|
|
Occupancy expense
|
840
|
909
|
1,605
|
1,802
|
|
Professional fees
|
439
|
980
|
683
|
1,419
|
|
Regulatory insurance assessments
|
417
|
475
|
783
|
988
|
|
Impairment losses and other expenses on OREO
|
(18)
|
1,157
|
666
|
2,073
|
|
Impairment losses on goodwill and intangible assets
|
0
|
1,489
|
0
|
1,525
|
|
Impairment losses on investment securities
|
149
|
0
|
172
|
0
|
|
Other noninterest expense
|
974
|
1,010
|
1,957
|
1,949
|
|
Total noninterest expense
|
4,977
|
8,240
|
10,464
|
14,297
|
|
Income before income tax provision
|
3,650
|
(9,948)
|
5,136
|
(9,542)
|
|
Provision (benefit) for income taxes
|
1,478
|
(3,599)
|
1,912
|
(3,549)
|
|
Net Income
|
$2,173
|
($6,349)
|
3,224
|
(5,993)
|
|
|
|
|
|
|
United Security Bancshares
|
|
|
|
|
|
Selected Financial Data (Quarters Unaudited)
|
|
|
|
|
|
(dollars in 000s, except per share amounts)
|
|
|
|
|
|
Three months Ended
|
Three months Ended
|
Six Months Ended
|
Six Months Ended
|
|
June 30,
|
June 30,
|
June 30,
|
June 30,
|
|
2012
|
2011
|
2012
|
2011
|
|
Basic earnings per share
|
$0.16
|
($0.46)
|
$0.23
|
($0.43)
|
|
Diluted earnings per share
|
$0.16
|
($0.46)
|
$0.23
|
($0.43)
|
|
Weighted average basic shares for EPS
|
13,803,824
|
13,803,824
|
13,803,824
|
13,803,824
|
|
Weighted average diluted shares for EPS
|
13,803,824
|
13,803,824
|
13,803,824
|
13,803,824
|
|
|
|
|
|
|
Annualized return on:
|
|
|
|
|
|
Average assets
|
1.42%
|
(3.82%)
|
1.05%
|
(1.81%)
|
|
Average equity
|
13.40%
|
(31.64%)
|
10.23%
|
(15.63%)
|
|
Yield on interest-earning assets
|
5.11%
|
5.06%
|
5.10%
|
5.04%
|
|
Cost of interest-bearing liabilities
|
0.61%
|
0.74%
|
.63%
|
.77%
|
|
Net interest margin
|
4.71%
|
4.52%
|
4.69%
|
4.47%
|
|
Annualized net charge-offs to average loans
|
2.44%
|
10.99%
|
1.54%
|
5.89%
|
|
|
|
|
|
|
June 30,
|
June 30,
|
|
|
|
2012
|
2011
|
|
|
|
Shares outstanding – period end
|
13,803,824
|
13,803,824
|
|
|
|
Book value per share
|
$4.77
|
$4.50
|
|
|
|
Tangible book value per share
|
$4.42
|
$4.14
|
|
|
|
Efficiency ratio
|
51.67%
|
110.56%
|
|
|
|
Total nonperforming assets
|
$53,023
|
$76,705
|
|
|
|
Nonperforming assets to total assets
|
8.76%
|
11.64%
|
|
|
|
Total Impaired loans
|
$28,375
|
$36,953
|
|
|
|
Total nonaccrual loans
|
$18,189
|
$20,792
|
|
|
|
Allowance for loan losses to total loans
|
2.94%
|
3.29%
|
|
|
SOURCE United Security Bancshares
LOS ANGELES, CA — (Marketwire) — 07/23/12 — Seven Arts Entertainment Inc. (NASDAQ: SAPX) (“Seven Arts” or the “Company”) announced today that Seven Arts Pictures Louisiana LLC (“SAPLA”) has filed both an audit with the Louisiana Department of Economic Development of its film infrastructure expenses at 807 Esplanade Avenue in New Orleans, Louisiana (“Property”) and a compilation with the Department of Parks, US Department of Interior and the Louisiana Historic District Commission of its historic rehabilitation expenses in connection with the Property. Seven Arts will be entitled to receive on or before December 31, 2012 from SAPLA approximately $8,800,000 of Federal and Louisiana historic rehabilitation tax credits and Louisiana film infrastructure tax credits earned by SAPLA based on the audit and compilation. The Company expects to realize the cash value of these tax credits by assignment to third parties at discounts customary in the market, but which should result in receipt by Seven Arts of in excess of $8,000,000.
As has been previously announced, the Company intends to operate through an affiliate a full service production and post-production facility at the Property. The Company expects to commence full operations at the Property in September, 2012 for both its own productions and third party productions filming in Louisiana under Louisiana’s successful film investment tax credit provisions.
CEO Peter Hoffman stated: “We have completed construction and historic rehabilitation of this extraordinary pre-Civil War property after almost five years of work. We believe this building will be the ‘go to’ facility of major productions in Louisiana, as both artistically stunning and equipped with the best modern editing and sound facilities. The tax credit revenue to Seven Arts will be substantial.”
About Seven Arts Entertainment Inc.:
Seven Arts Entertainment Inc. is the successor to Seven Arts Pictures Plc, which was founded in 2002 as an independent motion picture production and distribution company engaged in the development, acquisition, financing, production and licensing of theatrical motion pictures for exhibition in domestic (i.e., the United States and Canada) and foreign theatrical markets, and for subsequent worldwide release in other forms of media, including home video and pay and free television.
Cautionary Information Regarding Forward-Looking Statements.
Forward-looking statements contained in this press release are made under the Safe Harbor Provision of the Private Securities Litigation Reform Act of 1995. Any such statements are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated.
Contact:
Seven Arts Entertainment Inc.
Peter Hoffman
323-372-3080
phoffman@7artspictures.com
Court Determines No Event Of Default Has Occurred
EAST BRUNSWICK, N.J., July 23, 2012 /PRNewswire/ — Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) today announced that the Delaware Court of Chancery has issued a bench ruling granting both of Savient’s motions in the lawsuit brought against the Company by Tang Capital Partners, LP and certain other holders of Savient’s convertible notes. The Court of Chancery decided that the plaintiff noteholders do not have standing to bring an action to appoint a receiver for Savient and that an event of default has not occurred under Savient’s convertible notes. The Court has not yet come to a conclusion on the plaintiff’s claims for breach of fiduciary duty and waste. Savient continues to believe that all outstanding claims alleged by the plaintiffs are without merit, and intends to vigorously defend this lawsuit to its completion. The Court of Chancery’s decision is subject to appeal by the plaintiffs. In addition, Savient’s claim for damages against Tang Capital remains outstanding.
ABOUT SAVIENT PHARMACEUTICALS, INC.
Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and commercializing KRYSTEXXA® (pegloticase) for the treatment of chronic gout in adult patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA and its uses from Duke University (“Duke”) and Mountain View Pharmaceuticals, Inc. (“MVP”). Duke developed the recombinant uricase enzyme and MVP developed the PEGylation technology used in the manufacture of KRYSTEXXA. MVP and Duke have been granted U.S. and foreign patents disclosing and claiming the licensed technology and, in addition, Savient owns or co-owns U.S. and foreign patents and patent applications, which collectively form a broad portfolio of patents covering the composition, manufacture and methods of use and administration of KRYSTEXXA. Savient also manufactures and supplies Oxandrin® (oxandrolone tablets, USP) CIII in the U.S. For more information, please visit the Company’s website at www.savient.com.
Contact:
|
Mary Coleman
|
Kelly Sullivan / Taylor Ingraham
|
|
Savient Pharmaceuticals, Inc.
|
Joele Frank, Wilkinson Brimmer Katcher
|
|
information@savient.com
|
ksullivan@joelefrank.com / tingraham@joelefrank.com
|
|
(732) 418-9300
|
(212) 355-4449
|
Galectin Therapeutics (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that it has received a notice of issuance from the U.S. Patent and Trademark Office for Patent Number 8,236,780 “Galactose-prolonged polysaccharides in a formulation for antifibrotic therapies”. The patent covers key methods of derivation and use for the Company’s carbohydrate-based galectin inhibitor compound for use in patients with chronic liver disease associated with the development of fibrosis, established liver fibrosis or end-stage scarring, or cirrhosis. Fibrotic disease of the liver is highly prevalent in the population because all chronic liver disease of multiple causes (e.g., viral hepatitis, fatty liver, alcohol) results in fibrosis of the liver and there are no currently approved pharmaceutical therapies.
“The issuance of this patent asserts Galectin Therapeutics as the leader in developing galectin inhibitors for the treatment of liver fibrosis, and its broad coverage allows us protection as we explore the range of liver fibrosis for which our compounds could be efficacious,” said Peter G. Traber, MD, President, CEO and CMO of Galectin Therapeutics. “There is a truly vast unmet medical need for liver fibrosis, with the only current treatment option being liver transplantation. Preclinical results of our candidates have shown reversal of fibrosis in rodent models of disease, particularly in non-steatohepatitis, NASH, or fatty liver disease, which will be our first clinical indication for our fibrosis program.”
The major claim is for a method of obtaining the galectin inhibitor compound, obtaining a composition for parenteral administration in an acceptable pharmaceutical carrier and administering to a subject having at least one of the following: chronic liver disease associated with the development of fibrosis, established liver fibrosis or cirrhosis. The use covers inhibiting or slowing the progression of fibrosis or the reversal of fibrosis. The lead compound in development for NASH with fibrosis, GR-MD-02, is covered by this patent and it provides opportunities for development of additional compounds in the class.
About Galectin Therapeutics
Galectin Therapeutics (NASDAQ: GALT) is developing promising carbohydrate-based therapies for the treatment of fibrotic liver disease and cancer based on the Company’s unique understanding of galectin proteins, key mediators of biologic function. We are leveraging extensive scientific and development expertise as well as established relationships with external sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer. Additional information is available at www.galectintherapeutics.com.
Forward Looking Statements
This press release contains, in addition to historical information, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or future financial performance, and use words such as “may,” “estimate,” “could,” “expect” and others. They are based on our current expectations and are subject to factors and uncertainties which could cause actual results to differ materially from those described in the statements. Factors that could cause our actual performance to differ materially from those discussed in the forward-looking statements include, among others: incurrence of operating losses since our inception, uncertainty as to adequate financing of our operations, extensive and costly regulatory oversight that could restrict or prevent product commercialization, inability to achieve commercial product acceptance, inability to protect our intellectual property, dependence on strategic partnerships, product competition, and others stated in risk factors contained in our SEC filings. We cannot assure that we have identified all risks or that others may emerge which we do not anticipate. You should not place undue reliance on forward-looking statements. Although subsequent events may cause our views to change, we disclaim any obligation to update forward-looking statements.
MoSys, Inc., (NASDAQ: MOSY), a leader in semiconductor solutions that enable fast, intelligent data access for network and communications systems, today reported financial results for the second quarter ended June 30, 2012.
Second Quarter Highlights
- Released first generation carrier-grade Bandwidth Engine® IC to production;
- Shipped first Bandwidth Engine IC production units;
- Expanded sales channel coverage in North America; and
- Ended the quarter with total cash and investments of approximately $49 million.
Management Commentary
Commenting on the quarter, Len Perham, MoSys’ President and Chief Executive Officer, said: “In the quarter, we released our first generation Bandwidth Engine IC into production and made initial production shipments for customer prototyping and system-level qualifications. The commencement of production shipments represents another major achievement in our evolution to become a fabless semiconductor company. We also completed multiple, onsite operational audits that fully affirmed our ISO 9000 compliance and carrier-grade rating, further assuring customers that we have the capabilities to meet or exceed their quality standards and support their future volume production requirements.
“We continue to collaborate closely with new and existing customers to integrate our high-speed, serial access Bandwidth Engine IC into their next-generation systems. Over the last few months, we expanded our sales and support channel, with a strong focus on accelerating customer adoption and increasing design win momentum.”
Second Quarter Results
Total net revenue for the second quarter of 2012 was $1.7 million, compared with $1.4 million reported in the first quarter of 2012 and $3.3 million in the second quarter of 2011.
Second quarter 2012 total revenue included licensing and other revenue of $0.6 million, compared with $0.2 million for the previous quarter and $1.2 million for the second quarter of 2011. Second quarter 2012 royalty revenue was $1.1 million, compared with $1.2 million in the previous quarter and $2.1 million for the second quarter of 2011.
Gross margin for the second quarter of 2012 was 90 percent, compared with 96 percent in the first quarter of 2012 and 86 percent for the second quarter of 2011.
Total operating expenses on a GAAP basis for the second quarter of 2012 were $8.1 million, compared with $8.6 million in the previous quarter and $8.5 million of expenses for the second quarter of 2011. Second quarter 2012 operating expenses included $0.6 million of amortization of intangible assets and $1.0 million of stock-based compensation expense.
GAAP net loss for the second quarter of 2012 was $6.6 million, or ($0.17) per share, compared with a net loss of $7.2 million, or ($0.19) per share, in the previous quarter and a net loss of $5.7 million, or ($0.15) per share, for the second quarter of 2011. The non-GAAP net loss for the second quarter of 2012 was $5.0 million, or ($0.13) per share, which excludes amortization of intangible assets and stock-based compensation expense. Earnings per share for the second quarter of 2012 were computed using approximately 38.9 million shares on a GAAP and non-GAAP basis. A reconciliation of GAAP results to non-GAAP results is provided in the financial statement tables following the text of this press release.
As of June 30, 2012, cash and investments totaled $48.9 million.
Financial Results Webcast / Conference Call
MoSys will host a conference call and webcast with investors today at 5:30 a.m. Pacific Time (8:30 a.m. Eastern Time) to discuss the second quarter 2012 financial results. Investors and other interested parties may access the call by dialing 1-800-659-2056 in the U.S. (1-617-614-2714 outside of the U.S.), and entering the pass code 79076983 at least 10 minutes prior to the start of the call. In addition, an audio webcast will be available through the MoSys Web site at http://www.mosys.com. A telephone replay will be available for two business days following the call at 1-888-286-8010 in the U.S. (1-617-801-6888 outside of the U.S.), pass code of 79831991.
Use of Non-GAAP Financial Measures
To supplement MoSys’ consolidated financial statements presented in accordance with GAAP, MoSys uses non-GAAP financial measures that exclude from the statement of operations the effects of stock-based compensation and amortization of recorded intangible assets. MoSys’ management believes that the presentation of these non-GAAP financial measures is useful to investors and other interested persons because they are one of the primary indicators that MoSys’ management uses for planning and forecasting future performance. MoSys’ management believes that the presentation of non-GAAP financial measures that exclude these items is useful to investors because MoSys’ management does not consider these charges part of the day-to-day business or reflective of the core operational activities of the Company that are within the control of management or that would be used to evaluate management’s operating performance.
Investors are encouraged to review the reconciliation of these non-GAAP financial measures to the comparable GAAP results, which is provided in a table below the Condensed Consolidated Statements of Operations. The non-GAAP financial measures disclosed by the Company should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. The non-GAAP financial measures used by the Company may be calculated differently from, and therefore may not be comparable to, similarly titled measures used by other companies. For additional information regarding these non-GAAP financial measures, and management’s explanation of why it considers such measures to be useful, refer to the Form 8-K dated July 20, 2012, that the Company filed with the Securities and Exchange Commission.
Forward-Looking Statements
This press release may contain forward-looking statements about the Company, including, without limitation, benefits and performance expected from use of the Company’s embedded memory and interface technologies, anticipated benefits and performance expected from the Bandwidth Engine product and the Company’s future markets and future business prospects.
Forward-looking statements are based on certain assumptions and expectations of future events that are subject to risks and uncertainties. Actual results and trends may differ materially from historical results or those projected in any such forward-looking statements depending on a variety of factors. These factors include, but are not limited, to the following:
- achieving additional design wins for the Bandwidth Engine IC;
- commencing volume shipments of Bandwidth Engine ICs;
- our ability to enhance our existing proprietary technologies and develop new technologies;
- achieving necessary acceptance of our IC architecture and interface protocols by potential customers and their suppliers;
- difficulties and delays in the development, production, testing and marketing of our ICs;
- reliance on our manufacturing partners to assist successfully with the fabrication of our ICs;
- availability of quantities of ICs supplied by our manufacturing partners at a competitive cost;
- our lack of recent experience as a fabless semiconductor company making and selling proprietary ICs;
- level of intellectual property protection provided by our patents, the expenses and other consequences of litigation, including intellectual property infringement litigation, to which we may be or may become a party from time to time;
- vigor and growth of markets served by our customers and our operations; and
other risks identified in the Company’s most recent reports on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission, as well as other reports that MoSys files from time to time with the Securities and Exchange Commission. MoSys undertakes no obligation to update publicly any forward-looking statement for any reason, except as required by law, even as new information becomes available or other events occur in the future.
About MoSys, Inc.
MoSys, Inc. (NASDAQ: MOSY) is an IP-rich fabless semiconductor company that provides high performance solutions for fast, intelligent data access in network and communications systems. Engineered and built for high-reliability carrier and enterprise applications, MoSys’ products are breaking bandwidth barriers™ in data processing to allow for faster packet access and analysis, expanded user capacity and new capabilities required by the expanding global infrastructure. MoSys’ Bandwidth Engine® family of ICs combines the company’s patented 1T-SRAM® high-density, embedded memory and high-speed, 10 Gigabits per second serial interface with its intelligent access technology and a highly efficient GigaChip™ Interface transport protocol to eliminate bottlenecks in high-speed data access. MoSys is headquartered in Santa Clara, California, and more information is available at http://www.mosys.com.
MoSys, 1T-SRAM and Bandwidth Engine are registered trademarks of MoSys, Inc. in the US and/or other countries. Breaking Bandwidth Barriers, GigaChip and the MoSys logo are trademarks of MoSys, Inc. All other marks mentioned herein are the property of their respective owners.
| MOSYS, INC. |
| CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
| (In thousands, except per share amounts; unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Six Months Ended |
|
|
|
|
|
|
June 30, |
|
June 30, |
|
|
|
|
|
|
|
2012 |
|
|
|
2011 |
|
|
|
2012 |
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net Revenue |
|
|
|
|
|
|
|
|
|
|
Licensing and other |
|
|
$ |
644 |
|
|
$ |
1,216 |
|
|
$ |
865 |
|
|
$ |
2,563 |
|
|
Royalty |
|
|
|
1,092 |
|
|
|
2,076 |
|
|
|
2,295 |
|
|
|
4,268 |
|
|
Total net revenue |
|
|
|
1,736 |
|
|
|
3,292 |
|
|
|
3,160 |
|
|
|
6,831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cost of Net Revenue |
|
|
|
|
|
|
|
|
|
|
Licensing and other |
|
|
|
179 |
|
|
|
469 |
|
|
|
236 |
|
|
|
1,159 |
|
|
Total cost of net revenue |
|
|
|
179 |
|
|
|
469 |
|
|
|
236 |
|
|
|
1,159 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross Profit |
|
|
|
1,557 |
|
|
|
2,823 |
|
|
|
2,924 |
|
|
|
5,672 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Operating Expenses |
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
|
6,688 |
|
|
|
6,566 |
|
|
|
14,194 |
|
|
|
12,721 |
|
|
Selling, general and administrative |
|
|
|
1,428 |
|
|
|
1,917 |
|
|
|
4,354 |
|
|
|
4,631 |
|
|
Gain on sale of assets |
|
|
|
– |
|
|
|
– |
|
|
|
(1,856 |
) |
|
|
– |
|
|
Total operating expenses |
|
|
|
8,116 |
|
|
|
8,483 |
|
|
|
16,692 |
|
|
|
17,352 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from operations |
|
|
|
(6,559 |
) |
|
|
(5,660 |
) |
|
|
(13,768 |
) |
|
|
(11,680 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income, net |
|
|
|
36 |
|
|
|
25 |
|
|
|
60 |
|
|
|
34 |
|
|
Loss before income taxes |
|
|
|
(6,523 |
) |
|
|
(5,635 |
) |
|
|
(13,708 |
) |
|
|
(11,646 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income tax provision |
|
|
|
30 |
|
|
|
17 |
|
|
|
60 |
|
|
|
35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
|
|
$ |
(6,553 |
) |
|
$ |
(5,652 |
) |
|
$ |
(13,768 |
) |
|
$ |
(11,681 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss per share |
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
|
($0.17 |
) |
|
|
($0.15 |
) |
|
|
($0.36 |
) |
|
|
($0.31 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares used in computing net loss per share |
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
|
38,880 |
|
|
|
37,738 |
|
|
|
38,723 |
|
|
|
37,505 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MOSYS, INC. |
| CONDENSED CONSOLIDATED BALANCE SHEETS |
| (in thousands, unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
December 31, |
|
|
|
|
|
|
|
|
2012 |
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
| Assets |
|
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
|
Cash, cash equivalents and investments |
|
|
|
|
$ |
30,313 |
|
$ |
49,438 |
|
|
Accounts receivable, net |
|
|
|
|
|
326 |
|
|
969 |
|
|
Unbilled contract receivables |
|
|
|
|
|
33 |
|
|
74 |
|
|
Prepaid expenses and other assets |
|
|
|
|
|
1,742 |
|
|
1,522 |
|
|
|
Total current assets |
|
|
|
|
|
32,414 |
|
|
52,003 |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term investments |
|
|
|
|
|
18,626 |
|
|
8,537 |
|
Property and equipment, net |
|
|
|
|
|
924 |
|
|
1,382 |
|
Goodwill |
|
|
|
|
|
23,134 |
|
|
23,134 |
|
Intangible assets, net |
|
|
|
|
|
3,154 |
|
|
4,400 |
|
Other assets |
|
|
|
|
|
177 |
|
|
181 |
|
|
|
Total assets |
|
|
|
|
$ |
78,429 |
|
$ |
89,637 |
|
|
|
|
|
|
|
|
|
|
|
| Liabilities and Stockholders’ Equity |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
|
Accounts payable |
|
|
|
|
$ |
623 |
|
$ |
336 |
|
|
Accrued expenses and other liabilities |
|
|
|
|
|
2,278 |
|
|
2,779 |
|
|
Deferred revenue |
|
|
|
|
|
851 |
|
|
920 |
|
|
|
Total current liabilities |
|
|
|
|
|
3,752 |
|
|
4,035 |
|
|
|
|
|
|
|
|
|
|
|
|
Long-term liabilities |
|
|
|
|
|
144 |
|
|
109 |
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity |
|
|
|
|
|
74,533 |
|
|
85,493 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and stockholders’ equity |
|
|
|
|
$ |
78,429 |
|
$ |
89,637 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MOSYS, INC. |
| Reconciliation of GAAP to Non-GAAP Net Loss and Net Loss Per Share |
| (In thousands, except per share amounts; unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
|
Six Months Ended |
|
|
|
|
|
|
|
June 30, |
|
|
|
June 30, |
|
|
|
|
|
|
|
|
2012 |
|
|
|
2011 |
|
|
|
|
|
2012 |
|
|
|
2011 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
|
|
$ |
(6,553 |
) |
|
$ |
(5,652 |
) |
|
|
|
$ |
(13,768 |
) |
|
$ |
(11,681 |
) |
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
-Cost of net revenue |
|
|
|
|
38 |
|
|
|
46 |
|
|
|
|
|
46 |
|
|
|
107 |
|
|
-Research and development |
|
|
|
|
730 |
|
|
|
507 |
|
|
|
|
|
1,496 |
|
|
|
810 |
|
|
-Selling, general and administrative |
|
|
|
|
252 |
|
|
|
291 |
|
|
|
|
|
521 |
|
|
|
636 |
|
|
Total stock-based compensation expense |
|
|
|
|
1,020 |
|
|
|
844 |
|
|
|
|
|
2,063 |
|
|
|
1,553 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of intangible assets |
|
|
|
|
563 |
|
|
|
654 |
|
|
|
|
|
1,246 |
|
|
|
1,309 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net loss |
|
|
|
$ |
(4,970 |
) |
|
$ |
(4,154 |
) |
|
|
|
$ |
(10,459 |
) |
|
$ |
(8,819 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss per share |
|
|
|
$ |
(0.17 |
) |
|
$ |
(0.15 |
) |
|
|
|
$ |
(0.36 |
) |
|
$ |
(0.31 |
) |
|
Reconciling items |
|
|
|
|
|
|
|
|
|
|
|
|
|
-Stock-based compensation expense |
|
|
|
|
0.03 |
|
|
|
0.02 |
|
|
|
|
|
0.06 |
|
|
|
0.04 |
|
|
-Amortization of intangible assets |
|
|
|
|
0.01 |
|
|
|
0.02 |
|
|
|
|
|
0.03 |
|
|
|
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP net loss per share: Basic and diluted |
|
|
|
$ |
(0.13 |
) |
|
$ |
(0.11 |
) |
|
|
|
$ |
(0.27 |
) |
|
$ |
(0.24 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares used in computing non-GAAP net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic and diluted |
|
|
|
|
38,880 |
|
|
|
37,738 |
|
|
|
|
|
38,723 |
|
|
|
37,505 |
|

As EmFinders Goes Out of Business, SafetyNet Offers Ongoing Protection from the Dangers of Wandering to People with Autism and Alzheimer’s
CANTON, Mass., July 20, 2012 /PRNewswire/ — With EmFinders suspending all of its business operations, LoJack SafetyNet, Inc., a wholly owned subsidiary of LoJack Corporation (NASDAQ: LOJN), announced today that it will waive the enrollment fee for its SafetyNet tracking and rescue service to former clients of EmFinders. The offer, which will provide continued protection from the dangers of wandering to people who have Alzheimer’s and autism, is valid in all areas where the SafetyNet by LoJack service is available. Former EmFinders clients who are interested in enrolling in the SafetyNet service, should call (877) 4-FINDTHEM (877-434-6384) or visit www.safetynetbylojack.com.
The SafetyNet by LoJack service helps caregivers provide an added layer of protection for loved ones with cognitive conditions such as autism and Alzheimer’s from the potentially life-threatening behavior of wandering. The service also provides public safety agencies with the tools and training to more effectively find and rescue those individuals if they wander and go missing.
“Our mission at LoJack SafetyNet is to bring this valuable service to people who are at risk to the dangers of wandering and provide peace of mind for their loved ones,” said Kathy Kelleher, Vice President, LoJack SafetyNet, Inc. “This offer provides people who were enrolled in the EmFinders’ service – and are now potentially without protection – an easy and affordable way to transition to SafetyNet, a highly effective alternative tracking and rescue service.”
How the SafetyNet Service Works
Once caregivers enroll their loved ones in the service, they receive a SafetyNet Bracelet, which is worn by the person at risk typically on his/her wrist or ankle. The caregiver provides information about the client to assist in search and rescue, which is then entered into a secure database. LoJack SafetyNet provides 24 hours 7 days a week emergency caregiver support. For participating public safety agencies, LoJack SafetyNet provides tracking equipment, certified training and ongoing support at no cost to the agencies or taxpayers.
The SafetyNet Bracelet constantly emits a Radio Frequency signal, which can be detected by public safety agencies in all areas where the SafetyNet by LoJack service is available. Radio Frequency is the technology of choice because its signal doesn’t rely on cellular networks or GPS systems and can often be tracked even if a client wanders into a shallow body of water, a densely wooded area, a concrete structure such as a garage, or a building constructed with steel.
The SafetyNet tracking equipment that is used by public safety agencies can detect the Radio Frequency signal emitted from a SafetyNet Bracelet typically within a range of approximately one mile in on-the-ground searches and 5-7 miles in searches by helicopter.
The SafetyNet certified training for public safety agencies focuses on the service’s specialized electronic equipment, technology, procedures and on how to effectively communicate with and approach individuals who have cognitive conditions. SafetyNet’s secure database contains information on each individual client enrolled in the service so that the search and rescue team can have information on the individual’s physical characteristics, personal habits and how he or she should be approached, spoken to and comforted.
Resources for Caregivers
LoJack offers an online information and resource center designed to assist caregivers seeking tips on how to protect their loved ones who wander. The resource center offers compelling content from across the web, access to the SafetyNetSource Twitter feed and YouTube channel, a Facebook page to help caregivers communicate with one another and engage in a community of support. It also provides a variety of valuable resources for caregivers such as a form to distribute to the local first responders and neighbors that may be helpful in the event their loved one wanders.
Availability & More Information
For more information about the SafetyNet service, please call (877) 4-FINDTHEM (877-434-6384) or visit www.safetynetbylojack.com.
|
CONTACT:
|
|
|
|
Jeremy Warnick
|
Jeanne Bock
|
Laura Feng
|
|
LoJack SafetyNet
|
Tier One Partners
|
Tier One Partners
|
|
781-302-4251
|
781-861-5249
|
978-975-1414
|
TAPPAHANNOCK, Va., July 20, 2012 /PRNewswire/ — Eastern Virginia Bankshares (NASDAQ:EVBS) today reported its results of operations for the three and six months ended June 30, 2012.
For the three months ended June 30, 2012, EVBS reported net operating income of $848 thousand, an increase of $625 thousand over the net operating income of $223 thousand reported for the same period of 2011. Net income to common shareholders was $473 thousand, or $0.08 per common share, assuming dilution, compared to a net loss of ($151) thousand or ($0.03) per common share for the same period in 2011. For the six months ended June 30, 2012, EVBS reported net operating income of $1.7 million, an increase of $965 thousand over the net operating income of $697 thousand reported for the same period of 2011. Net income to common shareholders was $912 thousand, or $0.15 per common share, assuming dilution, compared to a net loss of ($51) thousand or ($0.01) per common share for the same period in 2011. The difference between net operating income and net income (loss) to common shareholders is the deduction for the effective dividend to the U.S. Treasury on preferred stock.
For the three months ended June 30, 2012, the following key points were significant factors in our reported results:
- Provision expense for the allowance for loan losses of $1.3 million compared to $1.5 million for the same period in 2011;
- Net charge-offs of $1.5 million to write off uncollectible balances on nonperforming assets;
- Decrease in nonperforming assets by $6.2 million during the second quarter of 2012;
- Gain on the sale of available for sale securities of $832 thousand resulting from adjustments in the composition of the investment portfolio as part of our overall asset/liability management strategy;
- Decrease in net interest income by $766 thousand from the same period in 2011;
- Impairment losses of $292 thousand related to valuation adjustments on other real estate owned;
- Losses of $44 thousand on the sale of other real estate owned;
- Expenses related to FDIC insurance premiums of $587 thousand, compared to $931 thousand for the same period in 2011; and
- Expenses related to collection, repossession and other real estate owned of $350 thousand, compared to $567 thousand for the same period in 2011.
For the six months ended June 30, 2012, the following key points were significant factors in our reported results:
- Provision expense for the allowance for loan losses of $4.2 million compared to $3.5 million for the same period in 2011;
- Net charge-offs of $5.4 million to write off uncollectible balances on nonperforming assets;
- Decrease in nonperforming assets by $15.6 million during the first six months of 2012;
- Gain on the sale of available for sale securities of $3.4 million resulting from adjustments in the composition of the investment portfolio as part of our overall asset/liability management strategy;
- Decrease in net interest income by $1.1 million from the same period in 2011;
- Impairment losses of $907 thousand related to valuation adjustments on other real estate owned;
- Losses of $117 thousand on the sale of other real estate owned;
- Expenses related to FDIC insurance premiums of $1.2 million, compared to $1.4 million for the same period in 2011; and
- Expenses related to collection, repossession and other real estate owned of $655 thousand, compared to $1.0 million for the same period in 2011.
The return on average assets (ROA) and return on average equity (ROE), on an annualized basis, for the three months ended June 30, 2012 were 0.18% and 2.62%, respectively compared to (0.06%) and (0.86%), respectively for the three months ended June 30, 2011. For the six months ended June 30, 2012, on an annualized basis, ROA and ROE were 0.17% and 2.53%, respectively compared to (0.01%) and (0.15%), respectively for the same period of 2011.
In announcing these results, Joe A. Shearin, President and Chief Executive Officer commented “I am very pleased to report the continuation of our improved results for the quarter just ended. Our net operating income increased by over 280% during the second quarter of 2012, as compared to the same period in 2011, and our overall noninterest expenses continued to decline as targeted.” Shearin further commented, “As we expected, we had another very successful quarter in the liquidation of troubled assets and improving our overall asset quality. During the second quarter of 2012 we were able to reduce our nonperforming assets by almost 22%, bringing our year to date reduction to a little over 41%. In addition to this, our loans past due 30+ days as a percentage of net loans outstanding fell to a three year low of 2.17%. We are encouraged that these positive trends are reflective of an economic stabilization in the local markets we serve.”
Operations Analysis
Net interest income for the three months ended June 30, 2012 was $8.3 million, a decrease of $766 thousand or 8.5% from the $9.1 million for the same period of 2011. This decrease was due to a 32 basis point decrease in the net interest margin (tax equivalent basis) from 3.67% (includes a tax equivalent adjustment of $84 thousand) in the second quarter of 2011, to 3.35% (includes a tax equivalent adjustment of $29 thousand) in the second quarter of 2012. The year over year decline in interest income was primarily driven by the impact of declining loan balances due to weak loan demand, charge-offs and the natural amortization of the portfolio. While the average investment securities balance increased $42.4 million to $263.8 million during the three months ended June 30, 2012, the yield on investment securities declined 132 basis points from 3.42% to 2.10% for the second quarter of 2012. The lower yield resulted from the portfolio restructuring and investing in lower risk, shorter duration investments. As a result, the yield on our average interest-earning assets declined 63 basis points to 4.56% for the three months ended June 30, 2012 as compared to the same period in 2011. The decline in interest income was somewhat offset by a lower cost of funding. Our lower cost of funding was driven by the continuation of our deposit re-pricing strategy, reductions in the level of time deposits, and increased levels of interest-bearing checking, savings and money market savings accounts with lower rates. As a result, the average cost of interest-bearing deposits decreased 42 basis points to 0.95% for the three months ended June 30, 2012 as compared to the same period in 2011.
Net interest income for the six months ended June 30, 2012 was $16.7 million, a decrease of $1.1 million or 6.3% from the $17.9 million for the same period of 2011. The net interest margin (tax equivalent basis) decreased 22 basis points from 3.62% (includes a tax equivalent adjustment of $252 thousand) for the six months ended June 30, 2011 to 3.40% (includes a tax equivalent adjustment of $180 thousand) in the same period of 2012. The tax equivalent yield on average interest-earning assets declined 52 basis points in the six months ended June 30, 2012 compared with the same period of 2011, but was partially offset by a 32 basis point decrease in the cost of interest-bearing liabilities over the same period. Average interest-earning assets were $999.5 million in the six months ended June 30, 2012, which was a decrease of $10.2 million or 1.0% from the same period of 2011. Total average loans were 72.4% of total interest-earning assets in the six months ended June 30, 2012, compared to 76.0% in the six months ended June 30, 2011. This decline was driven by the impact of declining loan balances due to the aforementioned items in the quarterly analysis above and our desire to increase liquidity through the expansion of the investment portfolio.
Noninterest income for the three months ended June 30, 2012 was $2.2 million, an increase of $521 thousand or 31.4% over the same period of 2011. Debit/credit card fees decreased $48 thousand, or 11.7% in the second quarter of 2012, which was primarily attributable to a decrease in debit card income. Other operating income decreased $79 thousand, or 28.4% in the second quarter of 2012, which was driven by lower rental income on OREO properties, lower earnings from our subsidiary EVB Financial Services, Inc. (Investment, Mortgage) and increased write downs of our investments in community and housing development funds. Net gains on the sale of available for sale securities increased $703 thousand to $832 thousand for the three months ended June 30, 2012, up from $129 thousand for the same period in 2011.
Noninterest income for the six months ended June 30, 2012 was $6.1 million, an increase of $2.3 million or 62.3% over the same period of 2011. Service charges and fees on deposit accounts decreased $221 thousand, or 12.4% in the first six months of 2012, which was primarily attributable to a decrease in non-sufficient funds (“NSF”) fees. Other operating income decreased $174 thousand, or 26.3% in the first six months of 2012, which was driven by the aforementioned items in the quarterly analysis above. Net gains on the sale of available for sale securities increased $3.0 million to $3.4 million for the six months ended June 30, 2012, up from $322 thousand for the same period of 2011. In addition to the aforementioned items, the six months ended June 30, 2011 includes a $256 thousand gain on the sale of our former Aylett branch office, which was not present during the same period of 2012.
Noninterest expense for the three months ended June 30, 2012 was $8.1 million, a decrease of $985 thousand or 10.8% over noninterest expense of $9.1 million for the three months ended June 30, 2011. Occupancy and equipment expenses decreased $179 thousand, or 12.6% in the second quarter of 2012, due to decreased core IT service contracts and lower depreciation and amortization on equipment and software. FDIC insurance expense decreased $344 thousand, or 36.9% in the second quarter of 2012, due to modifications of the risk-based assessment system and the base assessment rates beginning in the second quarter of 2011. Expenses related to collection, repossession and OREO decreased $217 thousand, or 38.3% in the second quarter of 2012 primarily due to the overall decrease in the carrying balance of OREO and the Company’s efforts to focus resources internally to more efficiently manage collection and repossession activities. Other operating expenses decreased $248 thousand, or 12.1% in the second quarter of 2012, primarily due to decreases of $52 thousand or 16.2% in telephone, $107 thousand or 33.5% in consultant fees and $36 thousand or 16.7% in marketing and advertising. For the second quarter of 2012, noninterest expense includes $292 thousand in impairment losses related to valuation adjustments on OREO compared to $77 thousand for the same period in 2011. In addition, noninterest expense for the three months ended June 30, 2012 includes losses on the sale of OREO of $44 thousand compared to $48 thousand for the same period of 2011.
Noninterest expense for the six months ended June 30, 2012 was $16.7 million, a decrease of $934 thousand or 5.3% over noninterest expense of $17.6 million for the six months ended June 30, 2011. FDIC insurance expense decreased $253 thousand, or 17.7% in the six months ended June 30, 2012 due to the aforementioned items as described in the quarterly analysis above. Expenses related to collection, repossession and OREO decreased $365 thousand, or 35.8% in the six months ended June 30, 2012 primarily due to the overall decrease in the carrying balance of OREO. Other operating expenses decreased $297 thousand, or 7.6% for the six months ended June 30, 2012, primarily due to a decrease of $207 thousand or 34.9% in consultant fees. For the six months ended June 30, 2012, noninterest expense includes $907 thousand in impairment losses related to valuation adjustments on OREO compared to $229 thousand for the same period in 2011. In addition, noninterest expense for the six months ended June 30, 2012 includes losses on the sale of OREO of $117 thousand compared to $295 thousand for the same period of 2011.
Balance Sheet and Asset Quality
Total assets decreased $698 thousand or 0.1% between June 30, 2011 and June 30, 2012, and are down $9.3 million from March 31, 2012. Between June 30, 2011 and June 30, 2012, investment securities increased $37.8 million or 17.4% to $254.7 million, and are down $79 thousand from March 31, 2012. Loans, net of unearned income decreased $37.6 million or 5.0% from June 30, 2011 to $714.8 million at June 30, 2012, and are down $6.3 million from $721.2 million as of March 31, 2012. Total deposits decreased $2.4 million or 0.3% from June 30, 2011 to $832.1 million at June 30, 2012, and are down $11.6 million from $843.7 million as of March 31, 2012. Year to date average investment securities were $245.8 million as of June 30, 2012, an increase of $27.3 million or 12.5% compared to the same period in 2011. Year to date average loans were $724.0 million as of June 30, 2012, a decrease of $43.4 million or 5.7% compared to the same period in 2011. Year to date average total deposits were $833.9 million as of June 30, 2012, a decrease of $19.2 million or 2.3% compared to the same period in 2011.
The asset quality measures depicted below continue to reflect the Company’s efforts to prudently charge-off loans and increase our allowance for potential future loan losses.
The following table depicts the net charge-off activity for the three and six months ended June 30, 2012 and 2011.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
Six months ended
|
|
|
(dollars in thousands)
|
|
June 30,
|
|
June 30,
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
|
Net charge-offs
|
|
$ 1,534
|
|
$ 1,075
|
|
$ 5,395
|
|
$ 2,035
|
|
|
Net charge-offs to average loans
|
|
0.86%
|
|
0.57%
|
|
1.50%
|
|
0.53%
|
|
|
|
|
|
|
|
|
|
|
|
The following table depicts the level of the allowance for loan losses for the periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands)
|
|
June 30,
|
|
December 31,
|
|
June 30,
|
|
|
|
2012
|
|
2011
|
|
2011
|
|
|
Allowance for loan losses
|
|
$ 22,866
|
|
$ 24,102
|
|
$ 26,753
|
|
|
Allowance for loan losses to period end loans
|
|
3.20%
|
|
3.28%
|
|
3.56%
|
|
|
Allowance for loan losses to nonaccrual loans
|
|
156.51%
|
|
79.56%
|
|
116.97%
|
|
|
Allowance for loan losses to nonperforming loans
|
|
152.99%
|
|
79.12%
|
|
108.77%
|
|
|
|
|
|
|
|
|
|
The following table depicts the level of nonperforming assets for the periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands)
|
|
June 30,
|
|
December 31,
|
|
June 30,
|
|
|
|
2012
|
|
2011
|
|
2011
|
|
|
Nonaccrual loans
|
|
$14,609
|
|
$ 30,293
|
|
$22,871
|
|
|
Loans past due 90 days and accruing interest
|
|
336
|
|
168
|
|
1,724
|
|
|
Total nonperforming loans
|
|
$14,945
|
|
$ 30,461
|
|
$24,595
|
|
|
Other real estate owned (“OREO”)
|
|
7,226
|
|
7,326
|
|
10,980
|
|
|
Total nonperforming assets
|
|
$22,171
|
|
$ 37,787
|
|
$35,575
|
|
|
|
|
|
|
|
|
|
|
Nonperforming assets to total loans and OREO
|
|
3.07%
|
|
5.09%
|
|
4.66%
|
|
|
|
|
|
|
|
|
|
The following tables present the change in the balances of OREO and nonaccrual loans for the six months ended June 30, 2012.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OREO:
|
|
|
|
|
Nonaccrual Loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
(dollars in thousands)
|
|
|
|
|
Balance at December 31, 2011
|
|
|
$ 7,326
|
|
Balance at December 31, 2011
|
|
|
$ 30,293
|
|
Transfers from loans
|
|
|
2,885
|
|
Loans returned to accrual status
|
|
|
(6,681)
|
|
Capitalized costs
|
|
|
–
|
|
Net principal curtailments
|
|
|
(6,561)
|
|
Sales proceeds
|
|
|
(1,961)
|
|
Charge-offs
|
|
|
(5,363)
|
|
Impairment losses on valuation adjustments
|
|
|
(907)
|
|
Loan collateral moved to OREO
|
|
|
(2,885)
|
|
Loss on disposition
|
|
|
(117)
|
|
Loans placed on nonaccrual during period
|
|
|
5,806
|
|
Balance at June 30, 2012
|
|
|
$ 7,226
|
|
Balance at June 30, 2012
|
|
|
$ 14,609
|
|
|
|
|
|
|
|
|
|
In general, the modification or restructuring of a loan constitutes a troubled debt restructuring (“TDR”) when we grant a concession to a borrower experiencing financial difficulty. The following table depicts the balances of TDRs for the periods presented.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30,
|
|
December 31,
|
|
June 30,
|
|
(dollars in thousands)
|
|
|
2012
|
|
2011
|
|
2011
|
|
|
|
|
|
|
|
|
|
Performing TDRs
|
|
|
$ 4,332
|
|
$ 5,517
|
|
$ 7,896
|
|
Nonperforming TDRs*
|
|
|
9,349
|
|
13,378
|
|
8,846
|
|
Total TDRs
|
|
|
$ 13,681
|
|
$ 18,895
|
|
$ 16,742
|
|
|
|
|
|
|
|
|
|
* Included in nonaccrual loans.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forward-Looking Statements
Certain statements contained in this release that are not historical facts may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition, certain statements may be contained in the Company’s future filings with the SEC, in press releases, and in oral and written statements made by or with the approval of the Company that are not statements of historical fact and constitute forward-looking statements within the meaning of the Act. Examples of forward-looking statements include, but are not limited to: (i) projections of revenues, expenses, income or loss, earnings or loss per share, the payment or nonpayment of dividends, capital structure and other financial items; (ii) statements of plans, objectives and expectations of the Company or its management or Board of Directors, including those relating to products or services, the payment of dividends or the ability to realize deferred tax assets; (iii) statements of future economic performance; (iv) statements regarding the impact of the Written Agreement on our financial condition, operations and capital strategies, including strategies related to payment of dividends on the Company’s outstanding common and preferred stock and to payment of interest on the Company’s outstanding Junior Subordinated Debentures related to the Company’s trust preferred debt; (v) statements regarding the adequacy of the allowance for loan losses; (vi) statements regarding the effect of future sales of foreclosed properties; (vii) statements regarding the Company’s liquidity; (viii) statements of management’s expectations regarding future trends in interest rates, real estate values, and economic conditions generally and in the Company’s markets; and (ix) statements of assumptions underlying such statements. Words such as “believes,” “anticipates,” “expects,” “intends,” “targeted,” “continue,” “remain,” “will,” “should,” “may” and other similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements.
Forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those in such statements. Factors that could cause actual results to differ from those discussed in the forward-looking statements include, but are not limited to:
- our ability to assess, manage and improve our asset quality;
- the strength of the economy in our target market area, as well as general economic, market, or business factors;
- changes in the quality or composition of our loan or investment portfolios, including adverse developments in borrower industries, decline in real estate values in our markets, or in the repayment ability of individual borrowers or issuers;
- the impact of government intervention in the banking business;
- an insufficient allowance for loan losses;
- our ability to meet the capital expectations of our regulatory agencies;
- adverse reactions in financial markets related to the budget deficit of the United States government;
- changes in laws, regulations and the policies of federal or state regulators and agencies;
- changes in the interest rates affecting our deposits and our loans;
- the loss of any of our key employees;
- changes in our competitive position, competitive actions by other financial institutions and the competitive nature of the financial services industry and our ability to compete effectively against other financial institutions in our banking markets;
- our potential growth, including our entrance or expansion into new markets, the opportunities that may be presented to and pursued by us and the need for sufficient capital to support that growth;
- changes in government monetary policy, interest rates, deposit flow, the cost of funds, and demand for loan products and financial services;
- our ability to maintain internal control over financial reporting;
- our ability to raise capital as needed by our business;
- our reliance on secondary sources, such as Federal Home Loan Bank advances, sales of securities and loans, federal funds lines of credit from correspondent banks and out-of-market time deposits, to meet our liquidity needs;
- our ability to comply with the Written Agreement, which requires us to designate a significant amount of resources to complying with the agreement and may have a material adverse effect on our operations and the value of our securities;
- possible changes to our Board of Directors, including in connection with deferred dividends on our Capital Purchase Program preferred stock; and
- other circumstances, many of which are beyond our control.
Although the Company believes that its expectations with respect to the forward-looking statements are based upon reliable assumptions and projections within the bounds of its knowledge of its business and operations, there can be no assurance that actual results, performance, actions or achievements of the Company will not differ materially from any future results, performance, actions or achievements expressed or implied by such forward-looking statements. Readers should not place undue reliance on such statements, which speak only as of the date of this report. The Company does not undertake any steps to update any forward-looking statement that may be made from time to time by it or on its behalf.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selected Financial Information
|
|
Three months ended
|
|
Six months ended
|
|
|
|
(dollars in thousands, except per share data)
|
|
June 30,
|
|
June 30,
|
|
|
|
Statement of Operations
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
|
|
|
Interest and dividend income
|
|
$ 11,276
|
|
$ 12,860
|
|
$ 22,830
|
|
$ 25,558
|
|
|
|
Interest expense
|
|
2,985
|
|
3,803
|
|
6,089
|
|
7,693
|
|
|
|
Net interest income
|
|
8,291
|
|
9,057
|
|
16,741
|
|
17,865
|
|
|
|
Provision for loan losses
|
|
1,258
|
|
1,500
|
|
4,158
|
|
3,500
|
|
|
|
Net interest income after provision for loan losses
|
|
7,033
|
|
7,557
|
|
12,583
|
|
14,365
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service charges and fees on deposit accounts
|
|
790
|
|
845
|
|
1,559
|
|
1,780
|
|
|
|
Other operating income
|
|
199
|
|
278
|
|
487
|
|
661
|
|
|
|
Debit/credit card fees
|
|
361
|
|
409
|
|
680
|
|
733
|
|
|
|
Gain on sale of available for sale securities, net
|
|
832
|
|
129
|
|
3,363
|
|
322
|
|
|
|
Gain on sale of bank premises and equipment
|
|
–
|
|
–
|
|
–
|
|
256
|
|
|
|
Noninterest income
|
|
2,182
|
|
1,661
|
|
6,089
|
|
3,752
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and employee benefits
|
|
3,814
|
|
4,022
|
|
7,714
|
|
8,112
|
|
|
|
Occupancy and equipment
|
|
1,240
|
|
1,419
|
|
2,511
|
|
2,632
|
|
|
|
FDIC expense
|
|
587
|
|
931
|
|
1,175
|
|
1,428
|
|
|
|
Collection, repossession and other real estate owned
|
|
350
|
|
567
|
|
655
|
|
1,020
|
|
|
|
Loss on sale of other real estate owned
|
|
44
|
|
48
|
|
117
|
|
295
|
|
|
|
Impairment losses on other real estate owned
|
|
292
|
|
77
|
|
907
|
|
229
|
|
|
|
Other operating expenses
|
|
1,797
|
|
2,045
|
|
3,596
|
|
3,893
|
|
|
|
Noninterest expenses
|
|
8,124
|
|
9,109
|
|
16,675
|
|
17,609
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income taxes
|
|
1,091
|
|
109
|
|
1,997
|
|
508
|
|
|
|
Income tax expense (benefit)
|
|
243
|
|
(114)
|
|
335
|
|
(189)
|
|
|
|
Net income
|
|
$ 848
|
|
$ 223
|
|
$ 1,662
|
|
$ 697
|
|
|
|
Less: Effective dividend on preferred stock
|
|
375
|
|
374
|
|
750
|
|
748
|
|
|
|
Net income (loss) available to common shareholders
|
|
$ 473
|
|
$ (151)
|
|
$ 912
|
|
$ (51)
|
|
|
|
Income (loss) per common share: basic
|
|
$ 0.08
|
|
$ (0.03)
|
|
$ 0.15
|
|
$ (0.01)
|
|
|
|
diluted
|
|
$ 0.08
|
|
$ (0.03)
|
|
$ 0.15
|
|
$ (0.01)
|
|
|
|
Selected Ratios
|
|
|
|
|
|
|
|
|
|
|
|
Return on average assets
|
|
0.18%
|
|
-0.06%
|
|
0.17%
|
|
-0.01%
|
|
|
|
Return on average common equity
|
|
2.62%
|
|
-0.86%
|
|
2.53%
|
|
-0.15%
|
|
|
|
Net interest margin (tax equivalent basis)
|
|
3.35%
|
|
3.67%
|
|
3.40%
|
|
3.62%
|
|
|
|
Period End Balances
|
|
|
|
|
|
|
|
|
|
|
|
Loans, net of unearned income
|
|
$ 714,827
|
|
$ 752,467
|
|
$ 714,827
|
|
$ 752,467
|
|
|
|
Total assets
|
|
1,066,460
|
|
1,067,158
|
|
1,066,460
|
|
1,067,158
|
|
|
|
Total deposits
|
|
832,112
|
|
834,485
|
|
832,112
|
|
834,485
|
|
|
|
Total borrowings
|
|
130,832
|
|
132,433
|
|
130,832
|
|
132,433
|
|
|
|
Total capital
|
|
96,930
|
|
96,088
|
|
96,930
|
|
96,088
|
|
|
|
Shareholders’ equity
|
|
72,930
|
|
72,088
|
|
72,930
|
|
72,088
|
|
|
|
Book value per common share
|
|
12.11
|
|
12.04
|
|
12.11
|
|
12.04
|
|
|
|
Average Balances
|
|
|
|
|
|
|
|
|
|
|
|
Loans, net of unearned income
|
|
$ 717,860
|
|
763,261
|
|
$ 724,009
|
|
$ 767,450
|
|
|
|
Total earning assets
|
|
997,736
|
|
999,928
|
|
999,515
|
|
1,009,755
|
|
|
|
Total assets
|
|
1,065,662
|
|
1,073,688
|
|
1,067,824
|
|
1,084,766
|
|
|
|
Total deposits
|
|
831,425
|
|
842,031
|
|
833,935
|
|
853,177
|
|
|
|
Total borrowings
|
|
131,017
|
|
133,543
|
|
130,806
|
|
134,489
|
|
|
|
Total capital
|
|
96,547
|
|
94,033
|
|
96,527
|
|
92,844
|
|
|
|
Shareholders’ equity
|
|
72,547
|
|
70,033
|
|
72,527
|
|
68,844
|
|
|
|
Asset Quality at Period End
|
|
|
|
|
|
|
|
|
|
|
|
Allowance for loan losses
|
|
22,866
|
|
$ 26,753
|
|
$ 22,866
|
|
$ 26,753
|
|
|
|
Nonperforming assets
|
|
22,171
|
|
35,575
|
|
22,171
|
|
35,575
|
|
|
|
Net charge-offs
|
|
1,534
|
|
1,075
|
|
5,395
|
|
2,035
|
|
|
|
Net charge-offs to average loans
|
|
0.86%
|
|
0.57%
|
|
1.50%
|
|
0.53%
|
|
|
|
Allowance for loan losses to period end loans
|
|
3.20%
|
|
3.56%
|
|
3.20%
|
|
3.56%
|
|
|
|
Allowance for loan losses to nonaccrual loans
|
|
156.51%
|
|
116.97%
|
|
156.51%
|
|
116.97%
|
|
|
|
Nonperforming assets to total assets
|
|
2.08%
|
|
3.33%
|
|
2.08%
|
|
3.33%
|
|
|
|
Nonperforming assets to total loans and other real estate owned
|
|
3.07%
|
|
4.66%
|
|
3.07%
|
|
4.66%
|
|
|
|
Other Information
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares outstanding – period end
|
|
6,063,545
|
|
6,003,488
|
|
6,063,545
|
|
6,003,488
|
|
|
|
Average shares outstanding – basic
|
|
6,035,393
|
|
6,000,821
|
|
6,032,217
|
|
5,998,377
|
|
|
|
Average shares outstanding – diluted
|
|
6,035,393
|
|
6,000,821
|
|
6,032,217
|
|
5,998,377
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contact: Adam Sothen
Chief Financial Officer
Voice: (804) 443-8404
Fax: (804) 445-1047
SOURCE Eastern Virginia Bankshares, Inc.
DUBLIN, Calif., July 20, 2012 (GLOBE NEWSWIRE) — Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that Janssen-Cilag International NV was notified that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) granted a positive opinion recommending approval of DACOGEN® (decitabine) for Injection in the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukemia (AML), according to the World Health Organization (WHO) classification who are not candidates for standard induction chemotherapy. Janssen is the licensee for DACOGEN in territories outside of the United States, Canada and Mexico.
The CHMP is the committee responsible for the scientific assessment of products seeking centralized marketing authorization throughout the European Union. The CHMP’s positive opinion is now referred for approval to the European Commission. Janssen anticipates receiving the regulatory decision from the Commission in the end of the third quarter of 2012.
The CHMP positive opinion is based on data from the DACO-016 trial, the largest AML trial to date in this population of older patients. This randomized, open-label, multi-center phase 3 clinical trial compared DACOGEN versus patient’s choice with physician’s advice of either supportive care or low-dose cytarabine in patients 65 years and older with newly diagnosed de novo or secondary acute myeloid leukemia and poor- or intermediate-risk cytogenetics. DACOGEN was administered at 20 mg/m2 as a 1-hour intravenous infusion once daily for five consecutive days, repeated every four weeks, continued as long as the patient derived benefit. Key results from this study were published in the Journal of Clinical Oncology in June 20121.
“We are pleased to learn that the CHMP’s review of data from the DACO-016 trial has resulted in a positive recommendation for DACOGEN in this indication,” said James S.J. Manuso, PhD, chairman and chief executive officer of Astex Pharmaceuticals. “We look forward to the EMA’s decision later this year with the hope that clinicians and patients in Europe may soon have access to this treatment option.”
About Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is an aggressive, fast-growing cancer that starts inside the bone marrow with production of abnormal blood cells. It is generally a disease of older adults, with an average patient age of 64 at diagnosis, and is slightly more common among men than women. The most common symptoms of AML include tiredness, shortness of breath, bruising or bleeding easily, fever and infections. AML can sometimes spread to other parts of the body including the lymph nodes, liver and spleen. When diagnosed, treatment is to be started with minimal delay as AML usually results in death within just a few months if left untreated. In older adults, induction chemotherapy leads to a high 30-day mortality, and most patients are not candidates for or are unwilling to undergo this intensive therapy. Therefore, treatment options are limited and overall, irrespective of therapy, median survival is merely 2.4 months.
About DACOGEN (decitabine)
DACOGEN is a DNA hypomethylating agent currently approved for the treatment of myelodysplastic syndromes (MDS) in more than 30 countries worldwide including key markets such as the United States, Brazil, China, India, Korea, Russia and Turkey.
Janssen-Cilag International NV and its affiliates hold marketing and development rights for DACOGEN in all markets except the United States, Canada and Mexico, where rights are maintained by our partner, Eisai Inc. and its affiliates. These marketing rights flow from a worldwide license from Astex Pharmaceuticals to Eisai, Inc. Astex Pharmaceuticals receives royalties from the global sales of DACOGEN for any indication.
About Astex Pharmaceuticals
Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals co-developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.
For more information about Astex Pharmaceuticals, Inc., please visit http://www.astx.com.
The Astex Pharmaceuticals, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=12273
This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Astex Pharmaceuticals and its marketing partners. Risks and uncertainties include, but are not limited to, general industry conditions and competition; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of health care products and services; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; and increased scrutiny of the health care industry by government agencies. A further list and description of these risks, uncertainties and other factors can be found in the Astex Pharmaceuticals Annual Report on Form 10-K for the fiscal year ended December 31, 2011. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.astx.com or on request from Astex Pharmaceuticals. Astex Pharmaceuticals is not required to update any forward-looking statements as a result of new information or future events or developments.
Reference:
1 Kantarjian M., Thomas XG, Dmoszynska A, et al. Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia. J Clin Oncol. 10.1200/JCO.2011.38.9429
CONTACT: Timothy L. Enns
Astex Pharmaceuticals, Inc.
Senior Vice President
Corporate Communications & Marketing
Tel: (925) 560-2810
E-mail: tim.enns@astx.com
Alan Roemer
The Trout Group
Managing Director
Tel: (646) 378-2945
E-mail: aroemer@troutgroup.com
Susanna Chau
Astex Pharmaceuticals, Inc.
Manager
Investor Relations
Tel: (925) 560-2845
E-mail: susanna.chau@astx.com
Kari Watson
MacDougall Biomedical Communications
Senior Vice President
Tel: (781) 235-3060
E-mail: kwatson@macbiocom.com
System Designed to Showcase Lithium Ion Battery Energy Storage as a Fast, Accurate and Clean Resource for Facilitating the Increased Integration of Renewable Energy Generation onto China’s Power Grid
WALTHAM, Mass., July 20, 2012 (GLOBE NEWSWIRE) — A123 Systems (Nasdaq:AONE), a developer and manufacturer of advanced Nanophosphate® lithium iron phosphate batteries and systems, today announced that it will supply a 2MW grid energy storage system to Ray Power Systems Co. Ltd., a Chinese company focused on developing the frequency regulation market and relevant technologies.
“The project in China will be designed to validate the technical capabilities and benefits of energy storage as a fast-ramping, accurate and clean resource for providing frequency regulation services,” said Eldon Mou, CEO of Ray Power. “Limited overall system ramping capability has created renewable integration issues as well as potential risk of grid instability because of the high penetration of renewable generation, particularly in northern China. A123 Systems has demonstrated the viability and reliability of its product through a number of successful global commercial deployments, and we expect this project to showcase energy storage as a valuable resource for meeting China’s growing frequency regulation demand.”
“We believe that China represents a large market opportunity for our energy storage technology, including as a solution to address the ramp-management challenges associated with the increased deployment of wind and other renewable energy generation assets,” said Robert Johnson, vice president of the Energy Solutions Group at A123. “Today’s announcement builds on our progress in China and is a significant step toward proving the capability of our technology for providing frequency regulation in China. Ray Power has a deep understanding of China’s power market and of energy storage technologies and has developed a set of comprehensive solutions for deploying energy storage to capitalize on this growing opportunity, so we look forward to success in this initial deployment and believe it could lead to additional projects going forward.”
About A123 Systems
A123 Systems, Inc. (Nasdaq:AONE) is a leading developer and manufacturer of advanced lithium-ion batteries and energy storage systems for transportation, electric grid and commercial applications. The company’s proprietary Nanophosphate® lithium iron phosphate technology is built on novel nanoscale materials initially developed at the Massachusetts Institute of Technology and is designed to deliver high power and energy density, increased safety and extended life. A123 leverages breakthrough technology, high-quality manufacturing and expert systems integration capabilities to deliver innovative solutions that enable customers to bring next-generation products to market. For additional information, please visit www.a123systems.com.
The A123 Systems, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6600
Safe Harbor Disclosure
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including statements with respect to the deployment and the project’s commencement of operations, the progress of energy policy in China, the market conditions and opportunities in China for energy storage technology, including ancillary services, the capability of A123’s technology to provide frequency regulation in China, the expected performance of A123’s solutions and the possibility of future projects with Ray Power. Among the factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: changes or delays in Ray Power’s development and implementation of the A123’s products, delays or inability of A123’s solutions or other aspects of the energy storage project to meet their intended goals and objectives, the ability of A123’s energy storage systems to manage frequency regulation requirements of the power network, delays in customer and market demand for Ray Power’s products and services, delays in the implementation of A123’s solutions, delays in the development, production and delivery of A123’s products and solutions, revalidation and increased efficiency of A123’s manufacturing capacity, delays in A123’s manufacturing ramp, the potential for manufacturing defects, failure of A123’s cells to achieve their expected performance, capabilities, benefits, cost reductions and technical advantages, adverse economic conditions in general and adverse economic conditions specifically affecting the markets and geographies in which A123 and Ray Power operate and other risks detailed in A123 Systems’ quarterly report on Form 10-Q for the quarter ended March 31, 2012 and other publicly available filings with the Securities and Exchange Commission. All forward-looking statements reflect A123’s expectations only as of the date of this release and should not be relied upon as reflecting A123’s views, expectations or beliefs at any date subsequent to the date of this release.
CONTACT: A123 Systems PR Contact:
A123 Systems
Dan Borgasano
617-972-3471
dborgasano@a123systems.com
A123 Systems IR Contact:
ICR, LLC
Garo Toomajanian
617-972-3450
ir@a123systems.com
Velti (NASDAQ: VELT), the leading global provider of mobile marketing and advertising technology, today shared the results of a nationwide poll showing 40 percent of those who plan to follow the Olympics this summer will do so on two or more devices. The results also revealed that 35 percent of U.S. adults will turn to their tablet for news and coverage, while 27 percent will use their smartphone. The study was commissioned by Velti and conducted online by Harris Interactive® in June among 2,088 U.S. adults.
Among those turning to smartphones or tablets to track the games, online browsers trump application usage on both devices. Of those using a smartphone who will follow the Olympics, 77 percent will tune in using a browser (reading articles/blogs, viewing video clips, streaming live coverage or via social networking sites) while 63 percent will use an app (specifically designed for Olympics coverage, general news app or social networking app) for updates. Among tablet users, 80 percent will use a browser and only 58 percent will utilize apps.
Of those using a smartphone to follow the games, 45 percent will access video clips and replays, while 41 percent plan to stream live coverage via a browser. Fifty percent of tablet users will watch videos and replays on their browser, while 45 percent will stream live coverage. This is the first year the Olympic Games will stream all 32 sports live.
“This survey reveals that a significant number of Americans are choosing to consume Olympic content on the go, and while doing so they’re overwhelmingly turning to mobile browsers,” said Krishna Subramanian, Chief Marketing Officer of Velti. “Further, the Olympic audience is becoming more fragmented. For brands that want to reach Olympic viewers, this is an important finding as it highlights the ability to look beyond TV and focus on secondary devices such as smartphones and tablets.”
Of those who plan to follow the games on two or more devices, younger adults are more likely than their older counterpoints to do so. Of those 18 – 44 years old, 44 percent plan to use two or more devices while only 34 percent of those age 55+ plan to. Fourteen percent of U.S. adults who will follow the Olympic games will do so by using 3 or more devices. Overall, men are more likely than women to follow the games on three or more devices (18% vs. 11%, respectively).
Additional interesting findings:
- Of those who will follow the Olympics this summer: 36 percent will follow the games on a TV and a computer; 11 percent will use a TV and their smartphone; 10 percent will use a computer and their smartphone.
- A significant amount (39%) of U.S. adults using their smartphones to follow the games will also be doing so by communicating with their peers via talk and/or text. Thirty-two percent plan to text with others about the Olympics, and 21 percent will talk on the phone with others about the Olympics.
- Overall, among men between the ages of 18-34, 83 percent plan to follow the Olympics at all, vs. only 71 percent of females in the same age group.
Survey Methodology
This survey was conducted online within the United States by Harris Interactive on behalf of Velti from June 29-July 3, 2012 among 2,088 adults ages 18 and older. This online survey is not based on a probability sample and therefore no estimate of theoretical sampling error can be calculated. For complete survey methodology, including weighting variables, please contact Victoria Krammen at vkrammen@sutherlandgold.com.
About Velti
Velti is the leading global provider of mobile marketing and advertising technology and solutions that enable brands, advertising agencies, mobile operators and media to implement highly targeted, interactive and measurable campaigns by communicating with and engaging consumers via their mobile devices. The Velti platform, called Velti mGage™, allows customers to use mobile and traditional media to reach targeted consumers, engage the consumer through the mobile Internet and applications, convert them into customers and continue to actively manage the relationship through the mobile channel. Velti is a publicly held corporation based in Jersey, and trades on the NASDAQ Global Select Market under the symbol VELT. For more information, visit www.velti.com.
About Harris Interactive
Harris Interactive is one of the world’s leading market research firms, leveraging research, technology, and business acumen to transform relevant insight into actionable foresight. Known widely for the Harris Poll® and for pioneering innovative research methodologies, Harris offers proprietary solutions in the areas of market and customer insight, corporate brand and reputation strategy, and marketing, advertising, public relations and communications research. Harris possesses expertise in a wide range of industries including health care, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer package goods. Additionally, Harris has a portfolio of multi-client offerings that complement our custom solutions while maximizing our client’s research investment. Serving clients in more than 215 countries and territories through our North American and European offices, Harris specializes in delivering research solutions that help us – and our clients – stay ahead of what’s next. For more information, please visit www.harrisinteractive.com.
Represents Growth of Marine Hoist, Leasing and Service Business
BEIJING, July 19, 2012 /PRNewswire-Asia/ — Wowjoint Holdings Limited (“Wowjoint,” or the “Company”) (Nasdaq: BWOW, BWOWU, BWOWW), China’s innovative infrastructure solutions provider of customized heavy duty lifting and carrying machinery, today announced that it has entered into three contracts for projects and services in China.
Wowjoint entered into a contract with Zhejiang Xiangshan Fishing Trade Development Co., Ltd. for the sale of a 25 ton marine hoist. This hoist will be used for lifting smaller boats and is an extension of the yacht market that Wowjoint entered last year. The contract value is approximately $250,000 (RMB 1,600,000).
In addition, the Company entered into a leasing contract with No.1 Engineering Co., Ltd. of China Railway 25th Bureau Group. This leasing contract is to provide a 900-ton special launching carrier, Wowjoint’s proprietary product. The term of the lease is 10 months, beginning on August 1, 2012. The total payable by the customer under this contract is approximately $930,000 (RMB 5,900,000).
Wowjoint also entered into a service contract with 2nd Bureau of China Railway Co. Ltd., who commissioned Wowjoint to lift 37 rail bridge sections using one of Wowjoint’s 900-ton special launching carriers. Service will commence on August 15, 2012. The total value of the contract is approximately $850,000 (RMB 5,400,000).
“We’re very pleased with our recent orders from China,” stated Mr. Yabin Liu, Chief Executive Officer of Wowjoint. “These new contracts, in addition to the recent contracts we entered with customers from Malaysia and Peru, demonstrate Wowjoint’s continued pursuit of diversifying its revenue stream. We are pleased to see an improvement in the domestic Chinese market and we will continue to explore new markets to attain new contracts. We believe our world-class products and services, strong client relationships and our ability to provide unique solutions to our customers will help Wowjoint to continue to make considerable progress in the international markets, as well as in China.”
About Wowjoint Holdings Limited
Wowjoint is a leading provider of customized heavy duty lifting and carrying machinery used in large scale infrastructure projects such as railway, highway and bridge construction. Wowjoint’s main product lines include launching gantries, tyre trolleys, special carriers, marine hoists and special purpose equipment. The Company’s innovative design capabilities have resulted in patent grants and proprietary products. Wowjoint believes it is well-positioned to benefit directly from China’s rapid infrastructure development by leveraging its extensive operational experience and long-term relationships with established blue chip customers. Information on Wowjoint’s products and other relevant information are available on its website at http://www.wowjoint.com.
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements in this press release include matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Wowjoint undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after the date of this communication. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this communication. All forward-looking statements are qualified in their entirety by this cautionary statement. All subsequent written and oral forward-looking statements concerning Wowjoint or other matters and attributable to Wowjoint or any person acting on their behalf are expressly qualified in their entirety by the cautionary statements above. Wowjoint does not undertake any obligation to update any forward-looking statement, whether written or oral, relating to the matters discussed in this news release.
For additional information contact:
Wowjoint Holdings:
Aubrye Foote, Vice President Investor Relations
Tel: +1-530-475-2793
Email: aubrye@wowjoint.com
Website: www.wowjoint.com
SOURCE Wowjoint Holdings Limited

NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that its Chief Medical Officer was interviewed by KIDELA TV, a financial news network. The interview is available at: http://www.youtube.com/watch?v=6xY0jmYk44M&feature=youtu.be
In the interview, Dr. Snow discusses some of the complications of diabetes including diabetic peripheral neuropathy or DPN. DPN is the most common chronic complication of diabetes affecting over 50% of people with diabetes. It can lead to costly and debilitating foot ulcers and, ultimately, to amputation. Early detection provides the opportunity for clinical intervention and behavior modification which may moderate the effects of DPN. NeuroMetrix markets a medical device, NC-stat® DPNCheck™, which provides a fast, accurate, quantitative and cost effective test for the early detection of systemic neuropathies, such as DPN.
Dr. Snow, a practicing endocrinologist, notes that NC-stat DPNCheck is a significant advance over the tools historically available for detection of DPN. These tools include the monofilament and the tuning fork which detect DPN only at a late stage where a patient may already have lost protective sensation in his feet. Dr. Snow also comments on the correlation between DPN and risk of cardiac disease, as well as on the benefits in reinforcing patient compliance.
Dr. Snow has extensive experience in the field of diabetes, including patient care and clinical research. Prior to joining NeuroMetrix, he spent the 17 years at the Joslin Diabetes Center in Boston, MA which is affiliated with Harvard Medical School and is considered the world’s oldest and most respected diabetes care facility. Most recently, Dr. Snow was Director of Medical Programs at the Joslin Center for Strategic Initiatives and previously was Acting Chief of the Adult Diabetes Section at the Joslin. Dr. Snow also holds an appointment as Assistant Professor of Medicine at Harvard Medical School.
A business profile of NeuroMetrix is available at: http://www.kidela.com/members/neurometrix45/
About NeuroMetrix
NeuroMetrix is an innovative medical device company that develops and markets home use and point-of-care devices, associated consumables, and support software for the treatment and management of diabetes and its complications. The company is focused on nerve related complications of diabetes, called diabetic neuropathies, which affect over 50% of people with diabetes. If left untreated, diabetic neuropathies trigger foot ulcers that may require amputation, cause disabling chronic pain, and increase the risk of falling in the elderly. The annual cost of diabetic neuropathies has been estimated at $14 billion in the United States. The company’s products are used by physicians and other clinicians, in retail health settings such as pharmacies, and by managed care organizations to optimize patient care and reduce healthcare costs. The company markets the NC-stat® DPNCheck™ device, which is a rapid, accurate, and quantitative point-of-care test for diabetic neuropathy. This product is used to detect diabetic neuropathy at an early stage and to guide treatment. The company is in late stage development of SENSUS™, a pain management device. The company has additional therapeutic products in its pipeline. For more information, please visit http://www.neurometrix.com.
NORTHBROOK, Ill., July 19, 2012 (GLOBE NEWSWIRE) — Nanosphere, Inc. (the “Company”) (Nasdaq:NSPH), a leader in the development and commercialization of advanced molecular diagnostics systems, today announced the pricing of its previously announced underwritten public offering of 10,500,000 shares of its common stock at a public offering price of $2.40 per share. In connection with the offering, the Company has also granted the underwriters a 30-day option to purchase up to an additional 1,575,000 shares of common stock to cover over-allotments, if any. Piper Jaffray & Co. is acting as the sole book-running manager and Roth Capital Partners is acting as co-manager for the offering.
Net proceeds from the sale of the shares after underwriting discounts and commissions and other offering expenses are expected to be approximately $23.4 million. If the underwriters exercise their over-allotment option in full, net proceeds from the offering will be approximately $26.9 million. The offering is subject to customary closing conditions and is expected to close on Tuesday, July 24, 2012.
The Company plans to use the net proceeds from the offering for general corporate purposes and working capital.
The offering was made pursuant to a prospectus supplement to the Company’s prospectus, dated September 15, 2009, filed as part of the Company’s effective $100 million shelf registration statement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
Copies of the preliminary prospectus supplement and accompanying prospectus relating to these securities may be obtained by contacting Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402 or by telephone at 800-747-3924 or by email at prospectus@pjc.com.
About Nanosphere, Inc.
Nanosphere develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene® System, for detection of life threatening infections and cardiovascular diseases. This easy to use and cost effective platform enables simple, low cost and highly sensitive genomic and protein testing on a single platform. Nanosphere is based in Northbrook, IL. Additional information is available at http://www.nanosphere.us.
The Nanosphere, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4344
Except for historical information, the matters discussed in this press release are “forward-looking statements” and are subject to risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, the following: (i) Nanosphere’s ability to develop commercially viable products; (ii) Nanosphere’s ability to achieve profitability; (iii) Nanosphere’s ability to produce and market its products; (iv) Nanosphere’s ability to obtain regulatory approval of its products; (v) Nanosphere’s ability to protect its intellectual property; (vi) competition and alternative technologies; and (vii) Nanosphere’s ability to obtain additional financing to support its operations. Additional risks are discussed in the Company’s current filings with the Securities and Exchange Commission. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. The forward-looking statements are made as of the date of this press release, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
CONTACT: Investors:
Nanosphere, Inc.
Roger Moody, 847-400-9021
Chief Financial Officer
rmoody@nanosphere.us
or
Media
The Torrenzano Group
Ed Orgon, 212-681-1700
ed@torrenzano.com